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Part I The cross-sectional study
Objectives To examine the effects of high intensity physical exercise and
menstrual irregularity on the bone mineral density (BMD) of both weight-bearing and
non weight-bearing skeletal sites in female athletes aged 16-65 years and to
determine whether intensive weight-bearing exercise can offset bone loss associated
with athletic amenorrhoea at appropriate sites.
To assess the influence of morphological characteristics and fitness parameters on
BMD in all age groups and to determine whether abnormal eating habits in younger
athletes influences BMD.
Subjects The 124 athletes were divided into 3 groups:
Group A 50 middle or long-distance runners aged 16 to 35 years who ran at
least 25 miles per week and trained for at least 3 hours per week.
Group B 50 premenopausal veteran athletes aged 40 years and over who were
required to have run at least 15 miles per week or trained for at least 3
hours per week for the last three years.
Group C 24 postmenopausal veteran athletes who also were required to have
run at least 15 miles per week or trained for at least 3 hours per week
for the last three years.
Methods Bone mineral density of lumbar spine (L2-L4) and left proximal femur
was measured by Dual Energy X-Ray absorptiometry (DXA) and values were
compared between groups and with the European reference range. Morphological
measurements included weight, height, body mass index, percentage body fat, fat free
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mass. Fitness measurements included maximal oxygen uptake and utilisation
(V02max), back strength and grip strength. Eating disorders were assessed using the




Group A comprised top class runners who ran an average of 49 miles per week. The
group was subdivided into athletes who were amenorrhoeic (0-3 menstrual cycles per
year, AM, n=24), oligomenorrhoeic (4-9 cycles per year, OL, n=9) and
eumenorrhoeic (10 - 13 cycles per year, EU, n=17). Bone mineral density was very
low in the lumbar spine in the AM group when compared to the EU group (15.6%
lower, p<0.0001). Surprisingly, BMD of the proximal femur was also significantly
lower in the AM group (16.5 - 19.5% lower compared to the EU group, p<0.0001).
Bone density of the OL group lay between the two other groups.
When compared to the age-matched European reference range, BMD was again
significantly lower than expected in the AM group (p<0.05 - p<0.001). In all three
groups, BMD was higher at both sites in the proximal femur than in the lumbar spine,
reflecting a positive influence of mechanical stress on BMD in this weight-bearing
area. In the athletes who had always menstruated regularly, the benefits of regular
running on BMD in weight-bearing bones were demonstrated. In this group BMD
was high in the proximal femur but not the lumbar spine compared to the European
reference range (p<0.005).
Height and weight were consistent independent predictors of BMD in the AM group
but not the other groups. Eating disorders were common in the AM group in which
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more than 50% were found to have some aspect of disordered eating habits, and poor
scoring in the EAT26 was associated with low weight..
Group B was subdivided into athletes who had trained continuously since leaving
school (All-timers, AT, n= 23) and those who had started after the age of 30 years
(late-starters, LS, n=27). Each group was also divided according to whether they had
been continuously eumenorrhoeic (EU) or whether they had had at least two years of
prior menstrual irregularity (AM). Most of the athletes were long-distance runners or
walkers and the average distance run per week was 32 miles. There were no
significant differences between the AT and LS groups in bone density at the sites
measured, but both groups showed high bone density compared to the European
reference range (p<0.025-0.005). Late-starters showed particularly high values in the
femoral neck suggesting that even if exercise is commenced after the age of peak bone
mass, significant benefits can be achieved.
Those who had remained continuously eumenorrhoeic had particularly high bone
density with values 0.4-1.05 SDs above the European age-matched mean. Those who
had suffered 1 or more episodes of menstrual irregularity showed smaller benefits in
the femur and none in the spine.
Group C was also subdivided as above into all-timers (AT, n=10) and late-starters
(LS, n=14). Almost all were long-distance runners and the group ran an average of
30.6 miles per week. There were no significant differences in BMD at any site
measured between the AT and LS groups. Nor was BMD in either group different
from the European reference range matched for years since menopause (YSM). Bone
density (adjusted for YSM) of the proximal femur was associated with weight, body
mass index (BMI) and percentage body fat (p<0.05) There were no such associations
with spinal BMD. Low weight, BMI and percentage fat were associated with high
9
aerobic capacity (VC^max). It is postulated that intensive aerobic exercise in the
postmenopausal years may be disadvantageous to the skeleton by reducing weight and
body fat levels. Less intensive or alternative types of exercise may have more
beneficial effects on bone mineralisation
Conclusions Bone density at important fracture sites was substantially greater than
expected in women undertaking long-term exercise in the oestrogenized state whether
exercise started in the 'teens or the thirties. When endogenous oestrogen levels are
low, the apparent beneficial effects of exercise are lost. In postmenopausal women
this may be due to low body weight and body fat in those who are the most highly
trained. Amenorrhoea in young adult life may have persistent effects on non weight-
bearing sites. Individual circumstances must be assessed before exercise can be used
as a prescription for the prevention of osteoporosis.
Part 2 Theprospective study
Randomised prospective study of the effects of hormone replacement therapy and
calcium on bone mineral density in oligo- and amenorrhoeic runners
Objective
To examine the effects of hormone replacement therapy (HRT) and calcium
supplementation on bone mineral density in female runners aged 18-35 years who
had menstrual irregularity.
Method
34 middle and long-distance runners with either oligomenorrhoea or amenorrhoea
induced by intensive exercise were randomised to receive A) HRT and lOOOmg
calcium daily, B) lOOOmg calcium daily and C) no treatment, over 18 months. Bone
mineral density of lumbar spine and proximal femur was measured by DXA.
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Results
Over the first year of treatment there was no difference between the groups in BMD
although the trend was for increased BMD in those receiving HRT. When analysed
according to whether oestrogen levels had normalised either with resumption of
regular mentruation or with HRT, BMD increased in all areas whereas in those who
remained amenorrhoeic BMD declined in all areas. The differential change between
the 2 groups was significant in all areas except the neck of femur. Only 17 athletes
returned for the second follow-up appointment at 18 months and numbers were
therefore insufficient for further analysis.
Conclusion
Normalisation of oestrogen levels either by resumption of regular mentruation or by
HRT appears to result in an increase in BMD at least over the short term. Larger




Many studies have demonstrated higher bone density in young adults who regularly
exercise. The relationship between exercise and bone mineral density (BMD) is marked
in athletes (Heinrich et al., 1990, Risser et al., 1990, Wolman et al., 1991, Slemenda et
al., 1993) but has also been demonstrated in the general population in those with high
levels of normal daily activity (Aloia et al., 1988, Zylstra et al., 1989, Jonsson et al.,
1992, Zhang et al, 1992). At one time it was expected that the more intense the
exercise, the greater the bony response but during the last ten years it has become clear
that, in some young women, intensive athleticism is associated with low BMD (Cann et
al., 1984; Drinkwater et al., 1984; Marcus et al., 1985, Nelson et al., 1986; Lindberg et
al., 1987; Wolman et al., 1990). Such changes in BMD are linked to profound
alterations in the hypothalamic-pituitary-ovarian axis resulting in menstrual irregularity
such as oligomenorrhoea and amenorrhoea. Although these conditions were initially
thought to be relatively benign, it is now known that these hypo-oestrogenic states are
associated with reduced bone density. Some regions of the skeleton, for instance the
vertebral bodies, may be as much as 25% lower in BMD in amenorrhoeic women
compared to their eumenorrhoeic peers. In the short term, musculoskeletal injuries are
more common (Lloyd et al., 1986) and concern has arisen that in the long-term there
may be a risk of clinical osteoporosis and fracture. Attention has focused on the causes
of athletic amenorrhoea in an effort to find ways of reducing its incidence without
reducing athletic performance. A greater understanding will also enable sports personnel
and physicians to advise more precisely on types and intensity of exercise which will
avoid adverse effects on BMD.
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The role of exercise in developing peak bone mass, maintaining bone mineral during the
premenopausal years and then in the prevention of postmenopausal bone loss appears to
be complex. For this and other public health reasons, the promotion of increasing
amounts of moderate regular exercise throughout the population now has high priority,
but there is uncertainty about how much exercise is moderate and what type of exercise
should be proposed. This thesis examines the effect of regular exercise on bone density
in four parts:
1) the effect of exercise and menstruation on bone density in young athletes
2) the effect of exercise and menstruation on bone density in women in the decade
before the menopause
3) the effect of exercise on bone density in postmenopausal women
4) a pilot study on the treatment of reduced bone density in young amenorrhoeic
athletes.
The null hypotheses tested were:
1) Regular exercise has no effect on bone mineral density of the lumbar spine and
proximal femur in female athletes of any age






Bone metabolism in the general population
Bone mass continues to increase after the closure of the endochondral growth plates
and reaches a peak during the second and third decades. Teegarden et al, (1995)
estimated that by the age of 22.1 +/- 2.5 years, 99% of peak bone mineral density
(PBMD) is attained and by the age of 26.2 +/- 3 .7 years, 99% of peak bone mineral
content (PBMC) is achieved.. In women, factors contributing to the attainment of
PBMC include genetic disposition (Hansen et al., 1992, Krall et al., 1993), race (Harris
et al., 1995), physical activity (Slemenda et al., 1994, Valimaki et al., 1994), calcium
intake (Matkovic et al, 1979, Nieves et al., 1995) body mass (Rice et al., 1993,
Slemenda etal., 1994, Valimaki etal., 1994, Teegarden et al, 1995), alcohol, smoking,
medications and underlying disease. Between the ages of 18 and 21, after longitudinal
growth ceases, the skeleton goes through a period of consolidation during which it
becomes less metabolically active, remodelling driven by osteoclastic resorption reduces
and, as a consequence, a moderate amount of additional bone mineral is added to the
skeleton by the filling in of remodelling cavities ( Parsons et al, 1996).
After the mid-twenties there follows a period of relative stability in bone density until
the age of thirty-five to forty years. From then (until the menopause in women) there is
normally a slow decline in BMD of some regions of the skeleton, notably the femoral
neck (Pearson et al., 1995), but not others (Dequeker et al., 1995). Normally, spinal
bone mineral density is stable over this period. .
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During the perimenopausal and immediate postmenopausal years there is a phase of
accelerated bone loss throughout the skeleton which may initially be as high as 8% per
year in trabecular bone (Gotffedson et al., 1986, Reeve et al, 1995). Ravn et al. (1994)
found that the decrease in BMD of the proximal femur reached values of 9 - 13% in the
first 5 years after the menopause. In the spine, bone loss initially averages 3% annually
as assessed by dual energy photon or X-ray absorptiometry, but this loss rate is
attenuated to only about 1% annually some five years later (Reeve at al, 1995). In
Japanese women a decrease in spinal BMD of 20% has been found within 10 years of
the menopause. Beyond 10 years the rate of spinal bone loss appears to be very low
(Soda et al., 1993, Greenspan et al., 1994). Similarly, in the femur, the rate of loss of
bone mineral slows again within 10 years of the menopause to a background 0.5 - 1.0%
(Greenspan et al., 1994, Ravn et a/., 1994) until old age when it may again start to
accelerate in the femur (Jones et al., 1994).
Thus, two types of bone loss seem to occur during the lifetime of a woman. Firstly,
from the fourth decade onwards there is a very gradual age-related loss of bone mineral
which appears to occur in both cortical and trabecular type of bone. The mechanism by
which age-related bone loss is mediated is unknown but it has been likened to the
gradual decline in other organs such as muscle mass. Men may suffer from a similar type
of bone loss to this first type. In women, at the menopause and for 5 to 10 years
afterwards, there is an additional accelerated rate of bone loss which is most marked in
trabecular bone. Treatment with oestrogen-containing products at the menopause
reduces or eliminates the accelerated loss of bone mineral at this time (Gotfredson et
al., 1986, Riis et al., 1987) and it is now accepted that the loss of bone mineral is
directly linked to falling sex hormone levels (particularly oestrogen) at the menopause.
It follows that for a given rate of postmenopausal bone loss, the higher the bone mass at
the menopause, the less likely that bone density will fall low enough in later years to
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result in osteoporotic fracture (Black et al., 1992). An understanding of factors
contributing to high bone density is therefore important.. Kroger et al., (1995)
estimated that perimenopausal women in the lowest quartile of spinal BMD had a 2.9
times greater risk of fracture than those in the highest quartile. The respective risk for
femoral fracture was 2.2 times from the lowest to the highest quartile. Similarly,
Cummings et al., (1993) followed more than 8000 women aged 65 years or over for
approximately 2 years and found that bone densities of all regions of the hip were
closely related to the risk of hip fracture.. Women in the lowest quartile of femoral neck
BMD had an 8.5 times greater risk of fracture than those in the highest quartile. For
each standard deviation decrease in femoral neck BMD, the increased fracture risk was
2.6 and in the lumbar spine it was 1.6. These findings have been confirmed ina recent
meta-analysis of similar studies (Marshall et al., 1996). Also, Cummings et al.,
suggested that a one SD decrease in femoral neck BMD was associated with an increase
in risk of hip fracture equivalent to a 14.5 year increase in age. However it is now clear
that rates of bone loss vary rather unpredictably in postmenopausal women so that a
measurement of BMD made at menopause may not accurately predict risk 10 or 20
years later (Hui et al 1990).
Bone mineral density of the spine and femur has been shown to be correlated with
muscle strength (Pocock et al., 1989), most reports of such relationships concerning
older non-athletic women. Sinaki et al. (1989) found a significant positive relationship
between BMD of the lumbar spine and back extensor strength in postmenopausal
women which held true even after adjustment for age. In a large study of 709 and 1080
elderly men and women respectively, quadriceps strength was found to predict bone
density in the proximal femur in men only (Nguyen et al., 1994). However when age
and weight-adjusted BMD of the femoral neck was analysed, in tertiles of muscle
strength and calcium intake, those in the highest tertiles had approximately 5% greater
bone density than those in the lowest tertiles. This was true for both men and women.
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In younger women, femoral neck and spinal BMD have been found to correlate with
both quadriceps and hamstring and trunk extensor strength (Eickoff et al. 1993). Grip
strength has been found to correlate well not only with forearm BMD but also with
BMD at distal sites in elderly women (Bevier et a/., 1989, Kritz-Silverstein & Barrett-
Connor, 1994). It is likely that in this group of women at least, grip strength reflects
habitual level of daily activity. It should be remembered that such associations do not
necessarily imply causality.
Much interest has naturally centred on factors governing the attainment of maximal
potential peak bone density, maintenance of bone density in the premenopausal years
and on the minimisation of the post-menopausal loss of bone mineral. Encouraging
higher levels of physical activity within the general population might go some way
towards reducing the fracture epidemic, particularly in the elderly (Cooper, 1995) but
advice must be specific and capable of being complied with for it to be readily practical.
In the future, long-term prospective randomised studies on exercise will hopefully
provide the required information. In the meantime, studies on athletes show what can be
achieved with relatively high levels of exercise.
Section 2
The effect of exercise and mechanical forces on bone
Julius Wolff (1892) first suggested that bone responds to mechanical stress to increase
strength at areas of high strain. Ground reaction forces during weight-bearing activity
are therefore likely to provide a suitable stimulus for bone remodelling. Indeed, it is well
recognised that immobility due for example to bedrest, spinal cord injury or
weightlessness (in space) are associated with rapid and sometimes, profound losses in
bone mineral.
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However, the mechanical strain concept of bone remodelling suggests that mechanical
stress applied to bone will stimulate increased bone mass at that site even in the absence
of ground reaction forces. This is supported by studies on non weight-bearing bones.
National level Finnish squash players had 15 .6% greater BMD in the humerus of the
playing side compared to the non-playing side (Haapasalo et al., 1994) and in tennis
players, BMD is higher in the dominant arm than the non-dominant side (Dalen et al.,
1985; Pirnay et al., 1987). In a study of National level female rowers and non-rowing
athletes, back strength was greater in both flexion and extension in the rowers and bone
density of the lumbar spine was correspondingly higher in this group even when
adjusted for body weight (Wolman et al., 1990).
The number and weight of loading cycles applied to bone are probably as important as
the type of exercise undertaken. Rubin and Lanyon (1984) and Lanyon (1996) have
shown that, in experiments with some animal models, a maximal adaptive response can
be engendered by a very small number of cycles of increased strain with no additional
benefit gained by increasing the number of loading cycles providing the peak strain
achieved was sufficiently high. Frost's 'Mechanostaf theory of bone remodelling
requires that a minimum effective strain must be exceeded in order to initiate the
modelling process and thus promote an increase in bone mass driven by increased bone
formation (Frost, 1992). This suggests that the mechanical adaptability of bone is best
suited to respond to dynamic events of short duration and high intensity rather than low
intensity activities repeated over a long period of time. If this applies in humans one
might expect higher bone density in those performing short duration, high load exercise
than in those involved in predominantly aerobic, low intensity exercise.
Until recently the means by which mechanical strain is perceived by bone and converted
into messages controlling bone remodelling has been little understood. Recent work has
shown that one type of bone cell, the osteocyte, can perceive the application of
mechanical forces. Osteocytes are found in lacunae in bone and communicate with one
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another and with other cells in bone by means of dendritic processes which traverse the
canaliculi of bone. It is thought that nutrients and signalling molecules are carried by
'streaming' of the extracellular fluid and changes are detected by the osteocyte. This
mechanism is enhanced by minute deformations of the bone matrix of the order of 0.2%
(cortical bone) or 0.5% (trabecular or cancellous bone) (Lozupone 1996).
The mechanism by which osteocytes promote bone formation and resorption at selected
locations is less clear. El Haj et al., (1990) have demonstrated that after mechanical
stimulation there is a rapid, transient increase in the enzyme glucose 6-phosphate
dehydrogenase followed by a more prolonged production of prostaglandins which can
promote both bone formation and bone resorption in different circumstances. Bone
resorption is inhibited by repeated deformations of as little as 200-400 pstrain (0.02-
0.04%) (Lanyon 1990), whereas strains capable of promoting bone formation need to
be 10 fold larger. This level of activity in humans in most likely to be acheived by
children or athletes, particularly those performing strength exercises.
Until recently it was felt that the activity in cells involved in bone resorption
(osteoclasts) was closely 'coupled' with the cells which form new bone (osteoblasts). In
this way new bone formation followed bone resorption, with osteoclasts and osteoblasts
working together in teams (Eriksen 1986). However it is now known that in some
situations, cells lining the mineral matrix of bone can transform back into osteoblasts
without associated activity in osteoclasts. It is possible that this occurs after mechanical





BMD of the femur, pelvis, tibia and os calcis have all been shown to be high in athletes
undertaking weight-bearing sport (Heinrich et aI., 1990, Risser et al., 1990, Wolman et
al., 1991, Slemenda et al., 1993) when compared to sedentary controls. Of all sports,
weight-lifting is likely to provide the greatest stimulus to increase bone formation in the
spine. Granhed et al., (1987) calculated that the load applied to the third lumbar
vertebra during a single dead lift during the mens' World Championships in Power
Lifting was as high as 36.4 kN. Bone mineral content of the lumbar spine was
extremely high in the lifters compared to age and weight-matched sedentary controls
(7.06, SD 0.87 g.cm"1 vs. 5.18, SD 0.88 g.cm"1). There was also a close correlation
between the estimated annual weight lifted and BMC. Similar results were found by
Conroy et al., (1993) and Virvidakis et al. (1990), in elite junior weight-lifters. Studies
comparing women who lift weights with those who run, swim or cycle have found that
BMD is significantly higher in the lifters compared to sedentary control groups and the
other exercisers (Davee etal., 1990, Heinrich et al., 1990, Heinonen et al., 1993).
Bone mineral density of the spine and femur has been shown to be correlated with
muscle strength (Pocock et al., 1989) though most reports of such relationships concern
older non-athletic women. Sinaki and Offord (1988) found a significant positive
relationship between BMD of the lumbar spine and back extensor strength in
postmenopausal women which held true even after adjustment for age. In a large study
of 709 and 1080 elderly men and women respectively, quadriceps strength was found to
predict bone density in the proximal femur in men only (Nguyen et al., 1994). However
when age and weight-adjusted BMD of the femoral neck was analysed, in tertiles of
muscle strength and calcium intake, those in the highest tertiles had approximately 5%
greater bone density than those in the lowest tertiles. This was true for both men and
women. In younger women, femoral neck and spinal BMD have also been found to
correlate with both quadriceps and hamstring and trunk extensor strength (Eickoff et al.
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1993). It should be remembered that such associations do not necessarily imply
causality.
Grip strength has been found to correlate well not only with forearm BMD but also with
BMD at distal sites in elderly women (Bevier et al., 1989, Kritz-Silverstein & Barrett-
Connor, 1994). It is likely that in this group of women at least, grip strength reflects
habitual level of daily activity. Because of its relative ease of measurement, grip
strength might in future prove suitable as a contributing measurement in an overall
screening programme to detect those at risk of osteoporosis.
ii) Exercise programmes
Cross-sectional studies on athletes and the general population have demonstrated
relationships between bone density and type and intensity of exercise but it is possible
that these correlations are the result of selection bias, reflecting a likelihood that those
with higher bone density will exercise more intensively. Only prospective randomised
studies of exercise programmes can eliminate this possibility. Extremely intensive
weight-bearing training in military recruits has been found to result in marked increases
in bone density in the tibia (5.2 - 11.1%) over as little time as fourteen weeks. However,
the drop-out rate due to stress fractures was high at 40% and this type of training is
unsuitable for most of the population (Margulies et al., 1986). A more suitable
supervised aerobic exercise and weight-training programme of 35 weeks duration in
previously untrained college women was shown to result in small but significant
increases in lumbar BMD with no detectable changes in the femur (Snow-Harter et al.,
1992). In a similar study performed over 2 years, small gains in BMD were found in
both spine and femur (Friedlander et al., 1995). Even in previously trained gymnasts, an
increase in lumbar BMD has been noted with short term increased training programmes
(Nichols D.L., 1994). Other short-term studies support the relationship between
exercise programmes and beneficial effects on bone density in young adults (Bassey &
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Ramsdale, 1995) but the effect may be short-lived with return to baseline of bone
density after only 3 months of detraining (Vuori et al., 1994).
b) Bone density and exercise in children and adolescents
The effects of exercise on BMD during the prepubertal and pubertal years may be less
marked than in later adolescence. Slemenda and Johnson (1993) compared 44 young
female skaters and non-skaters aged 10 to 23 years. Bone density was higher in the
skaters but this difference was not apparent until about the age of 15 years.
Alternatively, this might have reflected overall levels of commitment to the sport and
length of participation at different ages. Kroger et al., (1993) found no relationship
between bone density or annual rate of increase of spinal and femoral BMD and levels
of sporting activity in 65 Finnish children aged 7-20 years. In contrast, Slemenda et al
(1994) found a more substantial effect of physical activity in boy twins participating in a
study of calcium supplementation than they did for calcium. Grimston et al., (1992)
were able to demonstrate higher BMD in 13 year old boys who trained intensively for
weight-bearing sports compared to swimmers but this trend was less evident in the girls.
Similarly, in a 15 year longitudinal study of 98 females and 84 males aged 13-27 years,
BMD of the lumbar spine at age 27 years was correlated with amount ofweight-bearing
activity during the preceding years in males but not in females (Welten et al., 1994).
Cooper et al (1995) found that BMD in a population-based study of young women was
correlated with past and present levels of physical activity.
Section 3
Menstrual irregularity and bone density in athletes
Normal bone metabolism requires an intact hypothalamic-pituitary-ovarian axis. In
women the key hormones are oestrogen and progesterone. Oestrogen prevents bone
resorption and decreases remodelling whereas progesterone promotes bone formation
and accelerates remodelling. In the normal hormonal milieu, bone resorption and
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formation are 'coupled' so that appropriate remodelling can occur as required. In the
presence of low levels of oestrogen and progesterone, resorption increases since bone
formation is insufficiently increased to compensate, with a net loss of bone mineral.
Even asymptomatic disturbances of ovulation such as anovulation or a short luteal
phase have been associated with bone mineral losses of up to 4% per year (Prior et al.,
1990). Many female athletes have disruption of their menstrual cycle and this has now
been recognised to have profound effects on bone mineral content.
a) Incidence ofmenstrual abnormalities
Short luteal phases, anovulatory cycles, oligomenorrhoea and amenorrhoea have all
been described in athletes. Whereas secondary amenorrhoea occurs in only 5% of the
general population it is common in sports in which thinness may be an added advantage
to performance, such as running, gymnastics, ice-skating and dancing. In the Great
Britain National squads of these sports in 1988, 50"! 00% of women reported at some
time previously some form of menstrual dysfunction (Wolman & Harries, 1989). The
incidence may also be high in other sports. Recently, Giiler and Hasgelik (1993)
demonstrated an overall rate of 30% for oligomenorrhoea and amenorrhoea amongst
top athletes in team games from a number of different countries. Volleyball players from
Czechoslovakia, Belgium and Sweden had the highest rates at 43%. The term athletic
amenorrhoea has now come into use to describe secondary amenorrhoea associated
with intense exercise .
b) Causes ofmenstrual disturbance
i) Severity of training
There is no doubt that the aetiology of athletic amenorrhoea is multifactorial. Increasing
severity of training has been shown in some studies to correlate with increasing
incidence ofmenstrual dysfunction (Feicht et al., 1978, Dale et al., 1979, Drinkwater et
al., 1984, Drinkwater et al., 1986, Giiler and Hasgelik, 1993). Others have been unable
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to confirm this relationship (Glass et al., 1987) and it is clear that there are other factors
correlated with intensity of training which must be accounted for.
ii) Body Composition
Amenorrhoeic runners have been found to be lighter and leaner than their
eumenorrhoeic peers (Feicht et al., 1978, Schwartz et al., 1981, Shangold & Levine,
1982, Marcus et al., 1985; Drinkwater et al., 1986, Glass et al, 1987, Harber et al.,
1991). It is well known that profound weight loss, as occurs in anorexia nervosa, is
associated with amenorrhoea and it seems likely that low weight or changes in body
composition in some way contribute to the development of this disorder in athletes. But
as yet the exact relationship remains obscure.
Hi) Menstrual history
There may be a relationship between age at start of training, age at menarche and
likelihood of later menstrual irregularity. Giiler & Hasqielik (1993) found that of the 96
top team-game athletes sampled, those with menstrual dysfunction tended to be
younger, had started training at an earlier age and were more likely to have started
training before menarche. In elite speed skaters, those who reported prolonged
intermenstrual intervals also had the highest average age at menarche (Casey et al.,
1991). It has also been shown that women with menstrual irregularity prior to the start
of training are more likely to develop irregularity during training (Schwartz et al., 1981,
Shangold & Levine, 1982). This suggests that immaturity of the hypothalamic-pituitary-
ovarian axis may make the development of menstrual irregularity more likely at times of
psychological or physiological stress.
iv) Nutritional intake
Several recent reports have suggested that the calorie intake of amenorrhoeic athletes
may be lower than that of eumenorrhoeic subjects and that restriction of energy intake
may be causally related to menstrual dysfunction. Nelson et al. (1986) used a three-day
dietary record to compare the intakes of 11 amenorrhoeic and 17 eumenorrhoeic highly
trained runners. They reported the mean energy intake of amenorrhoeic runners to be
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520 kcal.day""' less than eumenorrhoeics. The difference in calorie intake was highly
significant (P<0.005) when expressed as a function of lean body mass. Baer (1993) also
found lower intakes (P<0.05) in amenorrhoeic runners compared to both eumenorrhoiec
runners and controls (1627 +/- 75, 1944 +/- 45, 1950 +/- 56 kcal.day1 respectively).
Five out of a further seven studies on runners have shown lower total calorie intakes in
the amenorrhoeic athletes but these differences have not been statistically significant
(Brownell etal., 1988, Rosen & Hough, 1988, Kaiserauer et al., 1989, Rucinski, 1989,
Prussin & Harvey, 1991). In only two studies has calorie intake been shown to be
higher in amenorrhoeic athletes compared to eumenorrhoeic athletes (Snead et al.,
1992; Wilmore et al., 1992).
v) Eating disorders
The current literature suggests a high incidence of anorexic or bulimic types of
behaviour in some athletes, particularly those competing in events in which low weight
conveys an advantage or which are judged on aesthetic appeal (Weight & Noakes,
1987, Brownell et al., 1988, Rosen & Hough, 1988, Rucinski, 1989, Mulligan &
Butterfield, 1990, Prussin & Harvey, 1991). Preoccupation with weight and food, a
desire to maintain a low body weight or body fat and intensive exercise are all
hallmarks of anorectic behaviour. Both anorexia and bulimia are associated with
menstrual disturbance and it may be that disordered eating rather than energy intake
per se is the main contributor to the high incidence of amenorrhoea.
Section 4
The effects ofmenstrual irregularity on bone
a) Menstruation and bone density of non weight-bearing bones
During the last decade several studies have examined the effect ofmenstrual irregularity
on BMD. Studies on amenorrhoeic runners compared to either eumenorrhoeic runners
or sedentary controls have been consistent in showing lumbar BMD to be 10-20%
lower in those with amenorrhoea (Cann et al., 1984; Drinkwater et al., 1984; Marcus et
25
al., 1985, Nelson et al., 1986; Lindberg et al., 1987; Wolman et al., 1990). In the
largest study of its kind, Drinkwater et al., (1990) demonstrated a linear relationship
between vertebral BMD and lifetime menstrual history in 97 active women. Those who
had a long history of oligo/amenorrhoea had a mean BMD which was 17% lower than
in those who had always had regular periods. A linear relationship between lumbar spine
BMD and oestradiol has also been demonstrated by Nelson et al., (1986) in
amenorrhoeic and eumenorrhoeic runners.
The effect of hypo-oestrogenism may not be as marked in other athletes as in runners.
Young et al., (1994) found a significant but small reduction of only 3 .5% in the lumbar
spine of ballet dancers with slightly greater reductions of 5 - 6% in ribs, arms and skull
when compared to non-dancers with regular menstrual cycles. Robinson et al., (1995)
showed that runners had 12% lower lumbar BMD than controls, whereas values in
gymnasts were 5.5% higher than controls, despite a similar prevalence of
oligoamenorrhoea in the two athletic groups. The gymnasts were much stronger
generally than the runners or controls and it is possible that the greater muscular
stresses applied to the spine in gymnasts help to offset any reduction in bone mineral
due to menstrual dysfunction. Certainly in rowers this seems to be the case. Wolman et
al., (1990) found that in a group of elite athletes, rowers with prolonged amenorrhoea
had higher lumbar bone density than non-rowers and rowers with or without menstrual
dysfunction had significantly greater back strength than amenorrhoeic runners.
b) Menstruation and bone density of weight-bearing bones
There is less agreement about the effect of amenorrhoea on weight-bearing bones in
which the muscular stresses of exercise and the effect of ground reaction forces may
offset bone loss. Reduction in femoral shaft BMD in amenorrhoeic active women has
been noted by one author (Drinkwater et al., 1990) but Wolman et al. (1991) found no
difference in femoral shaft BMD between amenorrhoeic and eumenorrhoeic runners,
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rowers and dancers. Femoral neck, calcaneal and total leg BMD have also been shown
to be well maintained despite amenorrhoea (Drinkwater et al., 1990; Harber et al.,
1991, Myerson et al., 1992; Snead et al., 1992, Young et al., 1994). However, in
Robinson's study (1995) lower femoral neck BMD was found in a group of 20 runners
(of whom 30% were oligo- or amenorrhoeic) compared to eumenorrhoeic sedentary
controls. When analysed according to more detailed menstrual history there was a 17%
difference between those runners who had always had regular menstrual cycles and
those who had had prolonged amenorrhoea. Numbers in each group were too small for
more detailed analysis. More recently, studies from Drinkwater's group have also found
lower BMD in all femoral areas measured, thus refuting findings from the earlier study
(Rencken et al., (1996). This suggests that there may be a linear relationship between
number of yearly menstrual cycles and bone density of other skeletal regions in addition
to the spine.
More recently controversy has arisen about whether bone density should be expressed
according to body weight. Most population studies have shown that body mass is a
significant independent predictor of bone density: those who are lightest have the lowest
bone density. This is of particular relevance in athletes who are in general lighter than
their sedentary peers. Amenorrhoeic athletes tend to be even lighter still. Some authors
have therefore analysed their data after adjustment for body mass. Myerson et al.,
(1992), Robinson etal., (1995) and Young et a/., (1994) all found that previously noted
differences between amenorrhoeic and eumenorrhoeic athletes were eliminated when
this method was used. Only Drinkwater et al., (1990) found a continuing trend towards
reduced lumbar spine BMD even when adjusted for weight. It is possible that in
athletes, weight only becomes a significant predictor of bone density in the presence of
very low levels of sex hormones.
27
Section 5
Mechanism of reduced bone density in athletic amenorrhoea
Amenorrhoea in athletes is a form of hypothalamic hypogonadism. Pulsatile releases of
luteinising hormone (LH) and follicle stimulating hormone (FSH) are reduced in
amenorrhoeic athletes (Loucks et al., 1989). Some normally menstruating runners also
have reduced LH pulsatility (Cumming et al., 1985, Loucks et al., 1989).
Gonadotrophin releasing hormone (GnRH) stimulation studies have revealed an
exaggerated response of the pituitary to exogenous GnRH in amenorrhoeic athletes
(Vedhuis et al., 1985, Loucks et al., 1989). This implies that GnRH production by the
hypothalamus is suppressed whilst pituitary function is retained. Reduced LH and FSH
pulsatility means that the ovaries do not prepare a follicle for release, ovulation does not
occur and there is no corpus luteum. Levels of oestrogen and progesterone may remain
at early follicular levels throughout the cycle even if normal menses are present.
Very few investigators have been able to study the changes in bone occurring at the
microscopic level in such athletes. However, Warren et al., (1990) performed a bone
biopsy on a 20 year old dancer with long-standing anorexia and primary amenorrhoea
who suffered a femoral head collapse. She was known to have lumbar BMD which was
more than 2 standard deviations below the normal mean for her age. On microscopy,
femoral cortical bone was markedly reduced in thickness and increased in porosity. At
the trabecular level, the resorption surfaces were greatly increased although the
formation surface was normal. It is unknown whether such changes occur in all
amenorrhoeic athletes, the rate at which they might occur or whether they are reversible
with resumption ofmenses or treatment with appropriate hormones.
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Section 6
Consequences of low bone density in athletes
a) Stress fractures
Lloyd et al. (1986) reviewed the medical records of 207 collegiate athletes and found
X-ray confirmed fractures (type of fracture not defined) in 9% of regularly
menstruating women and 24% ofwomen with irregular or absent menses. In dancers,
two papers report a relationship between bone injuries or stress fractures and
amenorrhoea (Warren et al., 1986; Benson et al., 1989) and a survey of 240 female
athletes showed a higher incidence of stress fractures in those with fewer than 5
menses per year (49%) compared to those with 10 or more menses per year (29%)
(Barrow & Saha, 1988). Lindberg et al., (1984) found that 49% of the amenorrhoeic
runners in his study had had stress fractures in the previous year whereas none of the
eumenorrhoeic runners had suffered such injuries. However, two reports found no
significant relationship between menstrual history and stress fractures although both
contained small numbers of subjects and so lacked statistical power (Frusztajer et al.,
1990; Grimston et al., 1990). Recognition of the possibly increased risk of stress
fractures in amenorrhoeic women is important because delay in diagnosis can result in
full thickness fracture (Leinberry et al., 1992).
It remains unclear whether the increased rate of stress fractures in amenorrhoeic
athletes is related to low BMD. Femoral bone density has been shown to be low in
young male military recruits with femoral stress fractures (Pouilles et al., 1989) and
Myburgh et al., (1990) found that in athletes with similar training habits, those with
stress fractures were more likely to have lower femoral neck and spinal bone density,
lower dietary calcium intake, current menstrual irregularity and lower oral
contraceptive use. But Carbon et al. (1990) assessed elite female runners with and
without stress fractures and found no difference in the femoral BMD between the two
groups. Others have also described a lack of association between tibial BMD and
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stress fractures in military recruits (Milgrom et al., 1989). It is likely that the
association between amenorrhoea and stress fractures is due to impaired microfracture
healing, in the absence of adequate levels of oestrogen, rather than decreased
mechanical integrity. In hypooestrogenic states such as after the menopause or during
amenorrhoea, there is an increase in programmed cell death (apopoptosis) of
osteocytes (Tomkinson 1996). This change may affect the ability of bone to transduce
mechanical forces and to initiate the repair of microscopic cracks which occur even
under normal circumstances in spinal trabeculae and the femoral head and neck from at
least middle age onwards. If oestrogen suppression during athletic amenorrhoea leads
to osteocyte apoptosis, there may be a consequent disruption of the signalling
pathways responsible for micro-fracture repair, leading to crack enlargement and the
development of a clinical stress fracture.
b) Musculoskeletal injuries
Stress fractures may not be the only injury more prevalent in amenorrhoeic athletes.
Participants in a 10km race who responded to a questionnaire were more likely to
have taken time off training due to any form of musculoskeletal injury if they had
irregular menses (Lloyd et al., 1986). In Benson's study (1989) of 49 female dancers,
those with abnormal menses had more 'bone injuries' (mean = 15.0) than normally
menstruating dancers (mean = 5.0) (P<0.05). Additionally, dancers with a low body
mass index (<19.0 kg.nr2) had a greater duration of low-grade musculoskeletal injury
(mean = 24.1 days) than those with a higher BMI (mean =11.6 days) (P<0.05).
More severe bony injury also occurs in amenorrhoeic athletes. In dancers, scoliosis
was found to be more common in those with delayed menarche and in whom anorectic
behaviour was more prevalent (Warren et al., 1986). Warren et al. (1990) later
described a 20 year-old ballet dancer with long-standing anorexia nervosa, primary
amenorrhoea and low BMD, who suffered femoral head collapse. Recently we have
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reported an osteoporotic fracture in the neck of humerus of a 30 year old marathon
runner with a history of anorexia and low bone density (Wilson & Wolman, 1994).
c) Long-term consequences
Amenorrhoeic athletes may be at risk of premature osteoporosis and fractures but as
yet there is little long-term data on the natural history of bone metabolism in this
condition. As previously shown, bone mass peaks at approximately 20 - 30 years of
age so athletes should be at their highest BMD during their most athletic years.
Eumenorrhoeic athletes have higher peak BMD (PBMD) than the mean for the
population. But if amenorrhoeic athletes fail to attain their maximum potential PBMD
at this age, it is unknown whether they will be able to 'catch up' later in life. If the
lifetime risk of hip fracture is related to peak bone mass, eumenorrhoeic athletes are
likely to be at reduced risk of osteoporotic fracture throughout their lifetime whereas
amenorrhoeic athletes may always be at a relative disadvantage.
But BMD may increase when menstruation returns in these athletes. Drinkwater et al.
(1986) followed 9 athletes over a 15.5 month period. Seven of the women had
regained menses and two had remained amenorrhoeic. Lumbar BMD increased by
6.3% in the former amenorrhoeic women whilst decreasing a further 0.3% in those
who had remained amenorrhoeic. Small increases in BMD were also seen in the radius.
These results are very similar to those of Lindberg et al. (1987) who retested seven
amenorrhoeic runners at 15 months. Four had recovered menses and showed an
improvement of 6.5% in lumbar BMD. The other three remained amenorrhoeic and
showed no improvement in BMD.
Some data are available from anorexics with amenorrhoea. Rigotti et al., (1991)
followed cortical bone density of the radius in non-athletic patients with anorexia
nervosa over a median of 25 months. Only 6 of the 27 women regained menses
31
although most gained some weight, took calcium supplements and exercised regularly.
There were no significant changes in BMD in women who regained menses, received
oestrogen therapy or who gained weight to more than 80% of their ideal weight. In
addition there was a high incidence of vertebral compression fractures and non-spine
fractures. Weight gain however and either oestrogen therapy or return of menses in
anorexics has been shown to be associated with improvements in spinal BMD by
Bachrach et al., (1991). Studies on recovered anorexics also suggest that total body
BMD may return towards normal for the age (Treasure et al., 1987, Bachrach et al.,
1991).
These short-term studies suggest that small improvements in BMD may occur in some
regions of the skeleton, particularly those high in trabecular bone such as the spine,
when menstruation returns. However, changes in cortical bone may not occur so
rapidly, if at all. It is also unknown whether improvements in trabecular bone are
maintained over several years.
There is some evidence from cross-sectional studies of older premenopausal and
postmenopausal women that gynaecological parameters may have important
associations with BMD. Greater numbers of pregnancies, early menarche and greater
numbers of days bleeding have all been correlated with higher radial BMD (Fox et al.,
1993). In this study, for each decade ofmenstruation, radial BMD was 2% higher but
there was no association with length of the menstrual cycle or previous history of
irregularity. This contrasts with findings by Georgiou et al., (1989) who found that
BMC of the forearm in postmenopausal women had a better linear correlation with the
total number of menstrual cycles than with age or years since the menopause. Only
long-term prospective studies of amenorrhoeic athletes will be able to confirm or
refute the relationship between these various aspects of menstrual history and their
influence on BMD in the postmenopausal years.
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Section 7
Treatment of reduced bone density in athletes
Drinkwater et al. (1986) and Lindberg et al. (1987) demonstrated an increase in BMD
associated with resumption of menses but in all cases return of menses was associated
with a reduction in training volume or intensity and a concomitant increase in weight.
Not all athletes are willing to alter training habits in order to resume menstruation. For
many, menstruation would be a nuisance and for some it might interfere with
performance. In such athletes treatment to prevent further bone mineral loss or to
improve low bone density despite amenorrhoea would be of interest. Treatment regimes
used in women with secondary amenorrhoea not willing to resume monthly
menstruation have included calcium supplementation, recently introduced forms of
hormone replacement therapy such as continuous combined regimes, and intranasal
calcitonin.
a) Hormone replacement therapy
De Cree et al., (1988) used 2mg cyproterone acetate and 50pg ethinyl oestradiol as a
combined oral contraceptive in 7 amenorrhoeic athletes. During 8 months of treatment,
BMD in the lumbar spine increased by 9.5% compared to a control group of 4 athletes
in whom BMD increased by only 1.6%. Very little change occurred in either group in
the radius. It is difficult to assess the effect of the cyproterone acetate on bone density,
indeed the increase may have been solely due to the relatively high dose of oestrogen
used. In a study of 15 non-athletic women with primary and secondary amenorrhoea,
Haenggi et al., (1994) showed increases of 2.5 % and 2.9% per year in lumbar spine
and Ward's triangle respectively when treated with an oral contraceptive containing
0.03mg ethinyloestradiol and 0.15mg desorgestrel. Non-significant increases in BMD
were observed in the femoral neck and tibia suggesting that greatest effects occur at
sites high in trabecular bone. Similarly treatment with medroxyprogesterone in
physically active women with menstrual cycle disturbance has shown significant
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improvements in spinal BMD (Prior et al., 1994). But treatment with oestrogen and
progestins in anorexia nervosa patients with proven low spinal trabecular BMD have
given conflicting results. Only those with body weight less than 70% of ideal appeared
to derive benefit from treatment in that further bone loss was prevented compared to
controls. The greatest changes were seen in those controls who regained menses in
whom there was a 19.4% increase in BMD (Klibanski et al., 1995).
b) Calcium
Treatment with calcium has been suggested to be weakly effective by Prior et al.,
(1994) in his study of 61 active women but no effect has been shown by others. Baer et
al. (1992) treated 7 adolescent amenorrhoeic runners with 1200 mg calcium carbonate
and 400 IU vitamin D daily. During a 12 month period the subjects consumed an
average of 2400 mg calcium daily but BMD of the lumbar spine did not increase and in
two subjects it declined further.
c) Intranasal calcitonin
In non-athletes with menstrual abnormalities, intranasal calcitonin and oestrogen or
progesterone replacement have been used. In 7 women with primary amenorrhoea who
completed 6 months of treatment with either intranasal calcitonin or a combined
oestrogen/progesterone therapy, BMD of the lumbar spine increased by 4.1% in the
first group and by 9.2% in the latter group (Biberoglu et al., 1990).
d) Bisphosphonates
As yet there are no studies on the effect of the bisphosphonates on low bone density in
amenorrhoeic athletes. They are now becoming widely accepted as a treatment of
choice for established osteoporosis in postmenopausal women (Black 1996) but their
role in hypogonadal bone loss in premenopausal women is conjectural.
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Although some mention was made in these studies on the incidence of side effects with
treatment there was no mention made of effects of treatment on athletic performance.
Side effects associated with hormone therapy by women who have experienced
prolonged amenorrhoea such as breast tenderness, weight gain and emotional lability
are unlikely to be tolerated by runners. Calcium in high doses may also cause
troublesome gastrointestinal upsets in a minority, which is particularly difficult for
runners.
Effective treatment of reduced bone density in young women seems possible, at least in
the short-term, though side effects may be a particular problem in athletes and may
reduce compliance. Long-term effects of treatment are unknown and must await further
investigation. A more effective approach to the problem must be in the prevention of
athletic amenorrhoea with prompt assessment and treatment should it occur.
Section 8
Bone density in perimenopausal and postmenopausal women
A dramatic consequence of the ageing of the population has been the enormous increase
in the numbers of osteoporotic fractures. Although undoubtedly vertebral and radial
fractures cause considerable morbidity, it is the mortality and cost associated with hip
fractures that cause particular concern to the health planners. The mortality rate at one
year following fracture is almost 20% and in those who survive, very few regain their
previous level of mobility. Based on past trends in hip fracture rate it is estimated that
the total number of cases (men and women) will rise from about 50,000 in 1985 to
almost 120,000 in 2016 (Kanis & Pitt, 1992).
Vertebral fractures are harder to quantify as many are asymptomatic but Melton et a/.,
(1989) suggested that the prevalence may be as high as 26.5% in all women aged over
55 years. A report from the USA based on 1986 data estimates that vertebral fractures
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accounted for 10% of all osteoporosis-related hospital admissions in women over the
age of 45 years (Phillips et al., 1988). In Europe, rates of prevalent deformities in
population samples of men and women aged over 50 (mean age approximately 65
years) were in excess of 10%. However, not all vertebral deformities are due to
osteoporosis (O'Neill et al, 1996).
a) The role of exercise in preventing osteoporosis and fracture
Prevention of osteoporosis and its devastating consequences has become a key issue
and much effort has been devoted to an understanding of its aetiology. The incidence of
hip fractures is directly related to bone strength, the risk of falling and the
neuromuscular responses to falling. The higher the bone density in early adult life, the
lower the risk of fracture in later years. Those women with greater bone density at the
menopause are also at lower risk of fracture. Cooper et al., (1988) showed that
increased daily activity protected against fracture in men and women aged 50 years and
over. Muscle power was independently associated with risk of fracture with a five-fold
increase between the lowest and highest fifths of strength, and was significantly related
to all measured indices of activity. In a 15 year prospective study of 1419 elderly men
and women in Britain, Wickham et al., (1989) showed that the relative risk of hip
fracture was 5.2 in those who were housebound compared to those with full outdoor
activity. Physical activity such as household work, strenuous conditions of employment
and sport during early adult years also appears to protect women from later fracture,
regardless of level of activity at the time of fracture (Astrom et al., 1987).
A greater understanding of mechanisms by which bone mass in old age can be
improved, and the risks of falling reduced, will help to focus preventative programmes.
Regular exercise may be one method ofmaintaining BMD, preventing the development
of osteoporosis and reducing the rate of falling. However, the amount of exercise
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required to have a maximal effect is unknown. Nor is it known whether exercise in the
elderly is as beneficial as activity in the early adult years.
b) Cross-sectional studies
Population-based studies in older women have consistently shown higher bone density
in those women who are moderately active compared to those who are sedentary (Aloia
et al., 1988, Zylstra et al., 1989, Jonsson et al., 1992, Zhang et al, 1992). For instance,
Krall & Dawson-Hughes (1994) found higher whole body BMD in postmenopausal
women walking approximately 1 mile per day compared to those walking shorter
distances. The rate of bone loss in these active postmenopausal women was also
slowed.
Two cross-sectional studies on older 'athletic' women have also shown higher BMD
than age-matched non-exercisers. In both studies women were considered athletic if
they exercised for at least 1 hour, three times a week at the equivalent intensity of a
game of tennis. The most significant differences in bone density occurred in the oldest,
postmenopausal women in whom bone density was maintained compared to the control
groups in whom it declined (Jacobson et al., 1984, Talmage et al., 1986).
Thus regular activity in older women appears to be associated with significant skeletal
benefits. However, very intensive exercise in postmenopausal women may not have the
same advantages. Michel et al., (1989) found that women exercising for more than 5
hours per week had quite low lumbar BMD compared to other women who trained less
intensively. In a 2 year prospective follow-up study to this, Michel et al., (1991)
confirmed that, in females over the age of fifty, extreme levels of exercise (greater than
300 minutes per week) were associated with low bone density. And Nelson et al.,
(1988), found that endurance-trained postmenopausal women (running 22.6 +/- 2.4
miles per week) had surprisingly similar lumbar, femoral and radial BMD to age-
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matched sedentary women, although, when adjusted for weight, lumbar and radial bone
density was higher in the active group.
c) Exercise programmes
The evidence for beneficial effects of exercise intervention programmes on bone density
in postmenopausal women is conflicting. Most studies have involved small numbers of
subjects for a maximum of one year. In some, the type of exercise has been
inappropriate to the site of bone measured e.g. a weight-bearing exercise study has been
accompanied by bone density measurements at the radius. Other studies have involved
women over a wide age range and this may have obscured any benefits available in the
immediate postmenopausal period compared with the very elderly (or vice versa).
Not surprisingly, findings from these studies therefore range from no apparent benefit at
all (Blumenthal etal., 1991, Smidt et al., 1992) to marked increases in BMD. Dalsky et
al., (1988) noted an increase in lumbar BMD of 5.2% and 6.1% after 9 and 22 months
respectively of walking, jogging and stair-climbing in 55 - 70 year old women. After 13
months of detraining, BMD had declined to 1.1% above baseline. Chow et al., (1987)
measured changes in bone mass of the trunk and upper thigh by neutron activation,
expressed as the calcium index. After 1 year of aerobics and strength training 16
women, on average 7 years postmenopausal, had a significant increase in calcium index
compared to non-exercising controls. In a 2 year longitudinal study of men and women
over the age of 50 years, Michel et al., (1991) found a high correlation between
increasing exercise levels and bone density in those exercising at moderate levels but
low levels ofBMD at extremely high levels of exercise.
Others have shown that BMD may not increase with exercise in older women, but rates
of bone loss may be slowed or halted (Rundgren et al., 1984, Smith et al., 1989, Rikli
& McManis, 1990, Grove & Londeree, 1992, Revel et al., 1993, Bassey & Ramsdale,
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1995). This effect may be most marked in those women closest to the menopause
(Martin & Notelovitz, 1993).
It therefore remains unclear whether exercise intervention in postmenopausal women is
an appropriate form of treatment for established osteoporosis or whether indeed it can
be advocated for the maintenance of bone density. Although cross-sectional and
population studies support regular physical activity as a means of reducing
osteoporosis, the volume and intensity of exercise required is still unknown. The effects
of exercise on bone remodelling leading to net bone reduction may require the presence
of premenopausal levels of sex hormones. Prospective studies of exercise intervention in
postmenopausal women both on and off hormone replacement therapy would help
answer this question.
Regular exercise may have other benefits in the elderly population at risk of
osteoporotic fracture. Physical activity improves neuromuscular function and can
reduce the rate of hip fracture from falling (Wickham et al, 1989). Exercise intervention
programmes which improve balance and strength are also likely to reduce the rate of
falling. This effect has been recently demonstrated by Wolf et al., (1996) as part of the
Frailty and Injuries: Cooperative Studies of Intervention Techniques (FICSIT) Group.
They achieved a 47.5% reduction in the risk of multiple falls in men and women over
the age of 70 years who participated in a 15 week Tai Chi training programme. This
alone is compelling evidence for maintaining physical activity in the elderly.
Section 9
Calcium intake and bone density in athletes
Bone mass is higher in children and adolescents with a high calcium intake (Chan, 1991;
Sentipal et al., 1991) and this may result in an increased bone mass in later life
(Matkovic et al., 1979). Work on healthy premenopausal women supports a role for
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dietary calcium in the development of bone, particularly when associated with exercise
(Kanders et al., 1988; Halioua & Anderson, 1989). The synergistic effect of calcium
and exercise on bone has also been demonstrated in animal models (Lanyon, 1986).
A positive linear relationship between trabecular BMD in the lumbar spine and calcium
intake in athletes has been demonstrated by Wolman et al., (1992) a finding that was
independent of menstrual status and which has not been shown in other studies (Nelson
et al., 1986; Grimston et al., 1990; Heinrich et al., 1990). These differences may be due
to methodology, particularly in assessment of calcium intake or statistical confounding
by another risk factor. Alternatively the relationship between calcium intake and bone
mineral content may not be linear. Kanders et al. (1988) showed a positive relationship
between calcium intake and vertebral BMD in normal healthy eumenorrhoeic women
but not above a daily intake of 800 - 1000 mg. The ability of an individual to adapt to a
low calcium intake may be genetically determined (Krall 1995, Ferrari 1995).
Low calcium intakes have been reported in many athletes (Rucinski, 1989, Benson et
al., 1990, Pate et al., 1990, Bergen-Cico & Short, 1992, Delistraty et al., 1992,
Frederick & Hawkins, 1992, Stensland & Sobal, 1992) particularly in amenorrhoeic
women. Low oestrogen levels are associated with decreased intestinal absorption of
calcium and increased urinary loss (Nordin & Heaney, 1990) so dietary calcium
requirements may be even higher in amenorrhoeic athletes. Both Marcus et al. (1985)
and Nelson et al. (1986) found that 55% of amenorrhoeic athletes failed to meet the
recommended daily allowance (RDA) for calcium compared to 35 - 40% of cyclic
women. Kaiserauer et al., (1989) also noted a lower intake in amenorrhoeic compared
to eumenorrhoeic runners (600 mg versus 1200 mg.day"*> P<0.05). Yet it remains





Moderate regular physical activity appears to have beneficial effects on bone density at
all ages though exercise intervention programmes in elderly women have not been able
to demonstrate conclusive benefit. It remains unknown how much exercise and of what
type should be recommended as optimal for the general population. High intensity
training has advantages and disadvantages for skeletal metabolism and questions remain
about long-term effects of menstrual irregularity on bone mineral. As yet there is very




1) Selection of Subjects
Female athletes were recruited to the study after advertising in running and veteran
athlete magazines and by word of mouth. Women were recruited who fitted the
following criteria:
a) YoungAthletes
i) Aged 16-35 years
ii) Caucasian
iii) Non-smokers and in good health
iv) Currently training for and competing in middle and long-distance running
events
v) Training at least three hours per week and running a minimum of 25 miles per
week
vi) To have maintained this level of training for at least the last three years
vii) Not to have taken the oral contraceptive or other hormonal treatment in the
last one year
b) Veteran A thletes
i) 40 years or over
ii) Caucasian
iii) Non-smokers and in good health
iv) Currently running at least 15 miles per week if a long-distance runner
v) Competing in veteran events and training for at least three hours a week if not
a long-distance runner.
vi) To have maintained this level of training for at least the last three years
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Exclusion criteria
Those who had a current or past history of respiratory disease, diabetes, metabolic
bone disorders, rheumatoid arthritis, thyroid or parathyroid disease, malignancy,
cardiac, renal or inflammatory bowel disease or who were taking oral or inhaled
steroids were excluded because of their possible effects on bone metabolism. Possible
recruits who had had anorexia nervosa or another eating disorder prior to starting
training were not included. Menstrual irregularities were required to coincide with the
onset of training or an increase in training load to be considered secondary to
exercise.
All athletes gave informed consent as approved by the ethics committee ofNorthwick
Park Hospital. Details of sporting activities, gynaecological history, past medical





any previous or current irregularities in menstruation
dates of use of the oral contraceptive pill
number of pregnancies
details of the menopause
use of hormone replacement therapy
ii) Sporting History
age of starting sport of any kind
age of first training for current sport
other sports undertaken
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details of previous and current methods of training including e.g. hours per
week, miles per week, intensity
level of achievement
2) Grouping of Subjects
Athletes were categorised according to their menstrual history. The following
definitions are used throughout;
eumenorrhoea 10-13 menstrual cycles per year
oligomenorrhoea 4-9 menstrual cycles per year
amenorrhoea 0-3 menstrual cycles per year excluding pregnancy
a) Young Athletes
i) Eumenorrhoeic (EU). Women who were currently and had always been
eumenorrhoeic since menarche.
ii) Oligomenorrhoeic (OL). Women who had had 4-9 cycles per year for at least
the last 18 months but had not had more than three months without a
menstrual period.
iii) Amenorrhoeic (AM). Subjects who had had 0-3 cycles per year for at least
the last 18 months.
h) Veteran Athletes
These subjects were first divided into pre and postmenopausal. They were defined as
postmenopausal if they had not had a menstrual period for more than 12 months,
associated with raised FSH levels +/- menopausal symptoms or a surgical menopause.
Postmenopausal women who had had no gap between the onset ofmenopause and the
commencement of Hormone Replacement Therapy (HRT) were considered as
premenopausal.
44
Premenopausal veteran athletes only
Menstrual History
Subjects were required to have been eumenorrhoeic during the last one year. They
were then categorised according to past menstrual history using the definitions in
section 2a above.
i) Eumenorrhoeic (EU). Women who had always had 10-13 cycles per year
since menarche.
ii) Non-eumenorrhoeic (Non-EU). Women who had a history of at least 2 years
of either amenorrhoea or oligomenorrhoea which was considered secondary to
their exercise habits.
Pre- andpostmenopausal veteran athletes
Training History
Subjects were divided according to their current and past levels of physical activity.
To be considered athletic in the past, subjects were required to have performed
continuous aerobic exercise at least three times per week for a minimum of 20
minutes each time at 60 - 90% of their estimated maximum heart rate. This is the
minimum recommendation for the development and maintenance of cardiorespiratory
fitness as defined by the American College of Sports Medicine (1990).
Groups were:
i) All-timers (AT) - those who had consistently exercised since leaving school
except when pregnant.
ii) Late-Starters (LS) - those who had been sedentary since leaving school but
had taken up training after the age of 30 years
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Thus the veteran athletes were categorised as follows:
Group 1 - Premenopausal
All-timer / always eumenorrhoeic
(AT/EU)
Late-starter / always eumenorrhoeic
(LS/EU)
All-timer / previous oligomenorrhoea
(AT/non-EU)
Late-starter / previous oligomenorrhoea
(LS/non-EU)
Group 2 - Postmenopausal
Group A Group B
All-timer (AT) Late-starter (LS)
3) Morphological characteristics
Height, weight, skin fold thicknesses and fat free mass were determined and from
these values, body mass index and percentage body fat were calculated. All
measurements were made by the same observer (author) each time, thus reducing
inter-observer variation.
i) Height and weight
Using an Avery stadiometer and platform balance scale, height (in cms) and weight (in
kg) were measured. From this, body mass index (BMI) was calculated from the
following formula:
BMI = W/H^ where W = weight in kg and H = height in metres
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ii) Fatfree mass
Fat free mass (FFM) was determined on each veteran athlete from a measurement of
total body potassium (TBK) in mmol. The TBK measurements were made in a sodium
iodide whole body counter using the technique described by Smith et al. (1979). The
standard error on a value for TBK was approximately 4% and FFM was calculated
from TBK on the assumption that there is an average of 60 mmol of potassuim per kg
ofFFM (Boddy et al, 1973) in healthy adult females:
TBK - 14.76(W) + 22.07(H) - 9.05(Age) - 1669
Thus, FFM = TBK/60
The values obtained for TBK were compared to the expected values for age of each
individual, based on previously validated normal ranges for this Nal counter (Smith et
al 1979).
Thus %TBK = TBKobs./TBKexp x 100
where %TBK = % ofmean of normal population of that age,
TBKobs = observed TBK in mmol
TBKexp = expected TBK in mmol for that age
iii) Percentage bodyfat
1) Skin fold thicknesses were measured at four sites using Harpenden skin fold
calipers. The sites used were midbiceps, midtriceps, suprailiac and subscapular on the
right side of the body. Three measurements were made to the nearest mm at each site
and the mean of the three values was then taken. The sum of skin folds was the total
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of the means from each site. Percentage body fat (%BF) was calculated according to
the equation ofDurnin and Wormesley (1974):
%BF = (495/(1.1576 - (0.0657 x log (sum of skinfolds)) - (0.00033 x age))) - 450
2) In the veteran athletes only, percentage body fat was also derived from the
data obtained from the measurement of fat free mass as follows:
F = W - FFM, where F = fat in kg, W = weight in kg and FFM = fat free mass in kg
therefore %BF = F/W x 100
4) Bone mineral density
Bone Mineral Density (BMD) of the lumbar spine (L2-L4) and the left hip was
measured in each subject by dual energy x-ray absorptiometry (DXA) using the
Hologic QDR1000W densitometer and software version 6.1/4.26. This DXA system
uses a narrow beam (1mm) of X-rays with two energy components of 70 and 140
KVp. The x-ray beam and detector unit are synchronised together and used to
perform rectilinear scans of either the lumbar spine or hip region. Scanning time for
the lumbar spine was about 8 mins and for the left hip, 7 mins. Daily calibration
against a phantom in this laboratory has a long-term variation of 0.1%. In vivo
reproducibility of DXA is about 1% and effective dose equivalent for females is
estimated at 6.4uSv (Pye et al 1990). Scan analysis was performed by technicians with
daily experience in DXA analysis and who were blinded to the menstrual or activity
status of the athlete.
i) Lumbar spine
The subject lies supine on the table with the legs elevated on a foam block and hips
flexed to 45°. With the patient in this position, a rectilinear scan (12.5cm wide x
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20.0cm long) was performed of the lumbar spine. Subsequently, a region of interest
109 pixels* wide and of such length to include L2 - L4 was selected.
*(a pixel is the picture element of a matrix display whose size varies according to the
size of the display, in this case 1 pixel = 0.0965 x size of display)
ii) Left Hip
The subject lies supine on the table with the left foot placed in a femur repositioning
aid which places the femur in 25° of anteversion. In this position a rectilinear scan
(approximately 15cm x 15cm) was performed of the left hip region. Then for the
purposes of data analysis, a region of interest was selected that included tha entire
femoral head and the greater and lesser trochanters. BMD values (g.cm-2) were
calculated for the following regions of the proximal femur using Hologic software.
The following descriptions of the three areas of interest of the proximal hip are taken
from the Hologic QDR'^000 Operators Manual Oct. 1989.
Femoral Neck - the default size of the femoral neck is defined as a rectangular region
1.5cm wide and 6cm or less long where the bottom line of the neck region is centered
0.75cm below the narrowest area of the femoral neck.
Ward's Triangle - this is the area of the femoral neck deemed to be highest in
trabecular bone and is therefore an area of initial bone loss in osteoporosis. Ward's
Triangle is determined automatically by searching for an area of minimum density in
the femur. Initially the analysis compares an area of 11 x 11 pixels (1cm x 1cm) within
a box of 27 x 35 pixels (2.7cm x 3.5cm) centred on the lower end of the femoral neck
box (see diag.2). Some patients (especially young patients) do not have a defined area
of minimum density in the femoral neck and analysis of these patients may not give a
true density for Wards triangle.
49
Trochanteric Region - this is a triangular region whose boundaries are defined as the
lateral edge of the femoral neck region and a line connecting the midpoint of the
femoral midline to the point where the edge of the femur changes curvature below the
trochanter.
Expression ofbone mineral density
1) Bone mineral density is expressed initially as g.cm"2. Although this is not
strictly a density it is the form used by manufacturers of DXA machines and most
investigators and has therefore been used in this thesis for purposes of comparison
and consistency.
2) Using the Hologic database, each athlete was compared to the peak bone mass
for that region of interest (T-score). The Hologic database is derived from
measurements on 747 American women judged to be free from disorders or
medication likely to influence bone metabolism. Peak BMD (PBMD) is deemed to
occur at 22.0 years for the femoral neck and 30 .0 years for the trochanteric region
and lumbar spine.
3) During the course of the study, it became apparent that there are differences
between the reference databases of the various DXA machines available e.g. Hologic,
Lunar, and concern has arisen that the Hologic reference database for neck of femur
deviates from those derived from large samples of normal subjects (Genant et al.,
1994, Laskey et al., 1992, Pocock et al., 1992). Some of the work of the 'Concerted
Action of the European Community's COMAC-BME' programme was undertaken in
the same laboratory and it was possible to use this newly developed reference range,
instead of the Hologic reference range, for age-matched data.
The work by 'COMAC' has resulted in a European reference range for bone density
for both pre and postmenopausal women. This group measured proximal femur and
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lumbar spine bone densities of 855 women randomly selected from the normal
populations of 12 clinical centres in 8 countries. The three UK centres were Harrow,
Manchester and Aberdeen. Statistical analysis between machines and centres has
enabled the development of equations that now allow direct comparison with the
mean of the age-matched European reference range (Z-score) (Dequeker et. al., 1995,
Pearson et. al., 1995 a and b).
To enable this comparison to be made, measured BMD (g.cnr2) is first converted to a
specified density (X) using the equation X = 3.042 - (1/0.359 x In (2.98 - g.cmr2)).
This makes allowance for differences between the various machines used in the
different centres. The new specified density allows comparison with the mean of the
European population data using the following equations:
Premenopausal women
Neck ofFemur Z = LN(X) - 0.0275 + (0.003 x age)/0.1428
Trochanteric Z = LN(X) + 0.2836/0.14977
L2 - L4 Z = LN(X) - 0.1803/0.1253
Postmenopausal women
Neck Z = LN(X) + 0.14518 + (0.008324 x YSM) / 0.15544
Trochanteric region Z = X - 0.74811 + (0.004958 x YSM / 0.11736
L2 - L4 Z = LN(X) - 0.08127 + (0.00729 x YSM /
(0.12813 +(0.0038 x YSM))
where Z = Z-score
X - specified density
LN = natural logarithm
YSM = years since the menopause
T-scores and Z-scores are expressed as standard deviations (e.g. mean+lSD = +1).
5) Physiological characteristics
Grip strength, isokinetic back strength and maximal uptake and utilisation of oygen
(VC^max) were determined as measures of fitness levels and strength. Each test was
explained, demonstrated and assessed by the same operator (author) throughout.
i) Grip Strength
Grip strength in Kgf was determined in each hand of the veteran athletes using a
Takei grip dynamometer. Using a standardised method, grip strength was measured
three times in each hand with 30 seconds rest between each attempt. The best attempt
from the dominant and non-dominant hand was taken.
ii) Isokinetic Back Strength
Isokinetic back strength was measured using a Loredan Lido™ Active dynamometer.
The Lido dynamometer measures force applied to a peripheral attachment moving in
an arc about a fulcrum at a specified speed. To isolate trunk movements, the subject is
placed in a sitting position with the upper body clamped between two pads. The pelvis
is immobilised by a seat belt and the lower limbs held firm by a strap. The subject is
then able to move the equipment, using trunk flexor and extensor muscles only,
through a specified arc (30° extension to 30° flexion) with the hip at the point of the
fulcrum. The fulcrum will rotate at a set speed and maximum power is achieved by
asking the subject to push as hard and as fast as possible against the pads. Peak
Torque and Peak Torque to Body Weight ratio of both trunk flexion and extension
were measured at two different fulcrum speeds (60°.sec and 180°.sec _1). Each
subject was fully habituated to the equipment and the test before commencing. Three
consecutive efforts were performed and the peak torque taken as the maximum force
applied in each direction at any stage of the test. Verbal encouragement was given
throughout.
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iii) Maximal Uptake and Utilisation ofOxygen (V02max)
This test gives an indication of the aerobic fitness of the athlete and was performed on
a Powerjog treadmill using the Jaeger EOS Sprint on-line gas analysis system or the
Cosmed K2 portable on-line gas analysis system calibrated to the Jaeger. Constant
readout of the electrocardiograph (ECG) was obtained from three skin contact
electrodes placed on the chest. The subject was allowed time to acquaint themselves
with the treadmill before starting the test. After a five minute warm-up period at a
suitable speed, individualised for each subject, the speed of the treadmill was
increased by l .lkph each minute. When the respiratory quotient (RQ)* rose over 1.0,
the speed was maintained and the gradient of the treadmill increased by 1% each
minute. The test was continued to volitional exhaustion and verbal encouragement
was given throughout. Total time for the test was between 8 mins. and 15 mins.(in
accordance with the British Association of Sports Sciences, BASS,
recommendations).
Criteria for reaching V02max were:
1) No further increase in V02 despite increase in workload
2) RQ ofgreater than 1.10
3) Max heart rate (MHR) reached based on predicted value for age ( predicted
MHR = 220 - age)
* Respiratory Quotient is the ratio of carbon dioxide breathed out to oxygen usage.
When fat is burned for energy, the RQ is 0.7 and when carbohydrates are utilised, the
RQ is 1.0. An RQ ofgreaater than 1.10 indicates anaerobic metabolism.
6) Biochemical Tests
Blood and urinary tests for renal function and bone turnover were as follows:
a) Serum calcium, phosphate, alkaline phosphatase, albumin and osteocalcin
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b) Serum sodium, potassium and creatinine
c) Urinary hydroxyproline, calcium, creatinine
Tests for hormonal status were:
d) Serum oestradiol
e) Follicle Stimulating Hormone (FSH)
If appropriate, pregnancy was excluded prior to measurement ofbone density:
f) bHCG (human chorionic gonadotropin) on early morning specimen of urine
a) Blood was collected for serum calcium (Ca), phosphate (PO4), alkaline
phosphatase (AlkP) and albumin (Alb) using standard venepuncture techniques with
minimal use of the tourniquet. The blood samples were taken immediately to the
Northwick Park Hospital laboratories for analysis. Samples were separated and
analysed using the KODAK EKTACHEM colorimetric slides for Ca, PO4 and Alb
and the KODAK EKTACHEM multiple-point rate test for AlkP.
Blood for osteocalcin assay was collected as above, allowed to clot at room
temperature and then centrifuged at 2400rpm for ten minutes. It was frozen at -20°c
and analysed in batches of 50 using the Incstar 125I radioimmunoassay (Incstar
Corporation, Stillwater, Minnesota, USA). This assay was kindly performed by the
Clinical Research Centre laboratories at Northwick Park Hospital.
b) Serum collected as above was analysed for sodium (Na) and potassium (K)
using the KODAK EKTACHEM potentiometric slides and creatinine (creat) was
measured by the KODAK EKTACHEM blank-corrected colorimetric test in the
Northwick Park Hospital Laboratories..
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c) A fasting early morning urine specimen was collected on the day of attendance
at the BOMC following a 24 hour gelatine free diet. The sample was separated into
two aliquots:
i) analysis of urinary calcium (UrCa) and urinary creatinine (UrCreat) was performed,
using the KODAK EKTACHEM colorimetric tests, by the Northwick Park Hospital
laboratories
ii) the second aliquot was frozen at -20°c and analysed in batches of 20 for urinary
hydroxyproline (UrHP), using a spectrophotometric method developed and performed
by the Bone Diseases Research Group in the Clinical Research Centre laboratories.
From these results, UrHP:UrCreat and UrCa: UrCreat ratios were calculated.
d) Using the above venepuncture technique, blood was collected for oestradiol
and FSH estimation. It was separated by centrifuge at 2400 rpm for 10 minutes and
stored at -20°c. Oestradiol was measured using the DPC Coat-a-Count 125I
radioimmunoassay (Diagnostic Products Corporation, Los Angeles) in batches of 30
samples, thus reducing the interassay variation.
FSH was measured using the Abbott Laboratories Microparticle Enzyme
Immunoassay, also in batches of 30.
e) The measurement of Lumbar Spine bone density using DXA exposes the
female gonads to small doses of radiation and exclusion of pregnancy was therefore
required in some subjects prior to this procedure. J3HCG was estimated using the
Organon Neo-Planotest 200, a direct latex agglutionation slide test, on an early
morning specimen ofurine.
7) Dietary Calcium Intake
Current and past dietary calcium intake was assessed using the Calquest 2.1 Dietary
Questionnaire (Nelson et al., 1988). Responses were recorded immediately onto the
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computer version of the questionnaire which assessed the daily intake in mg.day"1. To
assist in standardisation of portion sizes, appropriate photographs were used. This
questionnaire has previously been validated against five-day and seven-day weighed
dietary inventories with reported correlation coefficients of r=0.76 and r=0.69
respectively.
8) Eating Disorders
Eating habits were assessed in the 16-35 year age group only. The Eating Attitudes
Test (EAT26) and the Bulimia Investigatory Test Edinburgh (BITE) questionnaires
were used which have been validated for anorexia (Garner et al., 1982) and bulimia
(Henderson et al., 1987) respectively. A score of >30 on the EAT26 score represents
a high likelihood of anorexia and a score of 15 - 30 represents a sub-clinical group
with disturbed eating habits and anorectic attitudes. The EAT26 is also divided into
three further factors: Factor 1 is related to a preoccupation with being thinner, Factor
II relates to bulimia and food preoccupation and Factor 3 relates to self-control of
eating. These subdivisions was also analyzed in our sample. In the BITE
questionnaire, a 'symptom scale score' of >20 represents highly disordered eating and
the presence of binge-eating and a score of 10 - 19 reflects a group with unusual or
disturbed eating habits (subclinical bulimia nervosa). A score of <10 is considered








To determine whether intensive weight-bearing exercise can offset bone mineral loss
associated with secondary amenorrhoea due to athleticism.
To assess morphological and nutritional parameters affecting bone mineral density in
highly trained athletes
Methods
50 national standard middle and long-distance female runners aged 16 to 35 years
(mean 26.3 years) were studied. Twenty-four had amenorrhoea (AM) and 9 had
oligomenorrhoea (OL), for at least the last 1.5 years. 17 had always been
eumenorrhoeic (EU). BMD of the proximal femur and lumbar spine was measured
by Dual Energy X-ray Absorptiometry and compared with both peak bone mass and
with age-matched European reference data.
Results
BMD was low in the AM group at all sites measured but high in the proximal femur
in EU athletes. In the AM group, height and weight were independent predictors of
BMD. Eating disorders were more common in this group and correlated well with
low body weight and body mass index.
Conclusions
Eumenorrhoeic runners have high peak bone mass in the proximal femur but in
amenorrhoeic athletes, despite intensive weight-bearing exercise, peak bone mass is
lower than appropriate in the proximal femur as well as in the lumbar spine.
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Introduction
Physical activity has been shown to have site-specific effects on bone mineral density
(BMD). For instance, in tennis players, bone density is higher in the dominant arm than
the non-dominant arm (Dalen et al., 1985, Pirnay et al., 1987, Haapasalo et al., 1994)
and rowers have high lumbar bone density associated with their greater back strength
(Wolman et al., 1990). However, intensive exercise can predispose to secondary
amenorrhoea and this condition is associated with low bone density, particularly in the
lumbar spine (Drinkwater et al., 1984, Marcus et al., 1985) Concern has arisen that
these athletes may be at risk of early osteoporosis and fracture. Most work in runners
has assessed BMD of the lumbar spine and non weight-bearing areas such as the radius
but there is much less data available on the proximal femur, an important site of
osteroporotic fracture in later life. It seems possible that femoral bone density may be
maintained despite amenorrhoea in runners and that they may not be at increased risk
of later hip fracture.
The aim of this study was to investigate site-specific effects of running on BMD and to
determine whether menstrual dysfunction has significant effects on femoral BMD.
Methods
50 national and international standard Caucasian runners aged 16-35 years were
recruited by advertisements in running magazines according to the criteria in Chapter
4. Seventeen women were considered eumenorrhoeic (EU), 9 had oligomenorrhoea
(OL) and 24 were amenorrhoeic (AM).
Questionnaires gave menstrual, obstetric and training histories. Eating habits were
assessed by the EAT26 and BITE questionnaires. A general medical examination
confirmed fitness to undertake the tests and informed consent was obtained.
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Body Composition, Physiological Characteristics andDietary Calcium Intake
As previously described in Chapter 2 , the following measurements were made:
i) weight and height
ii) body mass index (BMI; weight/height2)
iii) percentage body fat using the four-site skinfold thickness method
iv) isokinetic back strength
v) dietary calcium intake
Bone mineral density
Bone Mineral Density (BMD) in g.cm"2 of the lumbar vertebral bodies (L2-L4) and
the left hip (neck of femur, FN, and trochanteric region, FT) was measured in each
subject by dual energy x-ray absorptiometry (DXA), as described in Chapter 4. Scan
analysis was performed by technicians who were blinded to the menstrual status of the
athlete. The BMD value of each region of interest was compared to the Hologic
reference population at peak bone mass (T-score) and to the age-matched European
population data (Z-score) as previously described.
T-scores and Z-scores were expressed as standard deviations (e.g. mean + 1SD = +1).
Statistical analysis
The statistical package used was Microsoft Excel 5.0. Data were analysed by a single
factor analysis of variance across menstrual groups followed by a two-tailed students
'f test for between-group differences. Although small numbers were involved in some
of the comparisons, the data were considered to be normally distributed and
parametric tests were felt to be appropriate. Comparison of T-scores and Z-scores
against the reference range was performed using an independent "f test. Relationships
amongst variables were analysed using either simple correlation or linear regression
with BMD as the dependent variable. Further parameters were then added to the
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model in a forward selection multiple regression. Significance was accepted
throughout at p<0.05.
RESULTS
1) Demographic, menstruaI and training characteristics
See Tables 1-3. The three groups were similar in age and height. Amenorrhoeic
athletes were lighter and had a lower body mass index than the EU athletes. They also
had lower body fat than both the EU and OL women. As expected the AM athletes
had had fewer years of eumenorrhoea during their lifetime but there was no significant
difference between the duration of menstrual disturbance between the AM and OL
groups. Age at menarche was similar across groups.
The average age of commencement of training for running was 20 years across the
cohort with no differences between the groups. The AM athletes ran slightly more
miles per week but this difference was not significant and indeed the mean V02max
was remarkably similar across groups. Seventy-one per cent, 44% and 35% of AM,
OL and EU athletes respectively ran or had run for Great Britain, with the remainder
competing at top National level.
2) Eating habits
Eating habits were significantly different between the AM and EU groups (Table 4 and
Graph 1). In the AM group, 1 athlete had an EAT26 score of >30 (clinical anorexia)
and 8 had scores of 15 - 30 (disturbed eating). One subject on treatment for anorexia
did not complete her questionnaire and one subject with independently verified
anorexia and bulimia did not fully complete her questionnaire. One EU subject did not
return her questionnaire, reason unknown. The percentage of each menstrual group in
each category of EAT26 score are shown in Graph 1. The BITE symptom score
revealed disturbed eating (score of 10 - 19) in 45% (AM), 33% (OL) and 25% (EU)
60
athletes. One OL athlete had severe binge-eating. The EAT26, Factor 1 and Factor 3
scores were all negatively correlated with weight (r=-0.371, -0.32 and -0.44
respectively, p<0.02). The BITE score was not correlated with weight.
3) Calcium intake
Mean daily calcium intake was slightly higher in the EU group but this did not achieve
significance (Table 5). A large number of athletes consumed less than 600mg per day
(current recommended daily allowance); 25% (AM), 55.6% (OL), 17.6% (EU). Linear
regression of BMD with calcium intake showed a relationship (p=0.058) with
trochanteric BMD but this was eradicated when menstrual status was added to the
model. In addition there was no difference in BMD between those who consumed less
than or more than either 600mg/day or lOOOmg/day.
4) BoneMineral Density
Data analysed using g.cm-2
BMD values in g.cm-2 and between group analysis are shown in Table 6. There was
an approximate linear relationship between menstrual group and BMD with
significantly lower BMD in those with the greatest menstrual dysfunction. Bone
density was 16.5%, 19.5% and 15.6% lower in the AM group compared to the EU
group in FN, FT and LS regions respectively. Similarly, BMD was 12.4%, 11.1% and
10.1% lower in the OL group compared to the EU group.
Regression Analysis
Results of linear regression ofBMD as the dependent variable with various possible
independent variables are shown in Appendix 1, Table 1. Many of these were felt to
have colinearity with menstrual status and further multiple regression was therefore
performed with menstrual status as the main independent variable. Results of this
further step are shown in tables 2, 3, 4.
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Femoral neck
When adjusted for menstrual status, previously noted correlations were no longer
significant.
Trochanteric region
Age of the athlete and age at which the athlete started training (age began) were
negatively associated with BMD after adjustment for menstrual status. However, age
began was highly correlated with the age of the athlete (r=0.78) and one possible
explanation is that the greater number of years spent training, the greater the accrual
of bone mineral. After adjustment for menstrual group, the greater the number of
years of eumenorrhoea, the greater the BMD at this region.
Lumbar spine
Height also contributed to the variance, even when menstrual status was accounted
for.
Linear regression by menstrual group
To determine within group correlations, regression analysis was performed separately
for each group for height and weight. Results of this are shown in Appendix 1, Table
5. Bone density was consistently correlated with height in all areas in the AM group
but not in other groups. Similarly, weight was a predictor of bone density in the AM
group but only in the femur and lumbar spine.
Comparison with the age-matched European reference range
Comparison ofBMD with European data (Z-scores) is shown in Table 7, Graph 2. In
comparison to the expected mean for the groups, the AM group had significantly
lower Z-scores at all regions, and the EU athletes had higher BMD at femoral regions.
Values in the lumbar spine for the OL athletes were significantly lower than expected.
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Between group analysis revealed the AM and OL athletes to have significantly lower
Z-scores in all regions than the EU athletes (p<0.001, p<0.01 respectively). Although
the Z-scores were higher in the OL group compared to the AM athletes this did not
reach significance.
Linear regression, using the whole cohort, revealed very similar results to those
obtained when using the unadjusted BMD g.cm-2 When menstrual status was added
to the model only three relationships remained significant: low FT BMD was
associated with later age at which training began and fewer years of eumenorrhoa
(p<0.05 each) and LS BMD was associated with height (p<0.01). The AM athletes
were significantly lighter than the other athletes but when weight was accounted for in
the model, menstrual status remained a significant variable (p<0.0001). There were no
significant relationships between BMD (any region) and any of the other measured
parameters (Appendix 1, tables 6,7,8)
The groups were then considered separately to determine within group correlation of
BMD with height, weight, BMI and % body fat. In the AM group, BMD was
significantly correlated with height at all regions (LS p=0.001, FN p<0.001, FT
p<0.05) and weight at LS (p<0.02) and FN (p<0.05). These associations were not
evident in the OL and EU groups. Within the amenorrhoea group alone, years of
amenorrhoea was not correlated with BMD.
Comparison with the Hologic reference range for peak bone mass
Comparison ofBMD with peak bone mass (T-score) is shown in Table 8, Graph 3 . T-
scores were significantly low at all regions in the AM group and in the spine in the OL
group. EU athletes had high T-scores in the femoral regions.
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5) Biochemical parameters
The mean values for biochemistry are shown in Table 9. Serum data were unavailable
for one AM and one OL athlete due to laboratory error. An appropriate urine sample
was not provided by three AM and one OL athlete. Serum phosphate was much
higher in the AM group compared to OL and oestrogen levels were lower in AM
athletes than the other 2 groups. This was only significant when compared to EU
athletes, probably because of small numbers in the OL group. Mean prolactin levels
were high in the EU group. These results were skewed by 3 athletes who had very
high results (>600 IU/ml, normal range <400 IU/ml). Subsequent investigation
revealed no abnormality. Osteocalcin levels were highest in the EU group (p<0.005).
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Table 1









Age (years) 27.21 (5.0) 25.44 (6.7) 26.29 (6.4) F2,47 = 0.33 0.72
Height (cm) 164.6 (4.5) 163.7(4.3) 165.9(4.5) F2 47 = 0.84 0.44
Weight (kg) 51.3 (5.1) ** 53.9(5.6) 57.5 (5.4) F2;47 = 7.05 0.002
Body Fat (%) 17.6(4.5) * 21.3 (7.3) <t> 21.0(1.8) F2,47 = 5-37 <0.01
BMI (kg/m2) 18.8 (1.8) ** 20.1 (2.1) 20.9(1.3) F2,47= 7.74 <0.002
Menstrual groups: AM = 0-3 menses per year, OL = 4-9 menses
per year, EU = 10 - 13 menses per year.
Student's 't'-test: *p<0.01, **p<0.005 for AM vs. EU;
^ p<0.05 for AM vs. OL
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Table 2











13.8 (1.3) 14.1 (1.8) 14.1 (2.2) F2,47= 0 16 0.85
Years of
Eumenorrhoea
6.4(4.8)** 7.1 (5.2) 11.7(6.6) F2,47 ~ 4-87 <0.02
Years ofOL/AM 7.0(3.7) 4.9(3.8) - FU1=2.25 0.14
Menstrual groups: AM = 0-3 menses per year, OL = 4-9 menses
per year, EU = 10 - 13 menses per year.
Student's 't'-test: **p<0.005 for AM vs. EU
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Table 3


















F2,44 = 004 0.96
Age began
Training (years)
20.2 (5.8) 20.7(5.5) 19.6 (6.4) F2,47 = 0.11 0.90
Menstrual groups: AM = 0-3 menses per year, OL = 4-9 menses
per year, EU = 10 - 13 menses per year.
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Table 4
Total EAT26 and BITE Scores.
Mean (Standard Deviation)
Group AM OL EU
(n=22) (n=9) (n=16)
EAT26 12.3 (9.4) ** 10.4(8.6) 5.6(6.0)
Factor 1 7.7(6.3) * 7.4(5.8) 3.8(3.8)
BITE 7.6 (3.7) 9.2(6.1) 5.4(3.7)
'symptom score'
Menstrual groups: AM = 0-3 menses per year, OL = 4-9 menses
per year, EU = 10 - 13 menses per year.
2 athletes in AM group and 1 athlete in EU group failed to return questionnaires
* p<0.05, **p<0.02 for AM vs.EU
Table 5
Dietary Calcium Intake by Menstrual Group
Mean (Standard Deviation)
Group AM OL EU
(n=24) (n=9) (n=17)
Dietary Calcium 829.1 (387.8) 807.7 (484.6) 1055.7(440.6)
Intake (mg.day1)
No significant differences in calcium intake between groups
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Attitudes towards eating assessed by EAT26 questionnaire.
Scores of 0-14 represent normal eating, 15-30 represents
disordered eating with anorectic attitudes, >30 indicates
clinical anorexia.
AM: amenorrhoeic athletes (n=22)
OL: oligomenorrhoeic athletes (n=9)
EU: eumenorrhoeic athletes (n=16)
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Table 6
BMD (g.cm-2) by menstrual group.
Mean (Standard Deviation)
Group FN FT LS
AM
(n=24)
0.81 (0.08)*** 0.66 (0.11)*** 0.92 (0.10)***
OL
(n=9)
0.85 (0.12)* 0.73 (0.07)*** 0.98 (0.07)**
EU
(n=17)
0.97 (0.11) 0.82 (0.07) 1.09 (0.10)
FN = Neck ofFemur, FT = Trochanteric Region, LS = Lumbar Spine, L2-L4
Students 'f test: **** p< 0.0001 for AM vs. EU
*** p< 0.005 for OL vs. EU
** p< 0.01 for OL vs EU
* p< 0.02 for OL vs EU
No significant differences between AM vs. OL
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Table 7
Comparison of BMD with age-matched mean of European reference population
Mean Z-Score (SD of Z-Score)
Group FN FT LS
AM
(n=24)
-0.57 (0.74) ** -0.57(1.19) * -1.27 (1.0) ***
OL
(n=9)
-0.23 (1.14) +0.19(0.6) -0.64 (0.7) *
EU
(n=17)
+0.98 (1.0) ** +1.14 (0.69) *** +0.41 (0.92)
Bone mineral density was compared with European population data
using equations prepared by Dequeker et ah, 1995 Pearson et al.,
1995. Z-score = SDs above or below the population mean.
* P<0.05, ** P<0.005, *** PO.OOl
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Bone Mineral Density (Z-score) of Proximal Femur and
Lumbar Spine in Female Athletes
□ AM BOL BEU
Graph 2
Mean (+/- SE) of bone mineral density of middle and long¬
distance runners compared to the age-matched European
reference range (Z-score). Z-score given in standard
deviations above or below the mean.
FN: neck of Femur, FT: trochanteric region, L2-L4: lumbar
spine.
t-test compares each group with the European range.
*p<0.05, **p<0.005, ***p<0.001
AM: amenorrhoeic athletes (n=24)
OL: oligomenorrhoeic athletes (n=9)
EU: eumenorrhoeic athletes (n=17)
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Table 8
Comparison of BMD with peak bone mass of Hologic reference population
Mean T-score (Standard Deviation of T-score)
Group FN FT LS
AM
(n=24)
-0.91 (0.74)*** -0.79 (0.96)*** "1.46 (0.88)***
OL
(n=9)
-0.51 (1.22) +0.03 (0.65) -0.88 (0.66)**
EU
(n=17)
+0.76(1.14)* +1.08 (0.80)*** +0.07 (0.86)
FN = Neck of Femur, FT = Trochanteric region, LS = Lumbar Spine
L2-L4
T-score = SDs above or below the mean peak bone mass ofAmerican
population at age 22 years (FN) and 30 years (FT and LS) using
Hologic reference database (T-score).
p values: *<0.02, ** <0.01, *** <0.001
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Bone Mineral Density (T-score) of Proximal Femur and
Lumbar Spine in Female Athletes
Graph 3
Mean (+/- SE) ofbone mineral density of middle and long¬
distance runners compared to the Hologic reference range. T-
score = standard deviations above or below the mean peak bone
mass of the American population at age 22 years (FN) and 30
years (FT and L2-L4).
FN: neck ofFemur, FT: trochanteric region, L2-L4: lumbar
spine.
t-test compares each group with the Hologic range:
*p<0.02, **p<0.01, ***p<0.001
AM: amenorrhoeic athletes (n=24)
OL: oligomenorrhoeic athletes (n=9)
EU: eumenorrhoeic athletes (n=17)
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Table 9









Calcium (mmol.l"1) 2.32 (0.07) 2.31 (0.04) 2.31 (0.09)
Phosphate (mmol.l"1) 1.26 (0.12)^ 1.10(0.15) 1.18 (0.16)
Alkaline Phosphatase
(mmol.l"1)
62.74(15.70) 56.25 (11.71) 62.29 (24.93)
Oestrogen (pg.ml"1) 161.3 (173.1)* 331.4 (350.6) 325.8 (229.7)
FSH (mIU.1"1) 5.50 (2.57) 5.09 (2.68) 5.10(2.61)
PRL (IU.H) 177.4 (90.7) 170.6(84.7) 350.9 (283.9)*
Osteocalcin (ng.ml"1) 2.45 (0.93) 2.63 (1.24) 3.52(1.14)*
Urinary Parameters (n=21) (n=8) (n=17)
Ca:creat 0.47(0.35) 0.29 (0.20) 0.34 (0.23)
OHPrcreat 38.7(68.7) 21.1 (11.8) 21.4(12.8)
FSH = Follicle Stimulating Hormone
PRL = Prolactin
Ca:creat = Urinary calcium : creatinine
OHPr:creat = Urinary hydroxyproline : creatinine
Students't' test: ^ p=0.005 AM vs.OL
* p<0.02 AM vs EU, ** p<0.005 AM vs EU
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DISCUSSION
1) The effect of menstrual history on BMD
The main focus of this study was to shed further light on the interplay between low
bone density due to athletic amenorrhoea and the beneficial effects of mechanical
stress at appropriate bone sites. The results for lumbar BMD support previous findings
that BMD is markedly low in amenorrhoeic runners. The relationship between
menstrual history and BMD was virtually linear between the groups. This may have
been further highlighted if data for lifetime number ofmenstrual cycles had been used
rather than the less sensitive categorisation used here. Nevertheless, the results are
very similar to those obtained by Drinkwater et ah, (1990) who showed a linear
relationship between menstrual history and lumbar BMD in 97 active women. In the
Drinkwater study those women with the severest menstrual dysfunction had BMD
17% lower than those who had always been eumenorrhoeic and in this study the
difference was 15.6%.
Highly trained middle and long-distance runners perform very little training other than
running which exerts minimal direct mechanical stress on the spine. In addition, the
lumbar spine is high in trabecular bone which is known to lose bone mineral early in
low oestrogen states. It is therefore not surprising that if detrimental effects of low
oestrogen levels are to be seen in such athletes, they will occur at this site.
What is surprising is the extent to which BMD is affected in these young women. The
emergence of the new European population reference range (Pearson et ah, 1995a,b)
has enabled comparison of the BMD of this small sample with a large number of age-
matched women. The finding that, on average, British top-class amenorrhoeic runners
have lumbar BMD that is 1.3 standard deviations below the population mean, with
54% having BMD >1.5 SD's lower gives concern for the future. At present there is no
method available to predict lifetime risk of vertebral fracture from peak bone density
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but if these women remain in the lowest quartile ofBMD until the menopause, Kroger
et. al., (1995) estimate that they may be at three times greater risk of fracture than
those in the highest quartile.
Weight-bearing exercise is associated with high BMD in weight-bearing skeletal sites
in eumenorrhoeic athletes (Heinrich et al., 1990, Risser et al., 1990, Wolman et al.,
1991, Slemenda et al., 1993). It would be expected therefore that the muscular
stresses exerted on the femur during running, combined with ground reaction forces,
could offset bone mineral loss associated with amenorrhoea, although this study has
clearly shown that a linear relationship also exists between degree of menstrual
irregularity and femoral BMD at both the trochanteric region and the femoral neck.
Whereas lumbar BMD (g.cm"2) was 15.6% lower in the amenorrhoeic athletes
compared to the eumenorrhoeic runners, BMD (g.cm"2) was 16.5% and 19.5% lower
in neck of femur and trochanteric regions respectively. But the deficit compared to the
population age-matched mean was less than that seen in the spine (mean Z-score -
0.6SD's for neck of femur and trochanteric regions in AM group). This suggests that
Wolffs law applies equally in amenorrhoiec and eumenorrhoeic athletes but that
running is an insufficient stimulus to prevent bone mineral loss associated with hypo-
oestrogenism. Data from animal models of bone turnover (Rubin & Lanyon 1984) and
weight-lifting athletes and gymnasts (Granhed et al., 1987, Conroy et al., 1993,
Robinson et al., 1995) also suggest that low impact, repetitive stress is less effective at
inducing bone adaptation than high impact, low frequency stimuli.
The results presented here differ from most previous studies on femoral BMD in
amenorrhoeic athletes. Amenorrhoeic dancers and gymnasts have been noted to have
normal or high femoral BMD (Young et al., 1994, Robinson et al., 1995) which may
reflect the different type of training. Previous studies on runners have primarily used
dual photon absorptiometry (DPA) which is less sensitive at the proximal femur than
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DXA which may account for some of the discrepancy (Drinkwater et al., 1990,
Myerson et al., 1992). Snead et al., (1992) showed no difference in BMD of femoral
neck, trochanteric region or Wards triangle BMD between a group of 10
oligo/amenorrhoeic runners and eumenorrhoeic runners or sedentary controls. But this
small group were defined as having 0-9 menses per year and were therefore more
closely allied to the present study's OL group than AM group. Robinson et al., (1995)
did show a relationship between menstrual history and femoral BMD in runners
although his group was too small to assess statistically. He found a 17% difference
between those with prolonged amenorrhoea compared to those with regular cycles.
Reduced BMD has also been noted in the femoral shaft by Drinkwater et al., (1990)
but in this original paper there was no difference in femoral neck BMD. A recently
published paper from the same laboratory has however shown reduced bone density in
all areas of the femur measured, thus supporting the present study (Rencken et al.,
1996). The strength of the present study lies in the relatively large number of
amenorrhoeic athletes, separated from oligomenorrhoeic subjects, and the use of
DXA, a more sensitive method of BMD measurement than Dual photon
absorptiometry which was used in some of the earlier studies.
In common with Drinkwater et al., (1990) we were unable to demonstrate any
relationship between the duration of amenorrhoea and BMD. It has been suggested
that during athletic amenorrhoea, the greatest rate of loss of bone mineral occurs
during the first few years (Cann et al., 1985). Our cohort of amenorrhoeic women had
a mean of 7.75 years of amenorrhoea and it is likely that this obscured any
relationship between BMD and the duration of amenorrhoea. More important in our
study appeared to be the duration of eumenorrhoea, particularly in the trochanteric
region and the lumbar spine. This suggets that the longer the skeleton is exposed to
normal sex hormone levels at this age, the greater the ability to accrue bone mineral.
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2) The beneficial effects of running on BMD
In common with other studies on the effects of weight-bearing exercise on BMD in
regularly menstruating women, this study has shown that long-distance running is
associated with high BMD at weight-bearing sites. In this group of eumenorrhoeic
women, BMD of the proximal femur was not only 1 SD above the European age-
matched mean, it was also just as high compared to the Hologic reference range for
peak bone mass in American women. If bone mineral content of these women follow
expected patterns of change they will have higher than average BMD at the
menopause and will have a reduced lifetime risk of hip fracture (Melton et al., 1988,
Black et al., 1992, Cummings et al., 1993, Kroger et al., 1995). As previously
discussed, there is little benefit of running on BMD of the lumbar spine.
3) The effect ofmorphological characteristics on BMD
Some authors have suggested that lower BMD in amenorrhoeic athletes is due to their
lower body weight (Myerson et al., 1992) but in the present study the relationship
with menstrual status remained very strong even after adjustment for these variables.
Height, weight, and body mass index were significantly associated with BMD,
predominantly in the lumbar spine although when menstrual group was accounted for,
only height continued to contribute significantly to the variance in BMD. Within
group analysis of these parameters however, showed that in the amenorrhoeic group,
height and weight were independent predictors of BMD whereas this was not
demonstrated in the other groups. These results are similar to those of Drinkwater
(Drinkwater et al., 1990, Rencken et al., 1996) who has also shown that BMD is
correlated with body weight and that this relationship is stronger in those athletes with
the greatest menstrual dysfunction.
It is possible that in the presence of normal levels of sex hormones and large amounts
of mechanical stress, other variables have only small additive influences on BMD
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which we have been unable to demonstrate in this small sample. However, when sex
hormone levels are low, as in athletic amenorrhoea, other factors may acquire more
influence. It seems likely that mechanical stress to the skeleton is greater in taller,
heavier women and this relationship is uncovered in the amenorrhoeic group.
4) Eating disorders and bone density
The prevalence of eating disorders was much greater in the amenorrhoeic group and a
high anorexia score was associated with low body weight, body mass index and
percentage body fat. Total EAT, Factor 1, Factor 3 and BITE scores were all
correlated with BMD, predominantly at the trochanteric region but were not predictive
of bone density when menstrual status was accounted for. These results support the
evidence for a high incidence of eating disorders in amenorrhoeic runners. Gadpaille et
al., (1987) found that nearly two thirds of amenorrhoeic runners had evidence of an
eating disorder compared to none of the cyclic runners in his study. Higher EAT
scores and subscales of the score have also been found in amenorrhoeic runners
compared to eumenorrhoeic runners (Myerson et al., 1991) and prolonged
amenorrhoea has been strongly associated with dieting in dancers. Brooks-Gunn et al.
(1987) found that a half of amenorrhoeic dancers reported anorexia nervosa as
opposed to only 13% of dancers with normal periods. The amenorrhoeic dancers
weighed less and were leaner (P<0.05) than their eumenorrhoeic peers and had higher
scores on the EAT26 scale (P<0.01). Although some workers have found no
differences between the incidence of either overt anorexia and bulimia or altered eating
behaviour or attitudes in amenorrhoeic athletes (Myburgh et al., 1992; Snead et al.,
1992), the majority of workers have shown a trend towards some form of
dysfunctional eating or weight control in those with menstrual abnormalities (Walberg
& Johnston, 1991; Wilmore et al., 1992) but no direct relationship with bone density.
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There have been no other reports of the use of the BITE questionnaire in athletes. This
questionnaire probes for the presence of bulimic symptoms in particular and it is
interesting to note that the oligomenorrhoeic subjects had significantly high results
compared to the eumenorrhoeic runners. Bulimia is often associated with normal
weight, body fat and body mass index in addition to menstrual irregularity and it is
possible that the oligomenorrhoeic athletes represent a distinct subgroup of long¬
distance runners.
Use of eating habits questionnaires such as the EAT26 and BITE may be helpful in
identifying those athletes most at risk of developing abnormal eating habits and
menstrual irregularity although they are not good independent predictors of bone
density.
5) Dietary calcium intake and bone density
In addition to low caloric intake, athletes tend to avoid foods high in fat (often dairy
products), and other studies have shown correlations between BMD and dietary
calcium in runners (Wolman et al., 1992). Although thirty per cent of our cohort
consumed less than the British recommended daily intake of calcium (600mg/day) we
found no differences in BMD at any region between those consuming either less than
600mg/day or more than 1 OOOmg/day compared to the remainder. Nor was there any
evidence of a linear relationship. It is possible that more detailed analysis of calcium
intake, for instance by daily weighing of food or 7-day dietary records, may have
revealed a closer relationship.
6) Conclusion
This study has confirmed the relationship between menstrual irregularity and low bone
density in athletes, not only in the spine but also in the femur. Although weight and
height contribute to some of the variance, this effect is far outweighed by the
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enormous impact of the hypo-oestrogenic state. The study also highlights the interplay
between low body weight, body mass index, eating disorders and amenorrhoea in this
group ofathletes.
Cross-sectional studies can be criticised for not eliminating selection bias. It is
possible that those women who develop menstrual dysfunction have a constitutional
tendency towards lower BMD, although there is evidence against this explanation
(Slemenda et al., 1994). This question cannot be fully answered until longitudinal
studies follow adolescent athletes for many years. Furthermore, it is unknown whether
amenorrhoeic athletes continue to have low BMD up to and after the menopause.
There are suggestions that there may be a gain in BMD when menses return or when
training is reduced (Lindberg et al., 1987, Drinkwater et al., 1986). However, it
seems unlikely that these runners will ever reach their maximum potential peak bone








To investigate whether regular vigorous physical exercise is associated with high
levels of bone density in women in the decade before the menopause and whether this
effect is less in women who start training after the attainment of peak bone mass.
To see if a previous history of menstrual irregularity has long-lasting effects on bone
density despite exercise.
Methods
Bone density was measured by dual x-ray absorptiometry in 50 premenopausal
women aged 40 years and over who each week exercised for at least three hours or
ran 15 miles (24km). Twenty-seven began exercising after the age of 30 years (late-
starters, LS); the remainder had been active since leaving school (all-timers, AT).
Thirteen women had prior menstrual irregularity.
Results
There were no significant differences between the AT and LS groups in bone density
of the lumbar spine and two sites in the proximal femur; but both groups showed high
bone density at all three sites compared to the European reference range (p<0.025-
0.005). Those who remained continuously eumenorrhoeic had bone density values 0.4
-1.05 standard deviations above the mean for their age. Those with prior menstrual
irregularity showed smaller benefits in the femur and none in the spine. Late-starters




Bone density at common fracture sites was substantially greater than expected in
women undertaking long-term exercise in the oestrogenized state whether exercise
started in the 'teens or the thirties. Exercise may reduce the lifetime risk of fractures
by preserving adequate bone mass into the later postmenopausal period.
Introduction
An ageing population and an increasingly sedentary lifestyle have contributed to the
rising incidence of osteoporotic fractures in post-menopausal women (Cooper et al.,
1991). Because treatment of osteoporosis is often instigated only after fractures have
occurred, methods of prevention are likely to be of greater benefit. A reduction in
fracture rate of the proximal femur has been associated with increased levels of
physical activity and muscle strength in the elderly (Cooper et al., 1988). This may be
due to fewer falls (Wickham et al., 1989) but is also likely to be related to higher bone
mineral density (BMD) in those individuals with greater levels of activity (Pocock et
al., 1989).
Although studies on older athletic women have shown that higher BMD is linked with
greater physical activity (Jacobsen et al., 1984, Talmage et al., 1986, Jonsson el al.,
1992) little information exists on the long-term effects of regular exercise. Nor is it
known what exercise prescription is required to achieve maximum bone mass. It is
unclear whether exercise should be undertaken before the age when bone mass peaks
or whether similar levels can be achieved if exercise is started after this age. High
intensity exercise starting at an early age is associated with secondary amenorrhoea
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and low oestrogen levels which may result in reduced bone density, especially of the
lumbar spine (Marcus et al., 1985, Drinkwater et al., 1990, Wolman et al., 1990).
This study assesses the long-term effects of regular exercise on bone density of
premenopausal women forty years and over. It also examines the importance of the
length of time during which the subject has exercised and the effects of previous
episodes ofmenstrual irregularity.
Methods
Fifty premenopausal women, aged 40 years or over, were recruited after responding
to advertisements in running and athletic journals. Subjects were from the general
population of South-East England according to the criteria in Chapter 4. Twenty-
three women had trained consistently since leaving school (all-timers, AT). The
remaining 27 were sedentary after leaving school but commmenced training after the
age of thirty years and for a minimum of three years prior to the study (late-starters,
LS). Thirteen gave a history of menstrual irregularity lasting more than two years
(non-EU). The others had had normal menstruation (EU) and all were eumenorrhoeic
at the time of the study. These categories allowed further subdivision into four
groups: 1) AT/EU, n=15; 2) AT/non-EU, n=8; 3) LS/EU, n=22; 4) LS/non-EU,
n=5.
Questionnaires gave menstrual, obstetric and training histories. A general medical
examination confirmed fitness to undertake the tests and informed consent was
obtained.
Body Composition, Physiological Characteristics andDietary Calcium Intake
As previously described in Chapter 4 (Methods) , the following measurements were
made:
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0 weight and height
") body mass index (BMI; weight/height2)
iii) percentage body fat using the four-site skinfold thickness method and from
total body potassium (TBK).
iv) fat free mass (FFM) in kg estimated from TBK.
v) grip strength of the dominant and non-dominant hands
vi) isokinetic back strength
vii) dietary calcium intake
Bone mineral density
Bone Mineral Density (BMD) in g.cm"2 of the lumbar vertebral bodies (L2-L4) and
the left hip (neck of femur, FN, and trochanteric region, FT) was measured in each
subject by dual energy x-ray absorptiometry (DXA), as described in Chapter 4. Scan
analysis was performed by technicians who were blinded to the menstrual or activity
status of the athlete. The BMD value of each region of interest was compared to the
Hologic reference population at peak bone mass (T-score) and to the age-matched
European population data (Z-score) as previously described.
T-scores and Z-scores were expressed as standard deviations (e.g. mean + 1SD = +1).
Statistical methods
The statistical package used was Microsoft Excel 5.0. Between group differences
were assessed using ANOVA followed by Students 'f test. An independent 't' test
compared the mean Z-scores and T-scores with the reference population. Simple
correlation assessed relationships between physiological and morphological
parameters. Linear regression with BMD g.cm"2 or Z-score as the dependent variable
assessed relationships between BMD and the other variables. Multiple stepwise
regression was then used to determine the most significant variables. Data values are
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42 subjects were middle or long-distance runners, 3 were ultra-distance walkers and 5
competed in other events such as triathlon, hockey or javelin. Current and past sports
are shown in Tables 1 and 2. Thirty (60%) competed at National or International
veteran championship level and 20 (40%) competed at Club or County level. The
groups were similar in number of miles run, hours spent training and number of
sessions per week (Table 3). Weight-training was undertaken by 5 (33.3%) in groupl,
none in group 2, 8 (36%) in group 3 and 3 (60%) in group 4. There were no
differences in BMD between those who had weight-trained and those who had not.
Late-starter athletes had exercised for a mean of 9.0 years (range 5-20 years) and
were as successful at international level as the all-timer athletes (30%, 35% medals
respectively). The older the woman in the LS group, the more years they were likely
to have been training (correlation coefficient r=0.54, P<0.01).
2) Body composition and physiological parameters
Differences between the all-timer and late-starter athletes and between
eumenorrhoeic and non-eumenorrhoeic athletes
The AT women were significantly taller (p<0.03) and had greater fat free mass in kg
(p<0.05). When FFM was expressed as percentage of total body mass the difference
between the two groups was less significant (p=0.067). The AT women also had a
lower body fat content when assessed by skinfold thickness measurements (p<0.03)
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but not when assessed by the TBK method (p=0.14). There were no other differences
in strength measurements or body composition and maximal aerobic capacity (Table
4). There were no differences in training details, strength or physiological
characteristics when grouped according to menstrual group (EU vs. Non-EU).
Strength andfitnessparameters
The number of hours trained per week (HPW) correlated well with number of miles
run (MPW) (p<0.001) and VC^max (<0.05). VC^max was also correlated with MPW
and %body fat (p<0.01, p<0.001 respectively). There was no relationship between
grip strength and aerobic fitness.
Dominant hand grip strength was correlated with most measures of back strength
(p<0.01 - p<0.05) and non-dominant grip strength was highly correlated with all
measures of back strength (p<0.001 - p<0.01). Grip strength was dependent on body
weight (p<0.05).
3) Obstetric and gynaecological history
10 women had commenced hormone replacement therapy without a break in menses
(2 in group 1, 1 in group 2, 6 in group 3 and 1 in group 4). One subject (group 1) had
had a hysterectomy and bilateral oophorectomy with subsequent HRT administration.
There were no significant differences in BMD of any region measured between this
subgroup of eleven subjects and the whole sample. The EU women averaged 32.4
years of regular menses and the non-EU women had an average of 20.7 years of
regular menses (ANOVA; F= 61.8, p<0.0001). Oligoamenorrhoea had occurred for
12.1 (6.5) and 5.2 (1.8) years in groups 2 and 4 respectively. The AT athletes had had
fewer pregnancies than the LS group (mean 1.4 vs. 2.0, p< 0.04).
4) Dietary Calcium Intake
There were no differences across the groups in calcium intake. Only 6 subjects
currently took less than the recommended daily allowance of 600mg.day"^ and 48%
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consumed over lOOOmg.day"'. Although it was possible to assess past intake, this
data was not felt to be sufficiently reliable to analyse. There were no linear
correlations between BMD g.cnr2 or Z-scores and calcium intake. Nor was there any
difference in BMD between those currently consuming >1000mg.day"l and those
taking less.
5) Bone Mineral Density
i) Results expressed as g.cm"2
BMD in g.cm"2 are shown in Table 5.
Comparison by athletic activity andmenstrual status
There were no significant differences between the femoral densities for EU and non-
EU groups. However, BMD was lower in the lumbar spine in the non-EU group
(P=0.045). BMD was similar in the AT and LS groups at all regions.
Regression Analysis
Linear regression of BMD (g.cm"2) versus age showed no variation at any site.
However when athletic status was accounted for, older age in the AT group was
related to decreasing BMD in the lumbar spine and in the LS group was related to
increasing L2-L4 BMD (P<0.05).
Neck offemur
There were no significant demographic, menstrual, or physiological variables
associated with BMD of the FN.
Trochanteric region
Trochanteric BMD was positively associated with height and grip strength in the
dominant hand. The greater the number of pregnancies, the lower the tendency for
BMD (F=4.0, p=0.051). It was also negatively associated with the number of hours of
training undertaken. However, this result was skewed by two individuals who trained
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for 17.5 and 19 hours per week and in whom BMD was very low. When these results
were excluded, this relationship was not apparent in the remainder of the cohort.
Lumbar Spine
Very similar results were obtained for L2-L4 as for FT except that the relationship
between number of pregnancies and BMD was slightly stronger (F=5.24, p=0.03).
Again the apparent relationship between hours trained and low bone density was
skewed by two individuals. Lumbar BMD was also negatively associated with
VC^max.
Multiple regression
Menstrual group was used as the first independent variable followed by the
parameters above. All the above noted relationships remained significant. When
weight was accounted for the relationship between grip strength and lumbar BMD
disappeared but was just outside significance for the trochanteric region (p = 0.06).
ii) BMD compared to the age-matched European population (Z-scores)
BMD Z-scores are shown in Table 6
The BMD of each subject was compared to the mean bone density found in the
European reference population of that age. EU women (groups 1 and 3) had
significantly high Z-scores in almost all regions. They were also significantly high in
group 2 (AT/non-EU) in the neck of femur.
Comparison by athletic activity andmenstrual status
BMD Z-scores were also analysed by athletic activity (AT vs. LS) and menstrual
group (EU vs. non-EU). ANOVA showed no significant difference in BMD at any
region between AT and LS. In addition, the mean Z-scores for the AT and LS groups
were significantly above the age-matched mean (Graph 1). BMD was lower in non-
EU athletes when compared to the EU women but this only reached significance in
the lumbar spine (P<0.05), (Graph 2).
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Linear regression (Appendix 2, table 2)
Neck ofFermir
Again there were no apparent relationships between any of the variables measured and
Z-scores.
Trochanteric region
As noted for g.cmf2, FT Z-score was associated positively with height (p<0.02) and
dominant hand grip strength (p=0.054). There was a similar negative association with
number ofpregnancies and hours trained per week.
Lumbar Spine
The same associations were found as for BMD g.cm-2. Graphs 3 and 4 show the
relationship between BMD Z-score and the number of hours trained per week and
VC^max respectively.
Multiple regression (Appendix 2, tables 3 and 4)
When menstrual status was accounted for in multiple regression, greater height was
associated with higher Z-scores in the trochanteric region and the lumbar spine (both
p<0.05). L2-L4 Z-score remained negatively associated with the number of
pregnancies and V02max. The only additional finding was that spinal BMD became
positively correlated with back strength (peak torque in extension at 60°. sec" 1,
p<0.05, Appendix 2, table 4).
iii) BMD compared to the peak bone mass of the American population
(T scores)
T-scores are shown in Table 7.
BMD of each subject was compared to the peak bone mass of that region found in the
American reference population. EU women had positive T-scores in all regions but
this was only significant in group 1 in the trochanteric region (P<0.01). Non-EU
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women had negative T-scores except in the trochanteric region. The T-score in group
2 was low in the lumbar spine (P<0.05).
6) Biochemical Parameters
There were no differences between groups in any of the biochemical or hormonal
parameters measured. In 4 women, oestradiol was below the detectable range of 70
pmol.H (1 in group 1, 1 in group 2, 2 in group 3). FSH was not above the normal
range in these women and in view of regular menses, they were considered
premenopausal. There was no correlation between oestradiol levels and BMD g.cm"2
FSH was higher than the normal range in 7 women (2 in group 1, 1 in group 2, 3 in
group 3, 1 in group 4). In all these women, oestradiol was within the normal range
and 6 were on HRT. All had regular menses.
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Table 1
Current Sporting Activity of Premenopausal Veteran Athletes
Sport Definition Number of athletes
Triathlon Swim/cycle/run 3
Long-distance running > 1500m - marathon 36
Middle-distance ruuning 800- 1500m 4
Sprint 100/200/400m/hurdles 2





Previous Sporting Activity of All-Timer Premenopausal Veteran Athletes
Sport Definition Number of athletes
Long-distance running > 1500m - marathon 8
Middle-distance ruuning 800- 1500m 5
Race-walking > 1500m - marathon 1
Ball games Hockey/squash/badminton 6
Throwing Javelin/shot-putt/discus 1
Cycling 1


















Age (years) 45.5 (4.9) 42.5 (2.6) 46.0 (4.2) 43.2(4.1)
Miles run per
week
27.0(17.5) 38.7(13.7) 31.3 (15.8) 31.2(8.2)
Hours trained
per week





5.7(2.4) 7.9(3.8) 6.6(1.7) 6.0(1.7)


















Height (cm) 165.9(4.8)** 163.5 (4.5)** 161.7(4.2) 164.8 (4.5)
Weight (kg) 59.5 (4.9) 55.4 (5.5) 57.2 (4.2) 58.3 (6.0)
BMI (kg.rn"2) 21.6(1.6) 20.7(1.5) 21.9(1.4) 21.4(1.5)
Fat Free Mass
(kg)
46.8(3.2)* 45.1 (5.5)* 43.9(3.9) 43.1 (4.9)
Fat Free Mass
(%)
78.9(3.9) 81.4(6.0) 73.5 (8.5) 74.0 (5.9)















46.0 (6.8) 50.9 (7.4) 45.2 (8.3) 43.0(11.2)
AT = all-timer, LS = late-starter, EU = always eumenorrhoeic, non-EU = at least 3
years prior menstrual irregularity.
Body fat (%) measured by skinfold thickness method
Students 'f test for AT(groups 1&2) vs. LS (groups 3&4): * p<0.05, ** p<0.03
95
Comparison of Bone Mineral Density Z-scores
Between All-timer and Late-starter Athletes
Graph 1
Bone mineral density of'all-timer' (AT) athletes and
those who had started training after the age of 30 years
('late-starter', LS) athletes. Bone density shown as mean
Z-score (+/-SE) for each region of interest. No significant







Bone mineral density (g.cm-2) of Premenopausal Veteran Athletes
Mean (Standard Deviation)
Group n Neck of Femur Trochanteric Region L2-L4
1
(AT/EU)
15 0.900 (0.13) 0.805 (0.10) 1.162 (0.17)
2
(AT/non-EU)
8 0.880 (0.05) 0.741 (0.07) 1.025 (0.05)*
3
(LS/EU)
22 0.901 (0.08) 0.753 (0.10) 1.088 (0.09)
4
(LS/non-EU)
5 0.863 (0.09) 0.723 (0.09) 1.051 (0.15)*
AT = all-timer, LS = late-starter, EU = always eumenorrhoeic, non-EU = at least 2
years prior menstrual irregularity.
* p<0.05 for EU vs. non-EU groups combined
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Table 6
Comparison of BMD of Premenopausal Veteran Athletes with Age-matched
European Data (Z-score)
Mean (Standard Deviation)
Group n Neck of Femur Trochanteric Region L2-L4
1
(AT/EU)
15 +0.71 (1.17)* +0.97 (0.99)*** +1.05 (1.50)**
2
(AT/non-EU)
8 +0.52 (0.43)** +0.35 (0.74) -0.17(0.53)
3
(LS/EU)
22 +0.77 (0.81)**** +0.45 (1.02) +0.42 (0.83)*
4
(LS/non-EU)
5 +0.35 (0.84) +0.15 (1.00) +0.04 (1.40)
Z-score = SD's above or below the age-matched mean of the European population
reference data
AT = all-timer, LS = late-starter, EU = always eumenorrhoeic, non-EU = at least 2
years prior menstrual irregularity.




Comparison of BMD of Premenopausal Veteran Athletes with Peak Bone Mass
of American Reference Population (T-score)
Mean (Standard Deviation)
Group n Neck of Femur Trochanteric Region L2-L4
1
(AT/EU)
15 +0.05 (1.31) +0.92 (1.14)** +0.75 (1.57)
2
(AT/non-EU)
8 +0.14 (0.45) +0.21 (0.73) -0.49 (0.48)*
3
(LS/EU)
22 +0.06 (0.82) +0.35 (1.08) +0.08 (0.83)
4
(LS/non-EU)
5 +0.31 (0.93) +0.01 (0.96) -0.25 (1.36)
T-score = SD's above or below the mean BMD of the Hologic reference
population at 22 years for the neck of femur and 30 years for the trochanteric
region and lumbar spine. AT = all-timer, LS = late-starter, EU = always
eumenorrhoeic, non-EU = at least 2 years prior menstrual irregularity.
'f test for comparison of T-score versus mean of reference population, P values: *
<0.05, **<0.01
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Comparison of BMD Z-scores
between EU and non-EU Athletes
Graph 2
Bone mineral density of athletes who had had continuous
eumenorrhoea (EU) compared to BMD of those who had
a history of irregular menstruation (non-EU). Bone
density shown as mean Z-score (+/-SE) for each region
of interest. Although BMD is lower in all areas






BMD Z-score of premenopausal veteran athletes
versus number of hours trained per week
Hours trained per week r= -0.358
Graph 3
The age-adjusted bone mineral density (Z-score) was compared
to the number of hours trained per week. The trend was for lower
BMD in those who trained for the greatest number of hours per
week. However this result was skewed by two individuals who
trained for 17.5 and 19 hours per week and who had very low
BMD. When these results were excluded the relationship was no
longer apparent.
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BMD Z-score of premenopausal veteran athletes











10 20 30 40 -5^ 60 70
VQ2max (ml/kg'nin) r= -0.351
Graph 4
The age-adjusted bone mineral density (Z-score) was
correlated with the maximal aerobic capacity (V02max).




1) The effect on bone density of a lifetime of physical activity
Although this study was unable to show that bone density increases with exercise (as
only a longitudinal study can), it has demonstrated that women with a lifetime history
of regular aerobic exercise have much higher bone density than expected when
compared to the European population. This was true for the lumbar spine as well as
the weight-bearing proximal femur which perhaps reflects the slightly more diverse
training in these older women than in the younger elite distance runners. Indeed, it
was possible to demonstrate a correlation between back extensor strength and bone
density of the lumbar spine. This has previously been shown in rowers by Wolman et
al. (1990), in young women by Henderson et al., (1995) and in older men by Bevier et
al., (1989).
Two other studies have looked at a similar group of women. Jacobson et al., (1984)
evaluated BMD in athletic women aged 40 - 55 years and found higher distal radius
and lumbar BMD compared to their control population. This group of athletic women
were predominantly tennis players and included both late-starter and all-timer athletes.
The same group ofworkers also showed that the age-related loss in bone mineral was
abolished in women who exercised regularly 3 times a week for 9 months of the year
and who had done so for the last 5 years (Talmage et al., 1986). There are no
available equivalent studies for femoral bone density and no studies which have
differentiated between late-starter and all-timer athletes.
Not only was bone density higher than age-matched European women, it was also
higher than the Hologic reference mean for peak bone density in the trochanteric
region. In these women who are approaching the menopause it is highly significant to
find bone density which is approximately 1SD above the age-matched mean in all
regions and nearly 1SD above peak bone mass in the femur. It has been shown by
103
several authors that high peak bone mass or high BMD at the menopause is associated
with a reduced risk of osteoporotic fracture in the spine and the femur (Melton et al.,
1988, Black et al., 1992, Kroger et al., 1995). Cummings et al., (1993) estimated
from a group of 8000 postmenopausal women that those in the 90th percentile of
femoral neck bone density had an 8% lifetime risk of fracture compared to a 25% risk
for those in the 10th percentile. It seems likely therefore that the athletic women in
this study will be at reduced risk of osteoporotic fracture.
2) The effect on bone density of regular exercise commenced after the age of
peak bone mass
It is perhaps unsurprising that those women with a lifetime history of regular sport
had high bone density. This could be predicted from all the studies on younger
athletes which have shown high BMD in those undertaking both aerobic and high
impact exercise. However, it has not been shown previously that women who were
sedentary until after the age of peak bone mass (30 years) can have as high BMD. All
of the subjects in this study were previously sedentary and none of them had had
heavy manual jobs so it seems unlikely that this is due to selection bias although this
cannot be ruled out. Indeed, cross-sectional population studies in women show that
those who do not exercise have the lowest BMD (Zylstra et al., 1989, Zhang et al.,
1992, Krall & Dawson-Hughes 1994). It seems more likely that significant beneficial
effects were accrued by starting to exercise. This could occur by two means. Firstly
that the age-related loss in bone mineral is reduced by regular activity as suggested by
Jacobson et al., (1984), Smith et al., (1989) and Talmage et al., (1986). Secondly,
that bone mineral content is actually increased by the onset of exercise as shown in
studies by Margulies et al., 1986, Friedlander et al., 1995 and Nichols et al., 1994.
This study has also shown that the longer the LS athlete had been training, the greater
the lumbar BMD, suggesting ongoing beneficial effects on BMD.
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3) Is there a limit to the volume of exercise which is beneficial?
Without doubt moderate amounts of exercise have beneficial effects on BMD. But
data in this study suggest that very high levels of exercise may be detrimental to some
regions of the skeleton. Lumbar spine and trochanteric BMD was found to be
surprisingly low in two athletes who trained for very long periods each week (17.5
and 19 hours) although there was no correlation between number of miles run per
week and BMD at any site. However, the lowest lumbar BMD was seen in those with
the highest aerobic capacity measured by V02max. This is at variance with other
studies that have demonstrated a positive correlation between lumbar BMD and
V02max (Bevier et al., 1989, Pocock et al., 1989). However, one study in
postmenopausal athletes has shown that high intensity exercise may be paradoxically
associated with low BMD. Beat et al., (1989) found lower than expected lumbar
BMD in 50 - 60 year old women exercising for more than 300 minutes per week
although in only two of these women was BMD extremely low. There may therefore
be a non-linear relationship between BMD and exercise with the lowest BMD
occurring at the two extremes of exercise. The reason for the negative correlation
between high aerobic capacity and low lumbar BMD is unclear. It may be related to
lower body fat levels and hence lower circulating oestrogen levels or other changes in
morphology that have not been shown in this study. The relationship requires further
evaluation.
4) The long-term effects of prior menstrual irregularity
Many studies have now demonstrated that young athletes with amenorrhoea have
lower than expected BMD in the spine and other non-weight bearing sites (Cann et
al., Drinkwater et al., 1984, 1990, Marcus et al., 1985, Wolman et al., 1990).
Short-term follow-up studies have demonstrated some improvement in BMD
following resumption ofmenses but at present there is no long-term follow-up.
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In this study we hoped to assess the impact of a history of menstrual irregularity on
BMD in older athletes who were now eumenorrhoeic. Duration of menstrual
irregularity varied between 2 and 22 years with a mean of 12.1 years in the AT
athletes and 5.2 years in the LS women. Bone density was lower in the non-EU
women at all sites but this only reached significance in the lumbar spine (p<0.05). In
addition there was no direct relationship between either the number of years of
oligo/amenorrhoea or the number of years of eumenorrhoea and BMD (although the
latter approached significance in the LS, p = 0.08).
Of importance was the finding that the Z-score was significantly high in the AT/non-
EU group in the neck of femur and at no sites were Z-scores low. This suggests that,
although there are long-term effects of prolonged menstrual dysfunction, exercise may
help to offset these detrimental effects if menstruation returns. These findings need to
be supported by longitudinal studies on amenorrhoeic athletes, a process that is
currently underway.
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5) Body composition and strength as determinants of bone mineral density
Several studies have demonstrated that height, weight and body mass index are
significant independent determinants of BMD in pre and postmenopausal women
(Pocock et al., 1989, Lanham et al., 1990, Nordin et al., 1992, Rico et al., 1993,
Henderson et al., 1995). In this study neither weight nor BMI were predictors of
BMD but height was associated with trochanteric and lumbar BMD both before and
after adjustment for age and menstrual status. It is unclear why weight was not an
important determinant ofBMD in this group ofwomen.
In common with others, this study demonstrates a relationship between strength and
BMD (Bevier et al., 1989, Sinaki et al., 1989, Pocock et al., 1989, Kritz-Silverstein
et al., 1994, Henderson et al., 1995). Back extensor strength was associated with
lumbar BMD, and dominant hand grip strength predicted trochanteric and lumbar
BMD although not when menstrual status or weight had been accounted for. It is
likely that grip strength reflects aspects of total physical activity since back strength
and grip strength were highly correlated. It could be a useful additional measure of
strength and physical fitness in the general population when risk factors for low BMD
are being assessed.
Conclusions
This study has demonstrated that bone mass is high in those that undertake regular
physical activity. This may result in a reduction in osteoporotic fractures in later life
In addition, women who commence training after the age of 30 years are able to
achieve similar bone density levels to those who have trained since school age. The
greater number of years they train, the greater the effect on BMD. Some athletes have
prolonged amenorrhoea due to their athletic activity and this results in reduced BMD.
Although running is able to offset the loss in BMD in the femur, long-term effects of
menstrual irregularity are seen in the lumbar spine. For the premenopausal woman,
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provided she remains eumenorrhoeic, it may never be too late for her bones to benefit
from exercise. If the differential in BMD at the femur between these athletes and
controls is maintained in the future, their lifetime risk offracture will be almost halved.
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CHAPTER 7
BONE DENSITY IN POSTMENOPAUSAL ATHLETES
Abstract
Objectives To investigate the effects of vigorous physical activity on bone mineral
density (BMD) in two groups of postmenopausal women. One group had exercised
throughout their lives and the second group had started exercising after the age of 35
years.
Methods Bone mineral density of hip and lumbar spine was measured in 24
postmenopausal women (age range 48 - 68 years) who all trained for at least 3 hours
per week or ran at least 15 miles per week. 10 had trained throughout their life (All-
timers, AT) and 14 had started training after the age of 35 years (Late-starters, LS).
Results Linear regression ofBMD (g.cm"2) with age or years since menopause
showed a decline in the trochanteric region p<0.002) and in the lumbar spine (L2-L4,
p<0.005) but not in the neck of femur. There was no significant difference in BMD at
any site measured between the AT and LS groups. Nor was BMD in either group
different from the European reference range matched for years since menopause
(YSM). BMD was significantly lower than the Hologic reference range for peak bone
mass.
Linear regression revealed BMD (adjusted for YSM) of neck of femur and
trochanteric region to be associated with weight, body mass index (BMI) and
percentage body fat (p<0.05) There were no such associations with spinal BMD. Low
body mass, percentage fat mass and BMI were associated with high aerobic capacity
(V02max).
Conclusions In postmenopausal women, low BMD of the femur is associated with
low weight and low body fat. High intensity training results in low body weight and
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percentage body fat and may therefore reduce beneficial effects of exercise on BMD.
Spinal BMD is not increased by running and is less influenced by body habitus.
Introduction
Regular physical activity has been associated with increased bone mineral density
(BMD) in postmenopausal women (Jacobson et al., 1984, Talmage et al., 1986
Jonsson et ah, 1992, Zhang et al., 1992, Krall et al., 1993). Exercise training
programmes have also been shown to increase BMD in post-menopausal women
(Dalsky el al., 1988). In addition to improving BMD, regular exercise increases
muscle strength and reduces the frequency of falls (Wickham et al., 1989, Province et
al., 1995, Wolf et al., 1996). It is likely that these combined effects contribute to the
lower rate ofhip fracture seen in those with greater levels of physical activity (Cooper
et al., 1989). Methods of treatment of established osteoporosis can be unrewarding
and interest is starting to focus on the possibility of exercise prescription for its
prevention.
Although most exercise programmes in postmenopausal women have included either
aerobic-type exercise (e.g. walking) (Dalsky et al., 1988, Grove & Londeree, 1992,
Martin & Notelovitz, 1993) or muscle-strengthening exercises (Chow et ah, 1987,
Rikli & McManis, 1990), there is very little information on either the long-term
effects of such exercise or whether more intensive training would be more effective.
However, two reports in veteran athletes have suggested that excessive exercise may
have detrimental effects on BMD in the post-menopausal years (Nelson et al., 1988,
Michel etal, 1989).
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The aim of this study was to determine the effects of a lifetime of regular physical
activity on BMD in postmenopausal women. We also wanted to determine whether it
was possible to have significant effects on BMD by taking up regular exercise after
the age of 35 years.
Methods
Twenty-four postmenopausal women were recruited after responding to
advertisements in running and athletic magazines according to the criteria in Chapter
4. Women who were taking hormone replacement therapy (HRT) were not included.
Subjects were divided according to whether they had trained consistently since school
age (all-timers, AT) or whether they had commenced training after the age of 35 years
(late-starters, LS).
Questionnaires gave menstrual, obstetric and training histories. A general medical
examination confirmed fitness to undertake the tests and informed consent was
obtained. Postmenopausal status was confirmed on serum measurements of follicle
stimulating hormone and oestradiol.
Body Composition, Physiological Characteristics andDietary Calcium Intake
As previously described in Chapter 4, the following measurements were made:
i) weight and height
ii) body mass index (BMI; weight/height2)
iii) percentage body fat using the four-site skinfold thickness method and from
total body potassium (TBK).
iv) fat free mass (FFM) in kg estimated from TBK.
v) grip strength of the dominant and non-dominant hands
vi) isokinetic back strength
vii) dietary calcium intake
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Bone mineral density
Bone Mineral Density (BMD) in g.cm"2 of the lumbar vertebral bodies (L2-L4) and
the left hip (neck of femur and trochanteric region) was measured in each subject by
dual energy x-ray absorptiometry (DXA), as described in Chapter 4. Scan analysis
was performed by technicians who were blinded to the activity status of the athlete.
The BMD in g.cm"2 of each region of interest was compared to the Hologic reference
population at peak bone mass (T-score) and to the European population data matched
for years since the menopause (Z-score) as previously described.
T-scores and Z-scores were expressed as standard deviations (e.g. mean + 1SD = +1).
Statistical Analysis
Between group differences were assessed using a two-tailed Students 'f test. Linear
regression was used to assess associations between measured parameters with BMD
Z-score as the dependent variable where appropriate. An independent *t' test was used
to compare the Z-scores and T-scores with the reference population. Significance was
accepted throughout at the p<0.05 level.
RESULTS
1) Training Details
Ten women had trained consistently since leaving school (all-timers, AT). The
remaining 14 women were sedentary after leaving school but commenced training
after the age of 35 years (late-starters, LS). The all-timer athletes had undertaken a
wide variety of sports previously (Table 1) but all were currently long-distance
walkers or middle and long-distance runners. The late-starter athletes were all middle
and long-distance runners and until the age of at least 35 years had undertaken less
than 60 minutes per week of exercise (as defined by the American College of Sports
Medicine, 1990 as the minimum requirement for the maintenance of cardiovascular
fitness).
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Twelve women competed at international and world class veteran championships and
10 had won medals in their age group in the last three years (5 in group AT, 5 in
group LS). The other women competed at either National or club level (Table 1). All-
timer athletes had exercised for a mean of 36.6 years (range 31 - 43) and LS athletes
had trained for a mean of 7.5 years (range 4 - 15).
The AT athletes ran more miles per week than the LS athletes (p<0.05) but otherwise
training characterisitics were similar between the two groups (Table 2).
2) Body composition and physiological parameters
All-timer athletes were taller than the LS athletes (p<0.02) but otherwise physical,
characteristics were similar in the two groups (Table 2). Although the AT athletes
were stronger in both hands and had greater aerobic fitness, these differences were
not significant. The AT athletes had greater flexor and extensor trunk strength than
the LS athletes but this was only significant for flexor strength at the faster torque
speed (180° sec ~1).
There was no correlation between the number ofmiles run per week or the number of
hours trained per week and weight, percentage body fat or body mass index.
However, maximal aerobic capacity (VC^max) was highly correlated with percentage
body fat (p<0.002, Graph 1) and body mass index (p<0.005). Low weight was also
associated with high V02max (p=0.059). VC^max declined with age (p<0.03).
3) Obstetric and gynaecological history
There were no differences between the two groups for age at menarche, approximate
number of years of regular menstruation or number of years postmenopausal. Three
AT women and 7 LS women had used the oral contraceptive pill (mean years of
usage, 1.05, 0.82 respectively). Three AT women and 5 LS women had used HRT
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(mean years of usage, 2.6, 2.9 respectively). There were no differences between the
two groups in the number of pregnancies or the number of months spent
breastfeeding.
4) Dietary calcium intake
There were no differences in calcium intake between the two groups. Only 2 athletes
consumed less than 600mg.day_1 and 14 athletes consumed more than lOOOmg.day"1
5) Bone Mineral Density
There were no significant differences in BMD at any region between the AT and LS




Bone density declined with age and 'years since menopause' (YSM) in the trochanteric
region and the lumbar spine (p<0.05) but there was no such trend in the neck of
femur.
ii) BMD compared to the European population (Z-score)
BMD of AT and LS athletes was not significantly different from the European
reference range for postmenopausal women when matched for YSM. (Table 2, Graph
2)-
Table 4 shows the associations between physical characteristics and Z-scores
Neck offemur. BMD Z-scores were positively associated with weight (p<0.05), BMI
(p<0.005) and % body fat (p<0.02).
Trochanteric region. BMD Z-scores were positively associated with weight
(p<0.005, Graph 3), BMI (p<0.02) and % body fat (p<0.05) High BMD in the
trochanteric region was associated with high fat free mass (p<0.05). In this region,
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strong associations were found between dominant and non-dominant grip strength
and Z-scores, (p=0.001, p=0.0005 respectively, Graph 4)
Lumbar spine: There were no associations between BMD Z-score and any of the
variables measured.
There was no correlation between BMD (any region) and miles run per week, hours
spent training per week or number of sessions per week. Back strength was not
fouund to be a predictor of bone density in any area. Additionally there was no
difference in BMD between those who were most successful in competition and those
who competed at a lower level or between those training for more than 5 hours per
week or more than 40 miles per week and those training less hard.
iii) BMD compared to the peak bone mass of the American population
(T-score)
As expected, BMD was significantly lower than the average peak bone mass of each
region in American women, according to the reference range utilised by Hologic
(Table 3).
6) Biochemical Parameters
There were no differences between the two groups in biochemical parameters
measured. Measurement of levels of oestrogen and FSH confirmed postmenopausal
state. In one athlete aged 63 years, levels of FSH were extremely low suggesting
hypothalamic suppression or insufficiency in addition to hypogonadism. Later
investigations on this subject found normal levels of other pituitary hormones and she
was felt to have hypothalamic suppression ofFSH secondary to her training.
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Table 1
Group Previous sport Sport now Level now
All-Timers (AT)
1 100/200/400 LDR World (6th 10k)
2 sprint hurdles LDR National
3 200/400/800 LD/MDR World (M)
4 discus/pent golf/keep World (MR)
fit/athletics
5 Racquet sports LDR World (M)
6 Racquet sports LDR/golf Club
7 MDR LDR World (M+R)
8 800/1 mile 800m/LDR National
9 Rowing LD walking International (MR)
10 100 - 800m LDR National
Late-Starters
(LS)
1 LDR World (M)
2 LDR International
3 LDR Club
4 LDR National (M)
5 MDR/XC National
6 Tri National (M)
(Run/Swim/Shoot)
7 LDR World (MR)
8 LDR Club
9 LDR World (M)
10 LDR World (M)







M Medal winner at National or World Championships
R World record holder for that age group
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Age (years) 54.6 (4.4) 56.5 (6.2)
Years since menopause 6.4 (5.0) 6.8 (5.5)
Years on HRT 1.0(1.9) 0.8(1.7)
Height (cm) 167.1 (6.7) 160.8 (4.6)*
Weight (kg) 60.9 (8.0) 57.7 (7.0)
Body Mass Index (kg.nr2) 21.7 (1.6) 22.3 (2.3)
% Body Fat 28.2 (4.2) 28.5 (5.8)
Fat Free Mass (kg) 46.3 (7.3) 42.4 (5.2)
V02max (ml.kg.~lmin.~l) 43.1 (6.8) 39.4 (10.6)
Age started training 48.9 (6.0)
Miles Run per Week 36.1 (15.7) 25.0 (9.3)
Hours Training per Week 7.3 (2.6) 6.1 (2.3)
Students't' test: *p<0.02
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Correlation Between Maximal Aerobic
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Body Fat (%) r= -0. 64
Graph 1
This graph demonstrates the strong relationship between
physical fitness, as measured by maximal aerobic capacity




Table 3 BMD of Proximal Femur and Lumbar Spine.
Mean (SD)





AT 0.759 (0.06) 0.675 (0.06) 0.959 (0.11)























BMD values in g/cm2 and in comparison with European data (Z-score) and peak bone
mass ofAmerican reference population (T-score). No differences between groups and
neither group significantly different from matched European data. T-scores
significantly lower than peak bone mass ofAmerican reference range:




Bone Mineral Density (Z-score) of Proximal




Mean (+/- SE) of bone mineral density compared to the European
reference range matched for years since menopause (Z-score). No
significant differences found betweeen the two athletic groups or
compared to the European range.
AT: 'all-timer' athletes who had trained consistently since school
age






Bone Mineral Density (Z-score) of Trochanteric
Region of Proximal Femur versus BodyWeight
Graph 3
Bone mineral density (Z-score) of trochanteric region of
proximal femur increases with increasing body weight in




Bone Mineral Density (Z-score) of
Trochanteric Region ofProximal Femur




This demonstrates the positive linear relationship
between grip strength and distant bony sites such as the
trochanteric region ahown here. Bone density shown
adjusted for years since the menopause (Z-score).
r = 0.045, p<0.005
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Table 4 Associations between BMD (Z-score) and Physical Characteristics
Linear Regression Analysis
Linear regression Neck of Trochanteric
with: Femur Region
F ratio p value F ratio p value
Weight (kg) 5.398 0.035 10.316 0.003
BMI (kg.m~2) 10.423 0.004 6.484 0.014
Body fat (%) 7.417 0.016 3.635 0.045
Fat free mass 0.235 0.671 4.187 0.032
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Discussion
1) The effect of a lifetime of physical activity
In this small section of the overall study, ten women were included who had exercised
continuously since school age (a minimum of 31 years exercise). The results from the
previous two sections predict that these postmenopausal women should have had
higher bone density than average throughout their adult years and into the menopause.
The finding that their BMD was no greater than expected for their postmenopausal
age was surprising and raises several possibilities.
Firstly, the level of exercise that they undertook during their younger years was
insufficient to generate an increase in BMD. Most of these women trained for and
competed in their chosen sport at National or International standard and although
intensity of training was lower 30 years ago than it is now, it is unlikely it was
insufficient to influence bone metabolism. None of the athletes had a history of
prolonged menstrual irregularity.
Secondly, if BMD of this group was high at the menopause there must have been a
rapid loss of bone mineral in the early postmenopausal years. Other studies (Smith et
al., 1989, Grove & Loneree, 1992, Martin & Notelovitz, 1993) have shown that
exercise intervention in the postmenopausal years can slow the normal rate of bone
mineral loss in sedentary women and it is therefore unlikely that this is the
explanation. IfBMD was low at the menopause in this group despite exercise it could
be said that continued physical activity in the postmenopausal years has actually
helped maintain BMD. These questions are unanswerable in the context of a small
cross-sectional study but are pointers for areas to be pursued in long-term prospective
studies of athletic women as they go through the menopause.
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An explanation that will be explored further in this discussion is that intensive exercise
in this group resulted in low body mass and fat mass and this has resulted in a BMD
appropriate to that mass.
2) The effect of regular exercise commenced after the age of peak bone mass
This group ofwomen were somewhat mixed as some had started exercise before the
menopause and some after. This seemed to have no effect on their BMD which was
very similar to that of the previous group. The cautions and explanations applied to
the all-timer athletes are also applicable here.
There are two previous reports of small numbers of older men and women who trained
intensively and who were found to have paradoxically low levels ofBMD. Michel et al.,
(1989) found that 5 of 28 women over 50 years, who were undertaking aerobic weight-
bearing exercise for more than 5 hours per week had lower than expected lumbar spine
bone density. Women exercising less than this showed a positive correlation between
amount of exercise and BMD. In a 2 year prospective follow-up study to this, Michel et
al., (1990) confirmed that, in females over the age of fifty, extreme levels of exercise
(greater than 300 minutes per week) were associated with low lumbar bone density.
Nelson et al. (1988) compared 18 sedentary women with 15 endurance-trained
postmenopausal women who ran a mean of22.6 miles per week (mean age, 62.2 years).
They found no difference in BMD of radius, proximal femur or lumbar spine between
the sedentary women and those undertaking large amounts of exercise although. The
results in this study support these previous findings and suggest that, in this age group,
large quantities of aerobic exercise such as running are not associated with high bone
density in either the femur or lumbar spine.
Slightly lower levels of repetitive aerobic exercise or other forms of activity may be
more beneficial to skeletal metabolism. Studies by Jacobsen et al., (1984) and
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Talmage et al., (1986) found that postmenopausal women who exercised for one hour
three times weekly at the intensity of a game of tennis did have higher radial and
spinal bone density than controls. And, as discussed previously, studies on younger
athletes, both male and female, have shown that the greatest stimulus to bone
formation appears to be weight-training. It is possible therefore that there is a non¬
linear relationship between amounts of aerobic exercise and bone density with low
density occurring at the two extremes of exercise. It is important to evaluate this
relationship further as many more postmenopausal women are now undertaking
vigorous forms of exercise. Before exercise programmes can be endorsed for
prevention ofosteoporosis, it is necessary to determine just how much is enough.
3) Body composition as a determinant of bone mineral density
Studies on pre- and postmenopausal women have found that body weight and body
mass index are independent determinants of bone mineral density (Pocock et al., 1989,
Lanham et ah, 1990, Nordin et al., 1992, Henderson et al., 1995, Johnell et al., 1995,
Orwoll et al., 1996). Obese women have a lower incidence of osteoporotic fracture than
women of normal habitus (Ribot et al., 1994). There are two postulates for this. Firstly
that skeletal stress is less in lighter women resulting in a lower stimulus to bone
remodelling. Secondly, androgens are aromatised to oestrogens in peripheral fat and in
postmenopausal women this may be an important source of oestrogens so that in very
lean women, levels of circulating oestrogens are likely to be lower. It is likely that both
are contributory.
These hypotheses may explain the paradoxically low bone density in this group of
highly active women. As a group, they had a body mass index similar to women under
the age of 30 years and certainly much lower than the mean for 50 - 64 year old
British women (25.2 +/-0.24 SE)*. Some of the women had very low levels of body
fat and the two subjects with the lowest percentage body fat also had two of the
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lowest bone densities. In view of these observations, it could be said that in this group
ofwomen undertaking high levels of exercise, the muscular stresses of running helped
maintain bone density despite low body mass and fat.
4) Strength and physical fitness as determinants of bone mineral density
Bone density of the spine and femur have been found to correlate with maximal aerobic
capacity (V02max). In a study of 91 elderly non-athletic men and women, aged 61-84
years, spinal bone density was assessed by dual photon absorptiometry and V02max
assessed by treadmill ergometry (Bevier et al., 1989). Spinal BMD was correlated with
V02max in the men but not in the women and in neither group was BMD of the radius
correlated with V02max. Pocock et al (1989) found that BMD of the proximal femur
correlated with physical fitness (VC^max) in 73 healthy female volunteers aged 20 - 75
years.
The present study was unable to show a direct relationship between maximal oxygen
uptake or volume of exercise (miles per week or number of hours spent training) and
bone density, but there was a trend for those women with very high aerobic capacities
to have the lowest percentage body fat, weight and body mass index. To a large extent
this reflects oxygen uptake which is measured in units per kilogram of mass. Only the
active muscles will have higher uptake during exercise and excess fat will reduce the
unit measured. However, it may also suggest that the training required to maintain or
improve aerobic capacity also results in low weight and body fat levels. Unfortunately
we were not able to further elucidate particular kinds of training which most affected
these factors. Evaluation of training intensity rather than volume may have been more
helpful. Adjusting the V02max for age may also have helped evaluate this relationship
further. Other studies have used submaximal fitness testing and a wider age range of
subjects which may partly explain the discrepancy between this study and others.
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Muscle strength has been shown to correlate with bone density in several studies. In
the above study by Bevier et al., grip and back strength were correlated with forearm
and spinal BMD in the men and grip strength predicted forearm and spinal bone
density in women. Pocock et al. (1989) also found that biceps and quadriceps muscle
strength predicted bone mass in the forearm, femur and lumbar spine in female
volunteers aged 20-75 years. In postmenopausal but not premenopausal women, grip
strength wasa predictor of forearm BMD. Back extensor strength has also been found
to correlate with bone density of the spine by Sinaki and Offord (1988) and Eickoff et
al. (1993). Sinaki et al. (1993) found that osteoporotic women aged 40 - 85 years had
lower back extensor strength than women with normal bone density. The results of
the current study show a strong correlation between grip strength and BMD but only
in the trochanteric region. In addition, back strength was not correlated with bone
density at any site even after adjustment for body weight. Other studies have used
non-athletic women and this, combined with small numbers may explain the
discrepancy between these results and past studies.
In conclusion, this study differs from most other reports on exercise and bone density
in postmenopausal women which have shown higher BMD in those that take most
exercise. However, other studies have used either non-athletic women or women who
train modestly. In this group of highly athletic women, low body weight and body fat
may have resulted in bone density which is lower than expected given the amount of
physical exercise they undertake. This supports similar findings of two other small
studies on endurance-trained postmenopausal women. In view of these observations,
further research is required to determine the type and volume of exercise required to
preserve or increase bone mass in postmenopausal women.
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CHAPTER 8
TREATMENT OF REDUCED BONE MINERAL DENSITY IN ATHLETIC
AMENORRHOEA: A PILOT STUDY
Abstract
Objectives To determine the influence of hormone replacement therapy (HRT) and
calcium supplementation on bone mineral density in athletes with irregular menstruation.
Design 18 month randomised prospective interventional study
Subjects 34 middle and long-distance runners, aged 18-35 years, with either
oligomenorrhoea or amenorrhoea induced by intensive exercise, were randomised to
three groups: A) to receive hormone replacement therapy (HRT) and lOOOmg calcium
per day (n=10), B) to receive lOOOmg calcium per day (n=14), C) a control group who
received no treatment (n=10).
Main outcome measures Comparison of pre and post-treatment bone mineral
density (BMD) of proximal femur and lumbar spine within and between groups at 9 and
18 months. Comparison of BMD between those who regained menstruation and those
who remained amenorrhoeic or oligomenorrhoeic.
Results Twenty-six athletes attended for at least one follow-up. Only 17 athletes
returned for a second follow-up appointment. Numbers were insufficient for analysis at
18 months. Only results from the first follow-up are presented. There were no
differences between pre and post treatment BMD in any group or between the groups.
Results were then analysed according to whether menstruation returned (either naturally
or secondary to HRT (EU)) or whether subjects remained amenorrhoeic (AM). During
the first year BMD increased in the EU group in all areas and decreased in all regions in
the AM group. The estimated differential change between the two groups over the first
12 months was 5.8%, (P<0.02) in L2-L4, 5.6% (P<0.02) in Wards area, 3.9% in the
trochanter (P<0.05) and 2.4% in neck of femur (NS). Serum oestrogen levels rose from
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275 pmol.l"1 to 589 pmol.l"1 in the EU group and fell from 110 pmol.l"1 to 96pmol.l"1 in
the AM group.
Conclusions The increase in oestrogen levels associated with resumption of
menstruation or treatment with HRT appears to be associated with an increase in BMD
in amenorrhoeic athletes. In athletes who remained amenorrhoeic, BMD declined.
Power calculations On the basis of an 'intention to treat' analysis, a study designed to
show, with 80% power and 5% significance, a benefit in lumbar spine BMD of HRT
treatment would require about 1150 athletes with amenorrhoea or oligomenorrhoea.
These large numbers are due to incomplete follow-up, withdrawal from treatment with
HRT and return of menstruation in the non-HRT groups. These numbers might be
reduced substantially by confining a definitive study to amenorrhoeic athletes, who
appear less likely to regain menses.
Introduction
Menstrual dysfunction due to intensive exercise is now well recognised and is associated
with a reduction in bone mineral density, particularly in the lumbar spine (Marcus et al.,
1985, Drinkwater et al., 1990, Wolman et al., 1990). Some studies have shown BMD in
the vertebral bodies to be as as much as 25% below eumenorrhoeic peers and there are
concerns that these athletes may be at increased risk of early osteoporosis and fracture.
Reports on small numbers of amenorrhoeic athletes suggest that BMD of the vertebral
bodies may increase when menstruation returns in response to a reduction in training
volume and weight gain (Drrinkwater et al., 1986, Lindberg et al., 1987). Unfortunately
there is no long-term data on BMD in these women and it remains unclear whether bone
density continues to increase when menstruation returns or whether it stabilises at low
levels. In view of the uncertainty, prevention of bone loss early in athletic amenorrhoea
appears a sensible option although the means by which this could be achieved are not
yet determined.
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Many athletes are unwilling to reduce training or increase weight so drug intervention
may have to be used. The anti-androgen cyproterone acetate in its contraceptive form
(which includes large amounts of ethinyl oestradiol) has been shown to increase BMD in
the lumbar spine (De Cree et al., 1988) in small numbers of athletic women and Prior el
al. (1991) in a brief report have shown a 2 to 3% increase in spinal bone density over a
year using medroxyprogesterone. Additionally, in elite athletes who take the oral
contraceptive pill, BMD is similar to that seen in eumenorrhoeic athletes (Wolman et
al., 1991). Some form of hormonal intervention may therefore be of benefit in either
treating low bone density or reducing further bone loss. Not all athletes are likely to
favour hormonal treatment and in these, calcium may have a part to play. Calcium
supplementation has a small but significant effect on reducing bone loss in
perimenopausal (Elders et al., 1994) and postmenopausal women (Cumming, 1990).
Dietary calcium intake has also been correlated with BMD of the lumbar spine in female
athletes (Wolman et al., 1992) and calcium and vitamin D3 supplementation may reduce
the rate of fractures in elderly women (Chapuy et al., 1992). The effect of calcium
supplementation on BMD in female athletes has so far been shown to be of little benefit
(Baer etal., 1992).
Recently a survey of physicians involved in the primary care of female athletes revealed
that 92% would use some form of hormone therapy and 87% would use calcium
supplementation in athletic amenorrhoea despite the lack of scientific evidence to
support their efficacy (Haberland et al., 1995). In order to answer some of the questions
regarding treatment of amenorrhoeic athletes, the effect of hormone replacement
therapy and calcium on BMD in thirty-four runners with menstrual dysfunction was
studied. The aim of this pilot study was to assess the feasibility of a full scale study in
this relatively rare group of athletes.
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Methods
34 middle and long-distance Caucasian runners aged 18-35 years were recruited from
advertisements in running magazines. Subjects were from the general population of
England and Wales and fulfilled the criteria detailed in Chapter 4. Nine subjects had 4
- 9 menstrual cycles per year for at least the last eighteen months (oligomenorrhoea,
OL). Twenty-five subjects had 0-3 cycles per year for at least the last eighteen
months (amenorrhoea, AM).
Questionnaires gave menstrual, obstetric and training histories. A general medical
examination confirmed fitness to undertake the tests and to receive treatment.
Informed consent was obtained and approval was granted by the Ethical Committee of
Northwick Park Hospital.
Body Composition, Physiological Characteristics andDietary Calcium Intake
As previously described in Chapter 4 (Methods), the following measurements were
made:
i) weight and height
ii) body mass index (BMI; weight/height2)
iii) percentage body fat using the four-site skinfold thickness method
iv) dietary calcium intake
v) maximal aerobic capacity (VC^max)
Bone mineral density
Bone Mineral Density (BMD) in g.cm-2 of the lumbar vertebral bodies (L2-L4) and
the left hip (Wards Triangle, FW, neck of femur, FN, and trochanteric region, FT) was
measured in each subject by dual energy x-ray absorptiometry (DXA), as described in
Chapter 4. Scan analysis was performed by technicians who were blinded to the
treatment status of the athlete. The DXA scans were reanalysed by the same technician
and the same scan area was used on each occasion aided by Hologic software. Bone
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density in g.cm-2 was compared to the European reference range as described in
Chapter 4. Z-scores were expressed as standard deviations above or below the mean.
Biochemicalmeasurements
Serum levels of oestrogen and follicle stimulating hormone were measured at each
visit. Serum prolactin, calcium and alkaline phosphatase levels and urinary P human
chorionic gonadotropin were measured to exclude other causes of secondary
amenorrhoea or reduced BMD.
Treatment
Subjects were randomly assigned to one of three groups:
A) daily oral treatment with Trisequens™ tablets (oestriol lmg and oestradiol
2mg for 12 days; oestriol lmg, oestradiol 2mg and norethisterone acetate lmg for 10
days; oestriol 0.5mg and oestradiol lmg for 6 days) + lOOOmg calcium carbonate
(Sandocal™) (n=10)
B) lOOOmg calcium carbonate (Sandocal™) orally per day (n=14);
C) Control group, no treatment (n=10).
Statistical analysis
Standard statistical tests were performed using the Microsoft™ Excel 5 statistical
package. Pre and post treatment bone density (gem-2) was compared using a paired 'f
test. The 9 month data were compared using a standard analysis of variance of the
annualized changes between groups. In addition, the results were used to perform
power calculations for a full study of HRT's effectiveness, as described by Armitage
(1971). In these calculations the assumption was made that HRT users who withdrew
from treatment would show the same range of bone density changes as the control
group, the opposite applying to controls who naturally regained their menses.
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RESULTS
25 athletes were amenorrhoeic (mean of 0 menses per year) and 9 athletes had
oligomenorrhoea (mean of 5.7 menses per year). Groups were similar in age, height,
weight, body mass index and training details (Table 1). Mean number of years of
menstrual irregularity was 6.9 (group A), 7.2 (group B) and 6.7 (group C). Starting
BMD was similar in all regions (Table 3). Mean BMD for the whole cohort was: -0.45,
-0.30 and "Vo standard deviations below European age-matched reference data in the
neck of femur, trochanteric region and lumbar spine respectively. Age-matched data
were not available for Wards area. Daily calcium intake at the start of the study was
986mg (group A), 815mg (group B) and 1037mg (group C).
Follow-up
26 athletes returned for at least one repeat measurement at a mean interval of 9.3
months (group A), 11.2 months (group B) and 11.7 months (group C). Reasons for
withdrawal are shown in Table 2. During this first treatment period, one subject in
group A and 2 in group B stopped treatment because of side effects. Calcium commonly
caused gastrointestinal upset. HRT caused breast tenderness, emotional lability and
subjective weight gain (not independently verified).
Despite intensive efforts to maintain compliance, the drop-out rate was high and only a
further 17 (50%) subjects, (6 in group A, 6 in group B and 5 in group C), returned for a
second follow-up appointment. Of these 75% had continued on treatment. Reasons for
withdrawal during the second stage are shown in Table 2. In total, it was known that 4
of the original 10 athletes on HRT and 2 of the 14 on calcium stopped therapy because
of side effects.
Because of the limited follow-up at 18 months, only the results obtained at the first
follow-up are presented. There were no differences between those that dropped out and
those that continued the study in any of the baseline parameters measured except for
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calcium intake. Estimated average calcium intake in the former group was 442mg.day"1
compared to 939day-1 in the latter group (p= 0.001).
Resumption of menstruation
During the first treatment phase, 4 athletes in group B and 3 in group C became
eumenorrhoeic. Only 1 of the 13 amenorrhoeic subjects not on HRT started to
menstruate naturally whereas all 6 of the oligomenorrhoeic subjects commenced normal
menstruation.
Bone Density Results
Paired 'f tests showed no difference between pre and post treatment BMD in any
group. The change in BMD (in gem"2) between the first two appointments were then
extrapolated to a change per year to account for the different times in reattendance. The
mean values for changes in BMD are shown in Table 3. ANOVA found no differences
in post-treatment BMD between the groups.
The subjects were then categorised according to whether normal oestrogen status had
been restored (either with HRT or natural menstruation). This gave a group of 14
athletes with 'normal' oestrogen status (EU) and 12 athletes that remained amenorrhoeic
or oligomenorrhoeic (AM). Paired't' test showed a significant increase in the BMD of
the EU group in Wards triangle and the lumbar spine (p<0.05). In all regions measured,
BMD increased in the EU group and fell in the AM group (Table 4). The annualised
differential change between the two groups over the first 12 months was 5.8%,
(P<0.02) in L2-L4, 5.6% (P<0.02) in Wards area, 3.9% in the trochanter (P<0.05) and
2.4% in neck of femur (NS) (Graph 1).
Serum oestrogen levels rose from 275 (+/-281) pmol.l"1 to 589 (+/-521) pmol.l"1 in the
EU group and fell from 110 (+/-39) pmol.l'1 to 96 (+/-34) pmol.l"1 in the AM group.
135














A 28.4 (4.8) 163.4(6.1) 53.6(5.6) 19.5 (1.0) 45.0 (20.7) 57.0 (7.7)
B 28.7 (6.0) 165.0(3.7) 51.1 (5.9) 18.8(2.1) 55.0(22.5) 56.0 (7.9)
C 25.0(5.3) 162.7(5.0) 51.5 (6.2) 19.5 (2.2) 53.1 (13.8) 61.8(4.7)
Group A - oestriol, oestradiol and norethisterone acetate (Trisequens™)
- calcium carbonate lOOOmg (Sandocal™) per day
Group B - calcium carbonate 1 OOOmg (Sandocal™) per day
Group C -no treatment
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Table 2 Reasons for Withdrawal from Study
Withdrawal in First Treatment Withdrawal in Second Treatment
Phase Phase
Grouf Group
A Non weight-bearing rest for bilateral A Chronic fatigue syndrome
femoral stress fractures
A Lost to follow-up B Lost to follow-up
A Wanted to commence OCP B Chronic fatigue syndrome
B Wanted to commence HRT B Chronic fatigue syndrome
B Lost to follow-up B Wanted to commence OCP
B Wanted to commence OCP C Wanted to commence OCP
B Wanted to commence HRT C Wanted to commence OCP
C Lost to follow-up C Lost to follow-up
C Training abroad
OCP - oral contraceptive pill, HRT - hormone replacement therapy.
Those athletes who wanted some form of hormone therapy and who were not in the
appropriate group withdrew in order to commence treatment.
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Tables 3a-d Changes in Bone Mineral Density ofProximal Femur During First
Treatment Phase
Mean BMD (g.cm~2)(SD)









A (n=7) 0.827 (0.10) 0.823 (0.10) -0.63 (2.21)
B (n=10) 0.782 (0.06) 0.784 (0.05) +1.33 (6.29)
C (n=9) 0.846 (0.10) 0.844 (0.12) -0.03 (4.14)








A (n=7) 0.692(0.13) 0.700 (0.12) +1.71 (2.86)
B (n=10) 0.668 (0.11) 0.663 (0.09) -0.33 (5.21)
C (n=9) 0.699 (0.09) 0.681 (0.10) -!.89 (6.29)
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A (n=7) 0.704 (0.15) 0.721 (0.13) +3.55 (4.05)
B (n=10) 0.656 (0.09) 0.659 (0.08) +1.37 (9.00)
C (n=9) 0.774 (0.12) 0.768 (0.13) -0.83 (5.21)
Table 3c Lumbar Suine (L2 - L4)







A (n=7) 0.941 (0.16) 0.974 (0.13) +5.67 (9.47)
B (n=10) 0.965 (0.11) 0.959 (0.11) -0.03 (5.01)
C (n=9) 0.929 (0.10) 0.922 (0.11) -0.29 (4.62)
Bone mineral density shown in g.cm"2 for before and after treatment at 9.3 months
(group A), 11.2 months (group B) and 11.7 months (group C). To allow for different
times of reattendance, individual changes in BMD were adjusted to give % change per
year. Analysis by ANOVA found no differences between groups.
Group A: oestriol, oestradiol and norethisterone acetate as daily hormone replacement
therapy (Trisequens™) + calcium carbonate lOOOmg (Sandocal™) per day
Group B: calcium carbonate (Sandocal™) lOOOmg per day
Group C: no treatment
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Table 4a-d Chanees in Bone Mineral Density according to
menstrual history during treatment phase
Mean BMD (g.cnr2)(SD)
Table 4a Neck of Femur







EU (n=14) 0.821 (0.15) 0.830(0.11) +1.42 (4.35)
AM (n=12) 0.811 (0.05) 0.798 (0.04) -0.94 (4.84)









EU (n=14) 0.697 (0.11) 0.705 (0.10) +1.48 (2.85)
AM (n=12) 0.670 (0.10) 0.649 (0.10) -2.42 (6.45)








EU (n=14) 0.714(0.16) 0.733 (0.15)* +3.12(6.34)
AM (n=12) 0.704 (0.07) 0.690 (0.07) "1.88 (5.42)
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Table 4d Lumbar Spine







EU (n=14) 0.964 (0.13) 0.991 (0.10)* +4.11 (6.88)
AM (n=12) 0.925 (0.11) 0.902 (0.11) "1.73 (4.98)
Tables 4a-d:
BMD in gem"2 for pre and post treatment at 9.7 months (group EU) and 12.2 months
(group AM).
Group EU: all athletes that commenced menstruaton naturally and those on HRT
Group AM: all athletes that remained amenorrhoeic or oligomenorrhoeic
Paired 'f test for pre and post treatment BMD: *P < 0.05
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FN FT FW L2-L4
Graph 1
Athletes were grouped according to whether they
resumed regular menstruation (EU, n=14) or whether
they remained amenorrhoeic or oligomenorrhoeic
(AM,n=12) during the first year of the study. Follow-up
was at a mean of 9.7 months for the EU group and 12.2
months in the AM group. The change in BMD (g.cnr2)
was annualised to account for the different times of
reattendance (bars indicate mean +/- standard error).
Those who regained normal menstrual cycles naturally
were grouped with those who were on HRT (n=14).
Four athletes in the calcium treatment group and 3 in
the control group regained regular menstruation.
ANOVA for the difference between the two groups:
*p<0.05,**p<0.02
FN = femoral neck, FT = trochanteric region
FW = Wards triangle
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Power calculations for a full study of the effectiveness of HRT in amenorrhoeic
athletes using LS BMD as the principal end-point.
(See also Appendix 4)
Although the difference between the changes in Lumbar Spine (LS) BMD in subjects
regaining a normal oestrogen status exceeded 5% annually (Graph 1), because these
data were recalculated from 9 months, it was assumed that, in an 18-24 month study,
HRT would result in a 5% lumbar spine increase relative to baseline in the treated
group and controls would not change. From Table 3 c, the SD for a change in lumbar
spine BMD is 6.37% of inital BMD value. If 30% of the control groups regain their
menses and gain 5%, the mean increase in the controls is projected to be 1.5%. If, as
within this pilot study, 40% of the HRT group withdrew from treatment, the mean
increase is only 3.0%. The mean expected difference in an 'intention to treat' analysis is
therefore only 1.5%. Therefore, for a power of 80% and significance of 5%, 280 are
required to submit to follow-up densitometry in each group. However, in this pilot
study, only 50% attended at 18 months so recruitment would have to be doubled to
560 in each group.
However, if the study was confined to athletes with amenorrhoea (<3 cycles per year),
only 8% would be expected to regain menses. The mean expected difference in BMD
would then be 2.6% and recruitment could be reduced to 188 in each group.
This power calculation was skewed by the outlying result of an annualised increase of
25 .62% in lumbar spine BMD in one athlete. Exclusion of this result would decrease
the standard deviation to 4.49 and recalculation results in a total number of athletes




Previous work on small numbers of amenorrhoeic athletes have suggested that
menstruation may return if training levels are reduced and/or weight is gained. This
resumption in menstruation has been associated with an increase in vertebral BMD of
approximately 6.5% over 15 months (Drinkwater et al., 1986, Lindberg et al., 1987).
Not all athletes are likely to accept either of these methods in order to resume
menstruation and it has therefore been suggested that some form of hormone
replacement therapy may be used to protect against bone mineral loss (Prior et al.,
1992) though until recently there was little research to support this. With this pilot study
it was hoped to determine likely changes in BMD with either HRT or calcium treatment
and from this to calculate the numbers of athletes required for a full-scale study.
In this study, in subjects treated with hormone replacement therapy, small but non¬
significant gains in BMD occurred at most regions measured. Additionally, in all
regions, BMD fell by small amounts in the control group although it was only in the
trochanteric region that BMD fell by more than 1% which is the in-vivo precision errror.
The results were most convincing at the lumbar spine and Wards triangle where the
difference between the two groups was 6.0% and 4.5%. Although these results are on
small numbers and there is a large variance, they do suggest a trend towards at least a
maintenance of bone mineral in those treated with HRT. Due to the small numbers, we
were unable to determine whether changes in BMD were similar in the first and second
treatment phases. Work on postmenopausal women supplemented with HRT suggests
that increases in BMD are maximal in the first 12 months (Johnston & Melton, 1993).
Whether a similar pattern occurs in younger women will require more prolonged studies
than presented here.
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The results in this study are more significant when the subjects are regrouped into those
who remained amenorrhoeic during the first year and those who had some form of
restoration of oestrogen levels either by resumption of normal menstruation or by HRT.
Not only did BMD increase by between 1.4% and 4.1% over 10 months in the
eumenorrhoeic group but BMD decreased by between 0.9% and 2.4% in the
amenorrhoeic group. Again this difference was most marked in the lumbar spine and
Wards area. Smaller effects are seen in the trochanteric region and little effect in the
neck of femur. This may reflect different rates of bone turnover associated with higher
levels of trabecular bone in the lumbar spine and parts of the proximal femur. These
results are similar to those reported by Prior et al. (1994) and ifBMD had continued to
increase over a 15 month period, these results would have been similar to those
previously published for athletes that regain natural menstruation.
Although there is little available research on treatment of bone loss in amenorrhoeic
athletes, lesons can be learnt from the management of women with other forms of
amenorrhoea. Haenggi et al., (1994) treated 15 amenorrhoeic women, with proven low
BMD, with ethinyloestradiol and desorgestrel over a 12-24 month period and also
found significant gains in BMD in the lumbar spine and Wards Triangle, the maximum
gain being 2.9%. These results are very similar to the 2.1% increase per year in the
lumbar spine seen by Gulekli et al. (1994) who treated 85 women aged 17-40 years
with amenorrhoea due to various causes. These authors used a number of different
formulations of oestrogen replacement, all of which resulted in significant increases in
BMD. Additionally, those women who received no hormone replacement but in whom
weight gain occurred also had increased BMD. Although the women in the above two
studies had a mixture of hypothalamic and ovarian amenorrhoea it is unlikely that this
obscures the significance of their findings for those women with athletic amenorrhoea.
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Anorexia nervosa is another disorder which is invariably associated with amenorrhoea
and profound loss of bone mineral. Klibanski et al (1995) randomized 48 anorexic
women to receive oestrogen and progestin replacement or no therapy. Over the follow-
up period of 18 months, treated patients maintained BMD whilst untreated patients lost
as much as 20% of their bone mineral.
It seems likely that treatment with some form of hormone replacement, whether by the
resumption of natural menstruation, the oral contraceptive pill or HRT, results in at
least small gains in BMD. Clearly though, loss of bone mineral can be prevented in
amenorrhoeic women and for this reason, early intervention within the first six months
should be advocated.
Power calculations for design of a full-scale study based on the findings of this pilot
study suggest that for a comparison of HRT with no treatment, very large numbers of
amenorrhoeic and oligomenorrhoeic athletes would be required (at least 1150).
However these two groups of athletes may have different long-term menstrual function.
All of the formerly oligomenorrhoeic athletes became eumenorrhoeic during the course
of the study whereas almost all of the amenorrhoeic athletes remained without menses.
Therefore, by confining recruitment to truly amenorrhoeic athletes, the differential
change in BMD over an 18 - 24 month treatment period would be greatly increased and
only 380 athletes, or fewer, would be required. Multi-centre trials on such numbers
might be possible.
These results do not show any significant effect on BMD of calcium supplementation
and in all athletes in this group who remained completely amenorrhoeic, BMD
continued to fall. In two athletes the decrease in BMD was substantial (7% - 8% in the
first year). A low dietary calcium intake has been associated with low BMD in female
athletes. Wolman (1992) found cross-sectionally that for every 100 mg increase in daily
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calcium intake, lumbar trabecular bone density rose by 3.9 mgcrrr' (measured by
quantitative computed tomography scanning) although he cautioned against assuming
there was a cause and effect relationship. In a study of seven adolescent amenorrhoeic
runners, supplementation with 1200mg calcium carbonate and 400IU vitamin per day
for 12 months did not prevent bone loss in two of the athletes and increases in bone
density were not as great as in the control group of eumenorrhoeic athletes (Baer et al,
1992). In postmenopausal studies, the change in BMD with calcium supplementation
has been modest (in the order of 1%) (Cumming et al., 1990) and it seems likely that if
any beneficial effect is to be seen in athletes, very large numbers of subjects will be
required.
Fifty per cent of the athletes withdrew from the study or were lost to follow-up. Many
of the reasons given reflect the nature of the population studied. If follow-up could be
improved, perhaps by more frequent contact or by providing greater benefit to the
athlete e.g. by fuller physiological assessment, fewer numbers would be needed for a
full study of this kind. Side effects were also a problem. In those that returned for
follow-up, 35% had stopped treatment during the 18 month period. HRT caused breast
tenderness and a subjective sensation of weight gain, particularly during the
progestogen phase of the cycle. Additionally, several athletes noticed emotional lability
that caused two to stop taking therapy. Side effects of breast tenderness and weight gain
are obviously a particular problem for runners. Possibly a different formulation more
suitable for younger women may reduce these side effects. Calcium also caused
problems, predominantly gastrointestinal. Diarrhoea and abdominal cramps were
sufficiently severe to prevent continuation of treatment in two subjects. If athletes are to
accept medication, it has to be with minimal side-effects that do not impair performance
or interfere with training.
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A small study of this nature can only provide some indication of where future research
may best be aimed. It is difficult to recruit large numbers of amenorrhoeic athletes that
fulfill all the requirements of such a study and, as shown here, many athletes do not
continue to have menstrual irregularity. The power calculations suggest that only a large




The prevention and management of osteoporosis is a challenge not just at the present
but also for the future. If the forecasts of the increase in the rate of fracture in the UK
are correct then huge sums of money will be expended on the treatment and
rehabilitation of elderly patients with osteoporotic fractures. Not only will money be
spent, but considerable morbidity and mortality will be suffered. But this need not
occur if methods of prevention of osteoporosis can be improved. Screening of those
at risk of osteoporosis can be undertaken but the correlation between osteoporosis
and risk factors is not good and time and money may be spent on those who are at
low risk of fracture. Primary preventative measures must at least play a part in
reducing the burden of osteoporotic fractures on society. Indeed the recent
Mediterranean Osteoporosis Study (MEDOS, Lyritis, 1996) found that the majority
of hip fractures could be explained on the basis of the potentially reversible risk
factors assessed in the study, one ofwhich was low levels of physical activity.
There are many approaches which could be utilised to increase the peak bone mass of
the population and to preserve bone mass into old age. Just one of these measures is
to increase the average level of exercise in women of all ages. This study has
contributed to the accumulating mass of evidence that eumenorrhoeic young women
who regularly exercise have substantially higher bone density at important fracture
sites compared to the average population. It has also shown that older women who
undertake regular exercise in the decade before the menopause, have significantly
higher bone mass than expected. The most surprising finding in this group of women
is the extent to which bone density is preserved in those women who came into
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exercise later in life. This is particularly encouraging to many women who start to
exercise after family commitments have eased.
However very intensive exercise may result in oligomenorrhoea or amenorrhoea and
evidence is accumulating that such menstrual disturbance has profound effects on
bone mineralisation. Initially most studies demonstrated this effect in the spine but this
study has shown quite clearly that the deficit in bone density between amenorrhoeic
and eumenorrhoeic runners is similar whether measured at a weight-bearing or non
weight-bearing site. Although site-specific exercise can offset these effects to some
extent, it is clear that maximum potential peak bone mass in these athletes is unlikely
to be achieved. But there has been a gap in our knowledge about the long-term
outcome of bone density in such women. This study has gone someway to address
this gap. The work on the older premenopausal athletes with a history of menstrual
irregularity suggests that continued exercise may at least maintain or possibly increase
bone density at certain sites provided oestrogen levels are normalised. In this group of
women, who were predominantly runners, this resulted in non-significant differences
in BMD in the femur between those who had been continuously eumenorrhoeic and
those with prior menstrual irregularity. But long-term effects were seen in the lumbar
spine which is less affected by weight-bearing exercise, and although bone density was
not lower than average at this site, the skeletal benefits of exercise had been lost.
These findings place even more emphasis on the need for early recognition and active
management of athletic amenorrhoea. There is still much ignorance within the
sporting community about this disorder, not only amongst the support staff but also
amongst the athletes. A strong treatment plan is important and as yet there is no
concensus on the best management approach or the likely results of treatment. The
treatment intervention study included in this thesis supports other work suggesting
that any form of oestrogen replacement, whether natural or synthetic, results in a
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small but significant increase in bone density. What remains unknown is the extent to
which this recovery may be maintained. The problems highlighted in this pilot study
will enable suitable multicentre longitudinal studies to be planned.
It appears too that high levels of aerobic exercise in the hypo-oestrogenic state
associated with the menopause may be deleterious to the skeleton. The relationship
between morphology and bone density is particularly strong after the menopause and,
by lowering their weight and body fat, those women who exercise intensively may end
up with paradoxically low bone density. It is likely that there is a level at which the
amount of aerobic-type exercise is sufficient to stimulate bone remodelling but not
sufficient to result in low body weight and fat. It is even more likely that the best form
of exercise to promote in the elderly is a mix between aerobic exercise and weight-
training. However it is clear that exercise prescription is not straightforward at any
age and each person must be assessed individually in order to achieve the maximum
potential benefit to the skeleton.
Finally, cross-sectional studies such as this can only give a snapshot of the overall
picture and perhaps give ideas for further research. This has indeed been the case and
a longitudinal study is underway which will endeavour to follow these active women
through the menopause and beyond. This longitudinal study may help to determine
why there is such a discrepancy in bone density between the premenopausal and
postmenopausal women. It will also establish whether bone mineral can be preserved
by continued exercise in the face of falling oestrogen levels. Even longer-term is the
aim to repeat bone density measurements on the amenorrhoeic young athletes as they
approach the menopause, a plan that will be harder to fulfill.
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APPENDIX 1
DATA AND FURTHER STATISTICAL ANALYSIS FOR ATHLETES AGED
16 - 35 YEARS
172
Amenorrhoeic and Oligomenorrhoeic Young Athletes
Demographic Variables
Number Age Height Weight Body Mass Index Body Fat
of Athlete (years) (cm) (kg) (kg.mf^) (%)
Amenorrhoeic Group
1 27 165.0 52.0 19.10 17.6
2 28 161.8 55.0 20.96 21.1
3 20 166.0 52.5 19.05 19.7
4 30 169.0 53.9 18.87 21.0
5 18 166.5 48.7 17.57 12.6
6 35 165.0 50.0 15.15 15.2
7 28 159.0 50.6 20.02 21.5
8 21 166.5 44.5 16.05 11.3
9 30 163.0 48.0 18.07 17.9
10 32 156.0 51.5 21.17 24.7
11 26 167.0 52.0 18.65 22.7
12 34 166.0 54.0 19.60 20.2
13 27 165.0 47.0 17.26 14.8
14 29 171.0 57.6 19.70 21.3
15 27 164.0 37.6 13.98 7.1
16 34 165.0 52.0 19.08 15.9
17 25 160.0 52.7 20.59 21.7
18 22 172.0 59.2 20.01 15.6
19 32 162.0 52.3 19.93 20.6
20 28 156.0 46.0 18.90 13.8
21 31 162.0 52.5 20.00 18.0
22 30 175.0 63.0 20.57 20.6
23 19 164.0 48.7 18.11 16.8
24 20 163.0 49.0 18.44 19.3
Oligomenorrhoeic Group
1 27 169.0 57.0 19.96 25.7
2 18 163.0 63.5 23.90 17.8
3 28 163.0 48.5 18.25 18.7
4 21 160.0 56.5 22.07 21.1
5 35 166.5 57.5 20.74 25.1
6 18 169.0 50.5 17.68 22.8
7 29 156.0 50.2 20.63 21.7
8 19 161.0 45.3 17.48 15.4











































Amenorrhoeic and Oligomenorrhoeic Young Athletes
EAT26 & BITE scores
Number EAT26 Factor 1 Factor 3 BIT!
of Athlete score score score scor
Amenorrhoeic Group
1 9 7 1 13
2 3 2 1 2
3 5 5 0 10
4 11 7 4 4
5 22 17 3 11
6 4 2 2 3
7 8 5 3 7
8 14 7 7 3
9 16 12 3 10
10 18 13 2 16
11 26 18 5 18
12 2 1 1 4
13 36 18 12 9
14 * * * *
15 * * * *
16 21 15 6 5
17 2 2 0 4
18 20 1 4 15
19 18 15 2 10
20 17 13 4 13
21 12 6 3 14
22 3 2 1 5
23 1 0 1 6
24 3 1 2 7
Oligomenorrhoeic Group
1 6 4 2 4
2 2 2 0 5
3 4 2 2 8
4 14 12 2 8
5 18 12 6 9
6 21 12 8 21
7 23 17 5 30
8 2 2 0 4
































































Amenorrhoeic and Oligomenorrhoeic Young Athletes
Menstrual History
Number Menarche Years of Years of
of Athlete (years) Eumenorrhoea Amenorrhoea/
Oligomenorrhoea
Amenorrhoeic Group
1 15.0 2.0 17.0
2 16.0 2.0 9.0
3 16.1 1.0 1.6
4 13.7 8.0 10.8
5 15.5 2.0 1.5
6 12.5 8.0 17.3
7 15.0 1.5 7.5
8 13.5 2.8 4.8
9 13.2 9.0 8.0
10 13.0 12.0 4.5
11 13.8 8.0 21.2
12 13.0 8.0 12.0
13 13.0 11.0 1.5
14 12.0 12.0 5.0
15 14.0 0.0 12.0
16 13.3 10.0 11.0
17 14.5 5.5 4.2
18 16.0 0.6 6.0
19 13.0 15.0 3.0
20 12.0 11.0 5.0
21 14.0 10.0 7.0
22 13.0 12.0 6.0
23 12.0 1.5 5.0
24 15.0 0.0 5.0
Oligomenorrhoeic Group
1 14.0 12.0 1.5
2 13.3 3.0 1.5
3 12.0 9.0 12.0
4 17.0 2.0 3.0
5 11.5 15.0 8.0
6 15.0 1.5 3.0
7 14.0 12.0 3.0
8 16.3 2.0 3.0




Number Menarche Years of Years of
of Athlete (years) Eumenorrhoea Amenorrhoea
1 20.0 5.5 0.0
2 13.0 3.5 0.0
3 13.0 12.0 0.0
4 13.0 10.0 0.0
5 14.2 4.0 0.0
6 13.3 17.0 0.0
7 12.5 7.0 0.0
8 11.3 22.0 0.0
9 18.0 16.0 0.0
10 12.8 13.0 0.0
11 15.0 10.0 0.0
12 13.2 21.0 0.0
13 16.3 1.0 0.0
14 14.5 22.5 0.0
15 13.0 9.0 0.0
16 14.0 16.0 0.0
17 12.6 9.0 0.0
178
Amenorrhoeic and Oligomenorrhoeic Young Athletes
Training Characteristics
Number Age began Miles run V02max
ofAthlete training perWeek (ml.kg~1.min"1)
Amenorrhoeic Group
1 16.0 32 59.6
2 19.0 80 injured
3 14.5 25 57.7
4 22.0 85 63.1
5 15.0 50 65.3
6 32.0 70 58.3
7 25.0 28 43.9
8 18.0 60 70.8
9 21.5 35 39.9
10 26.0 40 55.5
11 16.0 30 49.0
12 27.0 30 54.4
13 15.0 48 injured
14 25.0 75 61.2
15 12.0 90 60.7
16 32.0 80 59.4
17 18.0 45 59.0
18 18.0 30 57.6
19 24.0 80 61.1
20 19.0 55 61.0
21 21.0 60 66.0
22 22.0 65 53.5
23 11.0 50 65.8
24 15.0 60 65.9
Oligomenorrhoeic Group
1 19.0 25 57.2
2 14.0 50 61.6
3 21.0 38 56.3
4 17.0 63 63.4
5 29.0 55 50.2
6 17.0 35 46.1
7 25.0 70 65.4
8 16.0 50 69.0




Number Age began Miles run VC^max
ofAthlete training perWeek (ml.kg~1.mur1)
1 17.5 35 59.6
2 12.5 30 59.2
3 14.0 50 63.8
4 21.0 70 69.7
5 14.0 25 59.0
6 15.0 85 64.5
7 12.0 40 58.5
8 32.0 30 58.5
9 29.0 45 60.3
10 23.0 35 52.8
11 22.0 30 55.7
12 23.0 60 62.2
13 13.0 55 50.5
14 29.0 50 50.5
15 14.0 35 injured
16 24.0 50 56.2
17 18.0 30 50.5
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Amenorrhoeic and Oligomenorrhoeic Young Athletes
Bone Density of Neck of Femur
Number g.cm"2 Specified T-scor(
of Athlete Density (SD)
Amenorrhoeic Group
1 0.763 0.824 -1.320
2 0.646 0.681 -2.490
3 0.842 0.925 -0.530
4 0.871 0.963 -0.240
5 0.814 0.889 -0.910
6 0.808 0.881 -0.870
7 0.796 0.866 -0.990
8 0.801 0.872 -0.940
9 0.706 0.754 -1.890
10 0.742 0.798 -1.530
11 0.855 0.942 -0.400
12 0.772 0.836 -1.230
13 0.801 0.872 -0.940
14 0.946 1.064 0.510
15 0.744 0.801 -1.510
16 0.802 0.874 -0.930
17 0.770 0.833 -1.250
18 0.837 0.919 -0.580
19 0.711 0.760 -1.840
20 0.769 0.832 -1.260
21 0.782 0.848 -1.130
22 0.968 1.095 0.730
23 0.856 0.944 -0.390
24 0.913 1.019 0.180
Oligomenorrhoeic Group
1 0.794 0.864 -1.010
2 0.816 0.892 -0.790
3 1.099 1.282 2.040
4 0.974 1.103 0.790
5 0.819 0.896 -0.760
6 0.813 0.888 -0.820
7 0.803 0.875 -0.920
8 0.816 0.892 -0.790
9 0.672 0.712 -2.230






































Bone Density of Neck of Femur
Eumenorrhoeic Athletes
Number g.cnr2 Specified T-score Z-score
ofAthlete Density (SD) (SD)
1 0.936 1.051 0.410 0.741
2 1.115 1.306 2.200 2.013
3 0.960 1.084 0.650 1.020
4 0.994 1.131 0.990 1.151
5 0.801 0.872 -0.940 -0.770
6 0.859 0.948 -0.360 0.103
7 1.025 1.175 1.300 1.355
8 0.952 1.073 0.570 1.012
9 0.931 1.044 0.360 0.822
10 0.857 0.945 -0.380 -0.064
11 1.146 1.353 2.510 2.448
12 0.956 1.078 0.610 1.048
13 1.018 1.165 1.230 1.232
14 0.773 0.837 -1.220 -0.725
15 0.928 1.040 0.330 0.605
16 1.138 1.340 2.430 2.490
17 1.126 1.322 2.310 2.205
SD = Standard deviations
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Amenorrhoeic and Oligomenorrhoeic Young Athletes
Bone Density of Trochanteric Region of Femur
Number g.cm"2 Specified T-score
ofAthlete Density (SD)
Amenorrhoeic Group
1 0.697 0.680 -0.280
2 0.645 0.680 -0.850
3 0.978 1.108 -0.490
4 0.601 0.628 -1.340
5 0.782 0.848 0.670
6 0.636 0.669 -0.960
7 0.620 0.650 -1.130
8 0.678 0.719 -0.490
9 0.541 0.558 -2.010
10 0.506 0.519 -2.400
11 0.680 0.722 -0.470
12 0.523 0.538 -2.210
13 0.640 0.674 -0.910
14 0.646 0.681 -0.840
15 0.625 0.656 -1.080
16 0.704 0.751 -0.200
17 0.581 0.605 Or-i
18 0.695 0.740 -0.300
19 0.580 0.603 -1.580
20 0.607 0.635 -1.280
21 0.564 0.585 -1.760
22 0.774 0.838 0.580
23 0.861 0.950 1.540
24 0.769 0.832 0.520
Oligomenorrhoeic Group
1 0.665 0.704 -0.630
2 0.728 0.781 0.070
3 0.856 0.944 1.490
4 0.706 0.754 -0.180
5 0.709 0.757 -0.140
6 0.677 0.718 -0.500
7 0.737 0.792 0.170
8 0.765 0.827 0.480
9 0.681 0.723 -0.460
















































1 0.771 0.834 0.540 0.685
2 0.838 0.920 1.290 1.338
3 0.831 0.911 1.210 1.272
4 0.888 0.986 1.840 1.799
5 0.678 0.719 -0.490 -0.304
6 0.745 0.802 0.260 0.418
7 0.933 1.047 2.350 2.197
8 0.790 0.858 0.760 0.874
9 0.843 0.927 1.340 1.385
10 0.776 0.841 0.600 0.735
11 0.911 1.017 2.100 2.004
12 0.800 0.871 0.870 0.973
13 0.945 1.063 2.480 2.301
14 0.735 0.789 0.140 0.314
15 0.794 0.864 0.800 0.914
16 0.807 0.880 0.940 1.041
17 0.839 0.921 1.300 1.347
SD = Standard deviations
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Amenorrhoeic and Oligomenorrhoeic Young Athletes
Bone Density of Lumbar Spine (L2-L4)
Number g.cnr2 Specified T-score Z-score
ofAthlete Density (SD) (SD)
norrhoeic Group
1 0.857 0.945 -2.020 -1.891
2 0.876 0.970 -1.840 -1.682
3 0.894 0.994 -1.680 -1.487
4 1.014 1.159 -0.590 -0.261
5 1.013 1.158 -0.600 -0.271
6 0.936 1.051 -1.300 -1.045
7 0.891 0.990 -1.710 -1.520
8 0.877 0.971 -1.830 -1.671
9 0.860 0.949 -1.990 -1.857
10 0.825 0.903 -2.310 -2.251
11 0.945 1.063 -1.220 -0.952
12 0.813 0.888 -2.420 -2.388
13 0.875 0.969 -1.850 -1.693
14 1.122 1.316 0.390 0.755
15 0.762 0.823 -2.880 -2.993
16 0.991 1.127 -0.800 -0.488
17 0.770 0.833 -2.800 -2.896
18 1.002 1.142 -0.700 -0.379
19 0.878 0.973 -1.830 -1.660
20 0.855 0.942 -2.030 -1.913
21 0.876 0.970 -1.850 -1.682
22 1.054 1.216 -0.230 0.123
23 1.104 1.290 0.220 0.590
24 0.954 1.075 -1.130 -0.860
Oligomenorrhoeic Group
1 1.000 1.139 -0.730 -0.399
2 0.867 0.958 -1.930 -1.780
3 1.088 1.266 0.080 0.443
4 0.922 1.032 -1.430 -1.191
5 1.000 1.139 -0.350 -0.399
6 0.910 1.015 -1.540 -1.317
7 1.009 1.152 -0.640 -0.310
8 0.961 1.085 -1.080 -0.789
9 1.044 1.202 -0.320 0.028
SD = Standard deviations
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Eumenorrhoeic Young Athletes
Bone Density of Lumbar Spine (L2-L4)
Eumenorrhoeic Athletes
Number g.cm-2 Specified T-score Z-score
of Athlete Density (SD) (SD)
1 1.070 1.239 -0.070 0.275
2 1.100 1.284 0.140 0.554
3 1.203 1.441 1.120 1.474
4 1.210 1.452 1.190 1.535
5 0.840 0.923 -2.170 -2.080
6 1.141 1.345 0.560 0.927
7 1.154 1.365 0.680 1.043
8 1.089 1.267 0.090 0.452
9 1.136 1.337 0.510 0.882
10 1.084 1.260 0.050 0.405
11 1.034 1.187 -0.410 -0.068
12 1.046 1.205 -0.300 0.047
13 1.039 1.195 -0.360 -0.020
14 1.207 1.447 1.160 1.509
15 1.139 1.342 0.540 0.909
16 1.039 1.195 -0.360 -0.020
17 0.947 1.066 -1.200 -0.932
SD = Standard deviations
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Amenorrhoeic and Oligomenorrhoeic Young Athletes
Dietary Calcium intake and Biochemical Parameters
No. of Dietary Serum Serum Serum Serum
Athlete Calcium Calcium Phosphate Osteocalcin Alkaline
Phosphatase
(mg) (mmol."') (mmol."1) (ng.mH) (mmol."1)
1 1215 2.37 1.45 2.0 54
2 741 * * * *
3 444 2.25 1.42 0.8 57
4 1118 2.37 1.40 1.5 67
5 1134 2.21 1.28 2.0 43
6 1009 2.28 1.24 2.2 58
7 1935 2.23 1.42 2.7 53
8 1355 2.45 1.23 1.1 35
9 587 2.25 1.18 2.8 109
10 398 2.39 1.10 2.4 69
11 342 2.31 1.18 3.7 72
12 327 2.35 1.17 3.2 77
13 400 2.29 1.12 1.4 51
14 601 2.31 1.37 4.4 69
15 933 2.45 1.24 3.5 46
16 981 2.21 1.13 2.8 49
17 768 2.32 1.35 2.6 70
18 706 2.40 1.26 2.8 55
19 962 2.33 1.03 3.4 85
20 877 2.33 1.30 2.8 63
21 336 2.31 1.39 1.2 75
22 630 2.38 1.11 1.7 54
23 942 2.20 1.42 3.4 61
24 1157 2.34 1.19 1.8 71
Oligomenorrhoeic Group
1 476 2.23 0.90 3.2 63
2 1063 * * * *
3 590 2.36 0.86 3.4 59
4 186 2.31 1.24 3.5 75
5 583 2.29 1.19 2.8 37
6 489 2.34 1.26 4.4 57
7 1814 2.29 1.19 1.1 49
8 1066 2.37 1.11 1.2 63
9 1002 2.31 1.02 1.4 47
187
Eumenorrhoeic Young Athletes
Dietary Calcium intake and Biochemical Parameters
Eumenorrhoeic Athletes
Number Dietary Serum Serum Serum
ofAthlete Calcium Calcium Phosphate Osteocalcin





1 1380 2.43 1.11 3.1 60
2 327 2.39 1.29 4.8 67
3 621 2.22 0.92 2.8 65
4 890 2.33 1.10 2.6 39
5 1007 2.25 1.39 5.8 69
6 573 2.20 1.26 2.6 60
7 2107 2.23 1.01 3.9 125
8 1738 2.18 0.98 3.8 49
9 1212 2.41 1.21 4.3 66
10 1041 2.31 1.31 3.3 59
11 1015 2.31 1.08 3.5 44
12 500 2.29 1.37 2.2 60
13 1364 2.36 1.23 5.9 120
14 1131 2.25 1.22 2.2 39
15 1073 2.41 1.48 3.2 37
16 1010 2.28 1.03 3.5 46
17 958 2.49 1.15 2.3 54
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FSH: follicle stimulating hormone
PRL: prolactin































































FSH: follicle stimulating hormone
PRL: prolactin
* data not available
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Additional statistical analysis of data for athletes aged 16 - 35 years
Table 1
Linear regression of BMD (g.cm-2) with possible independent variables
Factor Trochanteric Neck of Femur Lumbar Spine
F P F P F P
Age 9.13 0.004 3.30 0.08 0.38 0.54
Height 4.31 0.043 3.63 0.06 6.95 0.011
Weight 6.45 0.014 10.40 0.002 10.60 0.002
BMI 3.01 0.09 5.83 0.02 4.38 0.04
% fat 0.19 0.67 1.57 0.22 3.17 0.081
Menarche 0.91 0.34 0.11 0.75 0.32 0.57
Yrs. Eumen 0.01 0.94 1.01 0.32 11.08 <0.002
Mpw 1.89 0.18 1.64 0.21 0.03 0.87
Age Began 4.56 0.038 1.07 0.31 0.39 0.53
Diet Ca 3.77 0.06 0.22 0.64 2.12 0.15
V02max 1.02 0.32 0.14 0.71 0.80 0.38
EAT 26 8.33 0.006 4.87 0.03 4.14 0.048
Factor 1 7.32 0.01 5.02 0.03 4.85 0.03
Factor 2 2.48 0.12 0.67 0.42 0.97 0.33
Factor 3 5.92 0.019 3.11 0.09 2.28 0.14
BITE 6.24 0.016 2.74 0.11 2.38 0.13









miles run per week




Linear regression within individual menstrual groups
BMD (g.cm-2)
Neck ofFemur
FN vs. Height FN vs. Weight
F P F P
AM 16.30 0.001 4.02 0.06
OL 0.32 0.59 0.34 0.58
EU 0.16 0.70 1.22 0.29
Trochanteric Region
FT vs. Height FT vs. Weight
F P F P
AM 4.02 0.06 0.18 0.68
OL 0.85 0.39 1.55 0.26
EU 1.89 0.16 1.05 0.32
Lumbar Spine
L2 - L4 vs. Height L2 - L4 vs. Weight
F P F P
AM 14.07 0.001 6.43 0.019
OL 0.03 0.87 1.42 0.28
EU 0.12 0.73 0.002 0.96
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Table 2
Multiple regression analysis of BMD (g.cm~2) of neck of femur
Variable Sta ?e 1 Stat;e 2
Ft,48 P-value F*,46 P-value
Age 3.30 0.08 3.90 NS
Height 3.63 0.06 2.33 NS
Weight 10.41 0.002 1.28 NS
BMI 5.83 0.02 0.14 NS
EAT26 score 4.87 0.03 0.52 NS
Factor 1 5.02 0.03 0.97 NS
Menstrual Status 15.069 <0.005
Menstrual status added in at stage 2.
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Table 3
Multiple regression analysis of BMD (g.cm-2) of trochanteric region
Variable Stage 1 Stage2 Stage 3
F1,48 P P P
Age 9.13 0.004 12.18 <0.01
Height 4.31 0.04 3.32 NS
Weight 6.45 0.014 0.02 NS
Years of Eumenorrhoea 0.01 0.94 7.21 <0.05 0.09 NS
Age began training 4.56 0.04 5.92 <0.05 0.07 NS
EAT26 score 8.33 0.01 2.54 NS
Factor 1 7.32 0.01 2.64 NS
Factor 3 5.92 0.02 1.10 NS
BITE 6.24 0.02 0.50 NS
Menstrual Status 15.69 <0.001
Variables added in at each stage shown in bold
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Table 4
Multiple regression analysis ofBMD (g.cm"2) of lumbar spine
Variable Sta ?e 1 Sta)?e 2
F1,49 P-value F1,48 P-value
Height 6.95 0.01 6.40 <0.05
Weight 10.60 0.002 1.43 NS
BMI 4.38 0.04 0.05 NS
Years of Eumenorrhoea 11.08 0.002 2.91 NS
EAT26 score 414 0.05 0.08 NS
Factor 1 4.85 0.03 0.69 NS
Menstrual Status 16.098 <0.001
Menstrual status added in at stage 2
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Table 6
Multiple regression analysis of Z-score of neck of femur
Variable Sta ?e 1 Sta)?e 2
Ft,48 P-value F?,4fi P-value
Height 4.09 0.049 3.71 NS
Weight 11.41 0.001 3.01 NS
BMI 5.99 0.018 1.08 NS
EAT26 score 4.33 0.043 0.29 NS
Menstrual Status 15.069 <0.005
Menstrual status added in at stage 2.
Table 7
Multiple regression analysis of Z-score of trochanteric region
Variable Sta ?e 1 Staj?e 2
Fl,49 P-value Fl,48 P-value
Height 4.47 0.040 3.65 NS
Weight 6.50 0.014 0.17 NS
Years of Eumenorrhoea 0.01 0.978 6.58 0.05
Age began training 4.19 0.046 5.57 0.05
EAT26 score 7.47 0.009 0.60 NS
Menstrual Status 15.69 <0.001
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Table 8
Multiple regression analysis of Z-score of lumbar spine
Variable Sta ?e 1 Stage 2
P-value Fl,48 P-value
Height 7.25 0.010 6.801 <0.01
Weight 11.10 0.002 1.692 NS
BMI 4.50 0.039 0.028 NS
Body Fat (%) 4.38 0.042 0.232 NS
Years of Eumenorrhoea 10.77 0.002 2.847 NS
Menstrual Status 16.098 <0.001
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APPENDIX 2




Demographic Variables ofAll-Timer Athletes
Number Age Height Weight Body Mass
ofAthlete (years) (cm) (kg) Index
(kg.nr2)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 48 162.5 60.0 22.72
2 43 160.0 50.0 19.53
3 45 161.3 53.5 20.56
4 42 172.0 60.0 20.28
5 52 164.0 64.5 23.98
6 51 176.0 67.0 21.63
7 40 163.4 56.7 21.24
8 40 160.5 64.5 25.04
9 41 166.0 59.5 21.59
10 44 171.0 63.0 21.55
11 48 172.0 60.0 20.28
12 44 164.0 63.2 23.50
13 40 167.5 62.1 22.13
14 55 165.0 53.8 19.76
15 50 163.0 54.5 20.51
Group Ab - Always Athletic, Irregular Menstruation
1 41 163.0 59.0 22.21
2 40 159.0 49.5 19.58
3 42 164.0 60.0 22.31
4 40 168.0 51.0 18.07
5 43 162.0 56.7 21.60
6 44 157.0 47.9 19.43
7 42 171.0 63.3 21.65
8 48 164.0 55.5 20.64
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Premenopausal Veteran Athletes
Demographic Variables of Late-Starter Athletes
Number Age Height Weight Body Mass
of Athlete (years) (cm) (kg) Index
(kg.nr2)
Group Ba - Late-starter, Always Eumenorrhoeic
1 48 163.3 61.2 22.95
2 45 163.0 58.5 22.02
3 43 165.0 52.0 19.10
4 46 167.3 58.5 20.90
5 48 164.0 53.5 19.89
6 49 165.0 60.5 22.22
7 45 161.0 60.5 23.34
8 47 162.5 56.9 21.53
9 43 161.4 74.4 28.56
10 45 155.0 47.6 19.81
11 47 158.0 53.0 21.23
12 44 165.0 63.3 23.25
13 48 159.0 58.4 23.10
14 55 161.0 62.0 23.92
15 46 153.0 47.3 20.21
16 50 166.5 54.5 19.66
17 40 164.0 54.0 20.08
18 44 159.0 54.5 21.56
19 46 163.3 55.8 20.92
20 44 160.7 58.2 22.54
21 42 154.8 54.2 22.62
22 46 164.5 60.6 22.39
ip Bb - Late-starter, Irregular Menstruation
1 50 160.5 50.4 19.57
2 41 162.5 53.6 20.30
3 40 166.0 61.5 22.32
4 44 163.0 62.0 23.34




Body Composition Details of All-Timer Athletes
Number Body Fat Total Body Fat Free Body Fat Body Fat Fat Free
of Athlete 1 Potassium Mass 2 Mass
(%) (mmol) (kg) (kg) (%) (%)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 29.5 2664.0 44.4 15.6 26.00 74.0
2 24.9 2502.0 41.7 8.3 16.60 83.4
3 25.4 2706.0 45.1 8.4 15.70 84.3
4 27.1 2892.0 48.2 11.8 19.67 80.3
5 26.5 3026.9 50.5 14.0 21.71 78.3
6 21.4 3138.0 52.3 13.7 20.45 78.1
7 26.1 2703.6 45.1 11.6 20.46 79.5
8 28.9 2760.0 46.0 18.5 28.68 71.3
9 24.3 3042.0 50.7 8.8 14.79 85.2
10 24.1 2830.9 47.2 15.8 25.08 74.9
11 24.5 2958.0 49.3 10.7 17.83 82.2
12 27.3 2889.8 48.2 14.0 22.15 76.3
13 24.1 2880.0 48.0 14.1 22.71 77.3
14 25.7 2570.6 42.8 22.5 20.37 79.6
15 24.9 2574.0 42.9 11.1 20.37 78.7
up Ab - Always Athletic, Irregular Menstruation
1 24.8 2784.0 46.4 12.6 21.36 78.6
2 24.1 2310.0 38.5 11.5 23.23 77.8
3 23.9 3210.0 53.5 6.5 10.83 89.2
4 16.1 2754.0 45.9 5.1 10.00 90.0
5 29.3 2442.0 40.7 16.3 28.75 71.8
6 20.4 2313.0 38.6 9.3 19.42 80.6
7 24.2 3054.0 50.9 12.4 19.59 80.4
8 26.5 2754.0 45.9 9.6 17.30 82.7
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Premenopausal Veteran Athietes
Body Composition Details of Late-Starter Athletes
Number Body Fat Total Body Fat Free Body Fat Body Fat Fat Free
ofAthlete 1 Potassium Mass 2 Mass
(%) (mmol) (kg) (kg) (%) (%)
Group Ba - Late-starter, Always Eumenorrhoeic
1 28.0 2752.2 45.9 0.0 25.05 75.0
2 25.8 2652.0 44.2 14.3 24.44 75.6
3 18.6 2568.0 42.8 9.2 17.69 82.3
4 25.1 3024.0 50.4 8.1 13.85 86.2
5 29.9 2706.0 45.1 8.4 15.70 84.3
6 28.8 3066.0 51.1 9.4 15.54 84.5
7 30.2 2520.0 42.0 18.5 30.58 69.4
8 28.2 * * * * *
9 31.4 2979.0 49.7 0.0 33.27 66.7
10 24.2 2310.0 38.5 8.5 17.86 80.9
11 24.5 2652.0 44.2 8.8 16.60 83.4
12 24.1 2724.0 45.4 7.9 12.48 71.7
13 29.2 2490.0 41.5 16.5 28.25 71.1
14 36.3 2202.0 36.7 25.3 40.81 59.2
15 20.3 2298.0 38.3 9.0 19.03 81.0
16 25.0 2568.0 42.8 11.7 21.47 78.5
17 22.4 2628.0 43.8 10.0 18.52 81.1
18 23.2 2863.9 47.7 21.7 12.42 87.6
19 28.5 2760.0 46.0 9.8 17.56 82.4
20 31.0 2292.0 38.2 20.0 34.36 65.6
21 32.5 2398.2 40.0 4.4 26.25 73.7
22 25.3 2800.0 46.7 3.2 22.99 77.0
up Bb - Late-starter, Irregular Menstruation
1 28.9 2124.0 35.4 15.0 29.76 70.2
2 23.4 2592.0 43.2 10.4 19.40 80.6
3 32.1 2761.0 46.0 15.5 25.20 74.8
4 31.9 2909.7 48.5 22.4 21.78 78.2




Gynaecological History of All-Timer Athletes
Number Age at No. Years No. Years No. Years HRT use
ofAthlete Menarche EU OL/AM PM (years)
(years)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 13.0 35.5 0.5 1.0 1.0
2 14.0 29.0 0.0 0.0 0.0
3 11.8 34.0 0.0 0.0 0.0
4 12.5 30.0 0.0 0.0 0.0
5 14.0 38.0 0.0 0.0 0.0
6 14.8 36.0 0.0 0.0 0.0
7 12.5 27.5 0.0 0.0 0.0
8 13.0 27.0 0.0 0.0 0.0
9 13.0 28.0 0.0 0.0 2.0
10 14.0 30.0 0.0 0.0 0.0
11 17.0 29.0 0.0 0.0 0.0
12 11.8 32.3 0.0 0.0 0.0
13 12.0 29.0 0.0 0.0 0.0
14 15.0 40.0 0.5 3.0 3.0
15 13.8 37.0 0.0 0.0 0.0
Group Ab - Always Athletic, Irregular Menstruation
1 15.0 13.0 12.0 0.0 0.0
2 14.5 17.0 4.0 0.0 0.0
3 13.0 22.0 6.0 0.0 0.0
4 12.0 6.0 22.0 0.0 0.0
5 12.0 13.0 16.0 5.0 5.0
6 12.5 12.5 16.0 0.0 0.0
7 12.0 26.0 5.0 0.0 0.0
8 14.0 12.0 16.0 0.0 0.0
KEY
HRT: hormone replacement therapy
EU: eumenorrhoea




Gynaecological History of Late-Starter Athletes
Number Age at No. Years No. Years No. Years HRT use
ofAthlete Menarche EU OL/AM PM (years)
(years)
Group Ba - Late-starter, Always Eumenorrhoeic
1 13.2 35.0 0.0 0.0 0.0
2 13.0 32.0 0.0 0.0 0.0
3 13.0 30.0 0.0 0.0 0.0
4 15.0 30.0 0.8 1.5 0.8
5 16.0 32.0 0.0 0.0 0.0
6 12.5 37.0 0.0 3.0 3.0
7 13.0 32.0 0.0 0.0 0.0
8 13.0 34.0 0.0 0.0 0.0
9 15.0 28.0 0.0 0.0 0.0
10 11.5 34.0 0.0 1.0 1.0
11 10.0 37.0 0.0 0.0 0.0
12 16.0 28.0 0.0 0.0 0.0
13 12.5 36.0 0.0 1.0 1.0
14 13.0 42.0 0.0 8.0 8.0
15 13.0 33.0 0.5 0.0 0.0
16 13.0 37.0 0.0 4.0 4.0
17 15.5 24.5 0.0 0.0 0.0
18 12.0 32.0 0.0 0.0 0.0
19 15.0 31.0 0.0 0.0 0.0
20 12.6 31.5 0.0 0.0 0.0
21 13.0 29.0 0.0 0.0 0.0
22 11.5 35.0 0.0 0.0 0.0
Group Bb - Late-starter, Irregular Menstruation
1 16.2 28.0 6.0 7.0 1.0
2 15.0 20.0 6.0 0.0 0.0
3 13.0 30.0 6.0 0.0 0.0
4 12.3 26.0 6.0 0.0 0.0
5 12.0 27.0 2.0 0.0 0.0
KEY
HRT: hormone replacement therapy
EU: eumenorrhoea




Obstetric History of All-Timer Athletes
Number OCP use Pregnancies Breast fed
ofAthlete (years) (months)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 1.0 3 22.0
2 0.0 0 0.0
3 14.0 0 0.0
4 2.0 2 7.0
5 4.0 3 9.0
6 0.0 0 0.0
7 10.0 1 5.0
8 3.0 2 12.0
9 21.0 2 24.0
10 1.0 2 6.0
11 10.0 0 0.0
12 1.0 2 1.8
13 0.0 0 0.0
14 0.0 2 8.0
15 0.5 2 11.0
Group Ab - Always Athletic, Irregular Menstruation
1 0.5 2 36.0
2 9.0 1 0.0
3 0.0 0 0.0
4 1.0 2 10.0
5 0.7 0 0.0
6 4.0 3 6.0
7 7.0 2 10.0
8 10.0 1 0.8
KEY
OCP Oral contraceptive Pill
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Premenopausal Veteran Athletes
Obstetric History of Late-Starter Athletes
Number OCP use Pregnancies Breast fed
ofAthlete (years) (months)
Group Ba - Late-starter, Always Eumenorrhoeic
1 4.0 3 3.0
2 0.5 2 0.0
3 5.0 1 10.0
4 3.0 2 8.5
5 15.0 1 0.0
6 1.5 2 4.0
7 10.0 0 0.0
8 6.0 3 27.0
9 3.0 1 0.0
10 5.0 4 0.5
11 9.0 2 2.0
12 11.0 2 0.0
13 0.0 3 1.5
14 0.0 2 13.0
15 1.0 2 5.0
16 25.0 2 20.0
17 11.0 3 4.0
18 5.0 2 1.5
19 0.0 0 0.0
20 1.0 2 0.0
21 5.0 2 15.0
22 12.0 1 4.0
up Bb - Late-starter, Irregular Menstruation
1 7.0 3 2.0
2 9.0 1 12.0
3 4.0 2 12.0
4 21.0 3 0.0
5 1.0 3 18.5
KEY
OCP Oral contraceptive Pill
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Premenopausal Veteran Athletes
Training Details of All-Timer Athletes
Number Distance Run Time Trained Sessions
of Athlete Per Week Per Week per week
(miles) (hours)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 10 3.0 3.0
2 30 7.0 7.0
3 12 2.0 2.0
4 75 10.0 7.0
5 40 14.0 10.0
6 40 7.0 7.0
7 30 5.0 5.0
8 20 5.0 5.0
9 15 5.0 6.0
10 33 7.5 6.0
11 20 9.0 6.0
12 20 5.0 5.0
13 5 2.0 2.0
14 40 17.5 10.0
15 15 4.0 4.0
Group Ab - Always Athletic, Irregular Menstruation
1 17 4.0 4.0
2 50 12.0 12.0
3 45 9.0 6.0
4 50 8.0 7.0
5 20 4.0 5.0
6 52.5 19.0 15.0
7 35 8.0 8.0
8 40 6.0 6.0
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Premenopausal Veteran Athletes
Training Details of Late-Starter Athletes
Number Distance Run Time Trained Sessions
ofAthlete Per Week Per Week per week
(miles) (hours)
Group Ba - Late-starter, Always Eumenorrhoeic
1 30 6.0 5.0
2 30 7.0 9.0
3 10 5.0 7.0
4 30 11.0 8.0
5 30 9.0 9.0
6 40 7.0 5.0
7 50 9.0 6.0
8 12 6.0 6.0
9 25 5.0 5.0
10 25 5.0 5.0
11 40 7.0 6.0
12 60 11.0 8.0
13 10 10.0 8.0
14 12 4.0 4.0
15 50 9.0 6.0
16 40 7.8 9.0
17 60 10.0 8.0
18 35 4.0 6.0
19 25 6.0 6.0
20 25 6.0 7.0
21 25 4.0 4.0
22 25 5.0 8.0
Group Bb - Late-starter, Irregular Menstruation
1 33 5.0 5.0
2 35 5.5 6.0
3 40 5.0 5.0
4 30 8.5 9.0
5 18 5.0 5.0
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Premenopausal Veteran Athletes
Maximal Oxygen Uptake and Grip Strength of
Number V02max Grip Strength Grip Strength
of Athlete Dominant Non-Dominant
(ml.kg^min-1) Hand Hand
(Kgf) (Kgf)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 42.7 34.5 28.5
2 59.3 32.0 26.5
3 48.1 30.0 24.5
4 50.2 42.5 40.0
5 44.7 30.0 33.0
6 37.1 32.0 27.0
7 46.1 37.0 34.0
8 34.8 38.5 38.0
9 53.1 38.5 36.0
10 50.7 39.0 33.5
11 40.3 48.5 48.5
12 46.7 32.5 30.5
13 39.3 46.5 42.0
14 54.2 32.5 31.0
15 43.2 41.0 36.0
Group Ab - Always Athletic, Irregular Menstruation
1 44.8 31.0 30.0
2 55.7 30.5 26.0
3 52.2 35.5 34.0
4 63.1 34.5 34.0
5 40.0 36.5 34.0
6 53.4 28.0 29.5
7 44.7 36.0 33.5
8 53.1 34.5 32.0
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Premenopausal Veteran Athletes
Maximal Oxygen Uptake and Grip Strength of
Late-Starter Athletes
Number V02max Grip Strength Grip Strength
of Athlete Dominant Non-Dominant
(ml.kg"1.min"1) Hand Hand
(Kgf) (Kgf)
Group Ba - Late-starter, Always Eumenorrhoeic
1 51.6 37.0 33.0
2 48.2 40.0 35.0
3 51.0 37.0 32.0
4 43.7 39.5 36.5
5 46.5 27.0 22.0
6 41.4 35.0 31.5
7 41.0 29.0 27.5
8 38.8 32.0 30.5
9 40.1 40.0 37.0
10 44.0 29.5 24.0
11 43.8 40.0 34.5
12 55.1 35.5 31.5
13 36.2 32.5 30.0
14 33.8 37.0 34.0
15 41.6 31.0 24.0
16 52.1 33.5 32.0
17 58.1 33.0 31.5
18 50.9 38.5 36.0
19 50.7 38.0 34.5
20 39.5 27.0 23.0
21 Unwell 32.5 31.0
22 41.8 29.0 28.5
Group Bb - Late-starter, Irregular Menstruation
1 46.5 26.5 23.5
2 59.3 27.5 28.5
3 28.8 36.0 32.0
4 38.9 38.0 37.0
5 41.3 32.0 29.5
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Premenopausal Veteran Athletes
Dietary Calcium Intake and Serum Parameters of Bone Metabolism
Number Calcium Serum Serum Alkaline
ofAthlete Intake Calcium Phosphate Phosphatase
(mg.day_1) (mmol.1-1) (mmol.1"1) (mmol.1"1)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 1445 2.32 0.94 64
2 322 2.15 1.54 48
3 850 2.47 1.14 56
4 1462 2.18 1.05 67
5 1310 2.14 1.35 47
6 920 2.33 1.18 55
7 1028 2.13 1.34 58
8 1049 2.12 1.66 72
9 794 2.25 1.43 57
10 947 2.20 1.59 54
11 1325 2.20 1.65 86
12 943 2.22 1.17 58
13 976 2.32 1.38 46
14 1005 2.29 1.09 82
15 938 2.27 0.90 41
Group Ab - Always Athletic, Irregular Menstruation
1 1004 2.23 1.02 52
2 466 2.26 1.09 58
3 780 2.21 1.09 58
4 878 * * 58
5 93 2.28 1.15 60
6 606 2.31 1.27 100
7 893 2.21 1.07 56
8 1003 2.25 1.29 49
♦denotes incomplete data
Serum calcium corrected for serum albumin
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Premenopausal Veteran Athletes
Dietary Calcium Intake and Serum Parameters of Bone Metabolism
in Late-Starter Athletes
Number Calcium Serum Serum Alkaline
ofAthlete Intake Calcium Phosphate Phosphatase
(mg.day"1) (mmol.1*1) (mmol.1"1) (mmol.1"1)
Group Ba - Late-starter, Always Eumenorrhoeic
1 1150 2.22 1.05 66
2 486 2.25 1.08 57
3 1409 2.21 1.07 47
4 1186 2.25 1.31 46
5 616 2.20 1.24 65
6 1403 2.35 1.24 96
7 1389 2.29 1.37 61
8 980 2.30 1.21 46
9 1059 2.39 1.10 50
10 768 2.36 1.25 67
11 1083 2.31 1.34 59
12 1141 2.23 1.67 78
13 N/A 2.16 1.18 46
14 559 2.37 1.33 55
15 796 2.26 1.22 54
16 779 2.24 0.87 48
17 1831 2.28 1.25 71
18 1011 2.31 1.33 60
19 607 2.16 1.14 64
20 1194 2.27 1.28 87
21 1314 2.31 1.42 63
22 332 2.24 1.06 48
up Bb - Late-starter, Irregular Menstruation
1 1000 2.21 1.31 71
2 1106 2.31 1.54 62
3 949 2.32 1.36 71
4 1123 2.20 1.18 58
5 684 2.22 1.23 63
Serum calcium corrected for serum albumin
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Premenopausal Veteran Athletes
Back Strength ofAll-Timer Athletes
Number Peak Torque Peak Torque
ofAthlete Extension Flexion
(60o.sec_1) (180o.sec_1) ^Oo.sec"1) (ISOo.sec"1)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 197 182 118 107
2 134 113 118 102
3 117 76 144 77
4 176 150 149 155
5 233 237 186 188
6 149 141 126 89
7 156 237 159 198
8 226 220 150 165
9 279 327 165 161
10 152 186 183 175
11 127 171 171 195
12 150 73 119 69
13 267 156 159 175
14 95 144 164 153
15 134 104 133 140
Group Ab - Always Athletic, Irregular Menstruation
1 205 182 171 144
2 150 108 130 142
3 222 225 167 163
4 171 212 125 121
5 164 186 150 118
6 138 121 108 89
7 164 164 134 84
8 205 161 167 145
213
Premenopausal Veteran Athletes
Back Strength of Late-Starter Athletes
Number Peak Torque Peak Torque
of Athlete Extension Flexion
(60o.sec_1) (180o.sec"l) (60o.sec_1) (180o.sec~*)
Group Ba - Late-starter, Always Eumenorrhoeic
1 206 176 142 148
2 174 149 156 136
3 209 201 106 98
4 175 127 168 146
5 148 122 133 100
6 136 123 172 117
7 197 178 146 144
8 161 195 138 132
9 212 197 164 153
10 125 113 106 83
11 174 136 132 103
12 190 190 167 119
13 87 94 126 114
14 180 125 141 126
15 85 60 85 69
16 218 212 134 155
17 current back injury
18 175 152 117 104
19 183 142 153 152
20 123 133 117 92
21 121 106 99 72
22 155 203 156 171
Group Bb - Late-starter, Irregular Menstruation
1 129 157 125 104
2 179 149 152 142
3 207 209 149 164
4 175 163 119 133
5 167 133 140 85
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Premenopausal Veteran Athletes
Urinary Parameters of Bone Metabolism in All-Timer Athletes
Number Urinary Urinary Urinary Ca:creat OHPRrcreat
of Athlete Creatinine Calcium OHPR ratio ratio
(mmol.1"1) (mmol.1"1)














































Group Ab - Always Athletic, Irregular Menstruation
1 11.3 4.7 254.0 0.4 22.5
2 16.7 7.0 61.0 0.4 3.7
3 15.9 3.0 147.0 0.2 9.2
4 7.5 3.4 113.0 0.5 15.1
5 24.8 6.7 132.0 0.3 5.3
6 4.1 1.9 29.0 0.5 7.1
7 5.1 3.0 58.0 0.6 11.4
8 8.1 8.0 300.0 1.0 37.0
KEY





Urinary Parameters of Bone Metabolism in Late-Starter Athletes
Number Urinary Urinary Urinary Ca:creat OHPRrcreat
of Athlete Creatinine Calcium OHPR ratio ratio
(mmol.1"1) (mmol.H)
1 4.6 2.0 43.0 0.4 9.3
2 7.3 1.9 92.0 0.3 12.6
3 3.9 1.0 51.0 0.3 13.1
4 5.4 4.0 85.0 0.7 15.7
5 2.9 2.0 33.0 0.7 11.4
6 4.5 1.5 69.0 0.3 15.3
7 7.0 1.1 72.0 0.2 10.3
8 6.3 2.1 40.0 0.3 6.3
9 23.5 11.8 171.0 0.5 7.3
10 12.5 2.4 128.0 0.2 10.2
11 9.5 2.9 130.0 0.3 13.7
12 19.3 6.5 446.0 0.3 23.1
13 12.4 5.8 121.0 0.5 9.8
14 7.3 2.9 80.0 0.4 11.0
15 8.0 0.5 178.0 0.1 22.3
16 2.9 1.6 87.0 0.6 30.0
17 7.2 4.2 161.0 0.6 22.4
18 4.2 3.3 92.0 0.8 21.9
19 10.7 2.3 97.0 0.2 9.1
20 7.3 4.4 86.0 0.6 11.8
21 5.7 5.8 99.0 1.0 17.4
22 4.0 1.8 62.0 0.5 15.5
Group Bb - Late-starter, Irregular Menstruation
1 13.6 2.1 134.0 0.2 9.9
2 6.7 * 272.0 * 40.6
3 9.8 2.3 155.0 0.2 15.8
4 4.8 2.9 56.0 0.6 11.7





* denotes incomplete data
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Premenopausal Veteran Athletes
Sporting Details of All-Timer Athletes
Number Previous sport Sport now Level now
ofAthlete
Group Aa - Always Athletic, Always Eumenorrhoeic
1 Cycling 100/200/400 Club vets
2 MDR/Hockey LDR County
3 Race-walking Race-walking International (MR)
4 Long jump LDR National/GB Vets
5 Hockey/squash XC/Triathlon National vets
6 MDR LDR World vets
7 LDR/racquet LDR Club
8 Hockey Hockey Club
9 400/800 400/800 World vets (R+M)
10 800/1500/XC 800/1500/XC National vets (M)
11 400/800 400/200 National vets(M)
12 LDR/netball XC/LDR Club
13 Javelin Javelin World vets (M)
14 LDR LDR International(M)
15 LDR LDR Club vets
Group Ab - Always Athletic, Irregular Menstruation




3 XC/LDR LDR National vets
4 3000/5000 LDR World vets (M)
5 Keep Fit/Badmint LDR Club
6 Hockey/tennis/all LDR/Cycling County
7 Keep fit/squash LDR National vets
8 badminton MDR World vets
KEY
MDR - middle-distance running
LDR - long-distance running
XC - cross-country running
vets - veteran races
M - medal winner in class
R - record holder for age group
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Premenopausal Veteran Athletes
Sporting Details of Late-Starter Athletes
Number Previous sport Sport now Level now
ofAthlete
1 LDR Club
2 LDR World vets (M)
3 UD Walking International (R)
4 LDR/Badminton National vets
5 LDR International
6 LDR National vets
7 UD Walking International (M)




12 LDR World vets(M)
13 LDR/Aerobics Club
14 LDR Club
15 LDR World Vets (M)
16 MDR Nat(M),Euro vets
17 LDR International (M)
18 LDR National
















MDR - middle-distance running
LDR - long-distance running
XC - cross-countn' running
UD - ultra-distance
vets - veteran races
M - medal winner in class
R - record holder for age group
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Premenopausal Veteran Athletes
Bone Mineral Density of Neck of Femur ofAll-Timer Athletes
Number g.cm-2 Specified Z-score T-score
ofAthlete Density (SD) (SD)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 0.766 0.828 -0.505 -1.290
2 0.849 0.935 0.236 -0.450
3 0.850 0.936 0.288 -0.450
4 0.876 0.970 0.477 -0.190
5 0.688 0.732 -1.288 -2.070
6 1.108 1.295 2.692 2.130
7 0.927 1.038 0.911 0.330
8 0.921 1.030 0.856 0.270
9 1.142 1.347 2.752 2.480
10 0.846 0.931 0.228 -0.490
11 0.778 0.843 -0.378 -1.170
12 1.023 1.172 1.842 1.290
13 1.060 1.225 2.069 1.650
14 0.855 0.942 0.547 -0.400
15 0.808 0.881 -0.026 -0.870
Group Ab - Always Athletic, Irregular Menstruation
1 0.909 1.014 0.767 0.150
2 0.869 0.961 0.368 -0.250
3 0.903 1.006 0.732 0.080
4 0.896 0.997 0.624 0.020
5 0.836 0.918 0.108 -0.580
6 0.797 0.867 -0.265 -0.970
7 0.942 1.059 1.090 0.470
8 0.889 0.987 0.726 -0.060
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Premenopausal Veteran Athletes
Bone Mineral Density of Neck of Femur of Late-Starter Athletes
Number g.cnr2 Specified Z-score
of Athlete Density (SD)
Group Ba - Late-starter, Always Eumenorrhoeic
1 0.885 0.982 0.688
2 0.821 0.898 0.001
3 1.002 1.142 1.641
4 0.862 0.952 0.426
5 1.025 1.175 1.943
6 1.035 1.189 2.049
7 0.891 0.990 0.682
8 0.974 1.103 1.481
9 0.880 0.975 0.536
10 0.793 0.862 -0.285
11 0.983 1.115 1.560
12 0.701 0.747 -1.306
13 0.861 0.950 0.458
14 0.943 1.060 1.372
15 0.958 1.081 1.318
16 0.913 1.019 0.993
17 0.959 1.082 1.201
18 0.865 0.955 0.413
19 0.790 0.858 -0.295
20 0.910 1.015 0.839
21 0.855 0.942 0.274
22 0.910 1.015 0.881
Group Bb - Late-starter, Irregular Menstruation
1 0.749 0.807 -0.646
2 0.954 1.075 1.177
3 0.905 1.009 0.708
4 0.780 0.846 -0.441
































Bone Mineral Density of Trochanteric Region in
All-Timer Athletes
Number g.cmr2 Specified Z-score T-score
ofAthlete Density (SD) (SD)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 0.664 0.703 -0.463 -0.650
2 0.820 0.897 1.167 1.090
3 0.684 0.727 -0.237 -0.420
4 0.782 0.848 0.795 0.670
5 0.754 0.813 0.511 0.360
6 0.958 1.081 2.412 2.620
7 0.767 0.829 0.644 0.500
8 0.758 0.818 0.552 0.400
9 0.912 1.018 2.013 2.110
10 0.746 0.803 0.429 0.270
11 0.801 0.872 0.983 0.880
12 0.812 0.887 1.090 1.000
13 0.931 1.044 2.180 2.333
14 0.684 0.727 -0.237 -0.420
15 0.998 1.136 2.747 3.070
Group Ab - Always Athletic, Irregular Menstruation
1 0.776 0.841 0.735 0.600
2 0.732 0.786 0.283 0.110
3 0.775 0.839 0.725 0.590
4 0.763 0.824 0.603 0.460
5 0.763 0.824 0.603 0.450
6 0.587 0.612 -1.390 -1.490
7 0.728 0.781 0.240 0.060
8 0.800 0.871 0.973 0.870
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Premenopausal Veteran Athletes
Bone Mineral Density of Trochanteric Region in
Late-Starter Athletes
Number g.cnr2 Specified Z-score T-score
ofAthlete Density (SD) (SD)
Group Ba - Late-starter, Always Eumenorrhoeic
1 0.666 0.705 -0.440 -0.620
2 0.744 0.801 0.408 0.240
3 0.943 1.060 2.284 2.450
4 0.721 0.772 0.166 -0.010
5 0.839 0.921 1.347 1.300
6 0.837 0.919 1.329 1.270
7 0.695 0.740 -0.116 -0.300
8 0.790 0.858 0.874 0.750
9 0.796 0.866 0.934 0.830
10 0.716 0.766 0.112 -0.070
11 0.892 0.991 1.835 1.890
12 0.540 0.557 -2.010 -2.020
13 0.690 0.734 -0.171 -0.360
14 0.805 0.878 1.022 0.930
15 0.701 0.747 -0.050 -0.230
16 0.905 1.009 1.951 2.030
17 0.771 0.834 0.685 0.540
18 0.799 0.870 0.963 0.860
19 0.634 0.667 -0.813 -0.980
20 0.750 0.808 0.470 0.310
21 0.633 0.666 -0.825 -0.990
22 0.701 0.747 -0.050 -0.200
up Bb - Late-starter, Irregular Menstruation
1 0.701 0.747 -0.050 -0.230
2 0.794 0.864 0.914 0.800
3 0.731 0.784 0.272 0.100
4 0.588 0.613 -1.378 -1.490
5 0.800 0.871 0.973 0.860
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Premenopausal Veteran Athletes
Bone Mineral Density of Lumbar Spine in All-Timer Athletes
Number g.cm-2 Specified Z-score T-score
of Athlete Density (SD) (SD)
Group Aa - Always Athletic, Always Eumenorrhoeic
1 1.135 1.336 0.873 0.510
2 1.145 1.351 0.962 0.600
3 0.960 1.084 -0.799 -1.080
4 1.153 1.363 1.034 0.670
5 1.075 1.247 0.321 -0.040
6 1.403 1.773 3.132 2.950
7 1.263 1.536 1.987 1.670
8 1.080 1.254 0.368 0.010
9 1.123 1.318 0.764 0.400
10 0.987 1.121 -0.527 -0.840
11 1.170 1.389 1.185 0.830
12 1.327 1.642 2.519 2.260
13 1.570 2.085 4.425 4.460
14 0.910 1.015 -1.317 -1.540
15 1.124 1.319 0.773 0.410
Group Ab - Always Athletic, Irregular Menstruation
1 1.023 1.172 -0.174 -0.510
2 1.029 1.180 -0.116 -0.450
3 1.064 1.231 0.218 -0.140
4 1.021 1.169 -0.193 -0.530
5 1.027 1.177 -0.135 -0.470
6 0.906 1.010 -1.359 -1.570
7 1.039 1.195 -0.020 -0.360
8 1.088 1.266 0.443 0.080
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Premenopausal Veteran Athletes
Bone Mineral Density of Lumbar Spine in Late-Starter Athletes
Number g.cm"2 Specified Z-score
ofAthlete Density (SD)
Group Ba - Late-starter, Always Eumenorrhoeic
1 0.975 1.104 -0.647
2 1.039 1.195 -0.020
3 1.157 1.369 1.070
4 1.083 1.259 0.396
5 1.140 1.343 0.918
6 1.051 1.212 0.095
7 1.038 1.193 -0.029
8 1.196 1.430 1.413
9 1.068 1.237 0.256
10 1.035 1.189 -0.058
11 1.358 1.695 2.771
12 1.056 1.219 0.142
13 1.045 1.203 0.038
14 1.230 1.483 1.707
15 1.083 1.259 0.396
16 1.114 1.304 0.682
17 1.009 1.152 -0.310
18 0.997 1.135 -0.428
19 0.979 1.110 -0.607
20 1.145 1.351 0.962
21 1.010 1.153 -0.300
22 1.125 1.321 0.782
Group Bb - Late-starter, Irregular Menstruation
1 0.955 1.077 -0.850
2 1.122 1.316 0.755
3 1.271 1.549 2.055
4 0.891 0.990 -1.520
































Hormone Levels in All-Timer Athletes
Number of Oestradiol FSH
Athlete (pg.ml-1) (mIU.1"1)



























Serum Hormone Levels in Late-Starter Athletes
































Linear regression of BMD (g.cnr2) with possible independent variables
Factor Neck of Femur Trochanteric Lumbar Spine
F P F P F P
Age 1.590 0.210 0.200 0.660 0.040 0.84
Menstrual status 0.759 0.388 1.743 0.193 4.240 0.045
Height 2.760 0.100 6.150 0.017 3.450 0.070
Weight 0.610 0.440 0.240 0.630 2.980 0.090
Body Mass Index 0.040 0.840 1.000 0.320 0.510 0.480
%fat 0.860 0.360 2.470 0.120 0.020 0.880
Fat free mass 3.120 0.080 2.590 0.110 2.210 0.140
Years of eumenorrhoea 0.200 0.660 1.140 0.290 3.210 0.080
No. Pregnancies 2.600 0.110 4.000 0.051 5.240 0.030
Mths breastfeeding 1.570 0.220 1.220 0.280 0.000 1.000
Grip strength (dominant) 0.040 0.850 4.300 0.040 4.930 0.030
Grip stremgth (non-dom) 0.090 0.770 2.000 0.160 1.890 0.180
Miles run per week 1.050 0.310 3.270 0.080 2.530 0.120
Hours trained per week 3.870 0.060 6.480 0.014 6.710 0.013
Dietary calcium intake 0.000 0.980 0.000 0.960 0.050 0.820
Peak Torque ext 60,).sec~1 2.210 0.140 3.840 0.060 3.850 0.080
Peak Torque ext 1800.sec_1 0.300 0.580 0.830 0.370 0.100 0.760
Peak Torque flex 60°.sec_1 0.170 0.680 0.240 0.630 0.030 0.880
Peak Torque flex 180°.sec"1 0.660 0.420 0.490 0.490 0.620 0.430
V02max 0.520 0.480 0.240 0.630 6.650 0.013
*HPW minus 2 outliers 2.329 0.134 2.150 0.150





Linear regression analysis of BMD (Z-score) with possible independent
variables
Factor Neck of Femur Trochanteric Lumbar Spine
F P F P F P
Age 0.500 0.480 0.150 0.710 0.040 0.840
Menstrual status 1.060 0.310 1.570 0.220 4.520 0.039
Height 2.530 0.119 5.980 0.018 3.394 0.072
Weight 0.499 0.483 0.235 0.630 2.996 0.090
Body Mass Index 0.059 0.808 0.964 0.331 0.530 0.470
%fat 0.555 0.460 2.132 0.151 0.015 0.904
Years of eumenorrhoea 0.586 0.448 1.027 0.316 3.310 0.075
No. Pregnancies 2.475 0.122 3.980 0.052 5.216 0.027
Mths breastfeeding 1.503 0.226 1.273 0.265 0.006 0.937
Grip strength (dominant) 0.013 0.909 3.902 0.054 4.708 0.035
Grip stremgth (non-dom) 0.161 0.690 1.850 0.180 1.757 0.191
Miles run per week 1.199 0.279 3.293 0.076 2.488 0.121
Hours trained per week 3.568 0.065 6.805 0.012 7.055 0.011
\O7n1ax 0.730 0.397 0.276 0.602 6.619 0.013





Multiple regression analysis of BMD (Z-score) of trochanteric region of
proximal femur in premenopausal veteran athletes
Variable Sta ge 1 Sta ge 2
Fl,48 p-value Fl,46 p-value
Height 5.98 0.018 6.56 <0.05
Number of
pregnancies
3.98 0.052 2.78 NS
Grip strength
(dominant)
3.90 0.054 2.95 NS
Hours trained
per week
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Table 4
Multiple regression analysis of BMD (Z-score) of lumbar spine (L2-L4) in
premenopausal veteran athletes
Variable Sta ge 1 Sta ?e 2
Fl,48 p-value Fl,46 p-value
Height 3.39 0.0725 4.26 0.05
Number of
pregnancies
5.22 0.027 5.33 <0.05
Grip strength
(dominant)
4.71 0.035 3.08 NS
Hours trained
per week
7.06 0.011 6.52 <0.05
V02max
(ml.kg-t.min"1)
6.62 0.013 5.55 <0.05
Peak Torque
(ext. 60°sec *)
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APPENDIX 3




Number Age Height Weight Body Mass
of Athlete (years) (cm) (kg) Index
All-Timer Athletes
(kg.nr2)
1 58 161.0 58.5 22.57
2 55 164.0 57.0 21.19
3 49 170.0 56.0 19.38
4 58 173.0 74.0 24.73
5 51 170.0 65.5 22.66
6 51 163.5 53.9 20.16
7 61 161.0 56.0 21.60
8 49 165.9 55.9 20.31
9 55 182.0 75.5 22.79
10 59 161.0 56.3 21.72
Late-Starter Athletes
1 56 167.6 52.3 18.60
2 57 165.2 65.5 24.00
3 54 162.0 64.3 24.50
4 62 158.3 58.7 23.42
5 50 163.8 58.6 21.84
6 51 161.0 61.3 23.63
7 63 159.0 43.0 17.01
8 50 161.7 63.2 24.17
9 68 151.3 53.6 23.41
10 65 163.4 58.5 21.91
11 56 155.7 49.0 20.21
12 48 157.8 54.5 21.89
13 52 166.2 69.5 25.16



















1 29.2 2748.0 45.80 12.7 21.7 78.3
2 28.0 2484.0 41.40 14.6 25.6 72.6
3 19.9 3048.0 50.80 5.2 9.3 90.7
4 34.1 3408.0 56.80 17.2 23.2 76.8
5 30.9 2910.0 48.50 17.0 26.0 74.0
6 26.5 2245.5 37.40 16.5 30.6 69.4
7 32.7 2298.0 38.30 17.7 31.6 68.4
8 23.6 2852.4 47.54 8.4 15.0 85.0
9 28.0 3426.0 57.10 18.4 24.4 75.6
10 29.6 2334.0 38.90 17.1 30.4 69.1
Late-Starter Athletes
1 22.7 2760.0 46.00 6.3 12.0 88.0
2 34.1 2369.5 39.49 26.0 39.7 60.3
3 33.0 2429.7 40.50 23.8 37.0 63.0
4 34.0 2400.0 40.00 18.7 31.9 68.1
5 29.4 2354.9 39.25 19.4 33.0 67.0
6 32.0 * * * * 0.0
7 16.9 2142.0 35.70 7.3 17.0 83.0
8 31.3 2895.9 48.27 14.9 23.6 76.4
9 31.6 2190.0 36.50 17.1 31.9 68.1
10 27.5 2946.0 49.10 9.4 16.1 83.9
11 18.9 2703.6 45.10 3.9 8.0 92.0
12 23.6 2916.0 48.60 5.9 10.8 89.2
13 35.1 2832.0 47.20 22.3 32.1 67.9
14 29.2 2099.3 34.99 20.3 36.7 63.3




Number Age at Years of Years of Years
ofAthlete Menarche EU OL/AM PM
(years)
All-Timer Athletes
1 15.0 32.0 11.0 11.0
2 11.0 37.0 5.0 5.0
3 12.0 34.0 2.0 2.0
4 13.8 35.0 10.5 8.0
5 12.8 35.0 4.0 2.0
6 13.0 * * 1.0
7 14.8 31.0 15.0 15.0
8 12.0 32.0 5.5 1.5
9 15.0 35.0 7.0 3.0
10 15.0 34.0 23.0 12.0
Late-Starter Athletes
1 16.3 38.0 6.0 7.0
2 11.0 31.0 10.0 7.0
3 15.0 37.0 1.0 3.0
4 16.0 37.0 9.0 7.0
5 13.0 29.0 8.0 5.0
6 13.0 37.0 0.0 1.0
7 17.0 32.0 14.0 14.0
8 14.2 36.0 0.0 0.0
9 13.0 39.0 18.0 14.0
10 15.0 45.0 5.0 9.0
11 16.0 34.0 1.0 5.0
12 11.5 33.0 4.5 1.5
13 13.0 37.0 2.0 2.0
14 12.5 28.0 17.0 16.0
KEY
*data not available OL/AM: oligomenorrhoea or amenorrhoea




Number OCP use Parity Breast fed HRT ii
ofAthlete (years) (months) (yean
All-Timer Athletes
1 9.0 2 14.0 0.0
2 0.0 3 1.0 0.0
3 0.0 4 16.0 0.0
4 0.0 1 6.0 0.0
5 0.0 0 0.0 0.0
6 1.6 3 4.0 0.0
7 0.0 1 1.5 5.0
8 15.0 0 0.0 0.0
9 0.0 0 0.0 1.5
10 0.0 3 0.0 4.0
Late-Starter Athletes
1 0.0 2 9.0 1.0
2 0.0 1 1.5 0.0
3 0.0 4 17.0 2.0
4 0.0 5 10.0 0.0
5 0.5 3 9.0 0.5
6 17.0 2 3.0 0.0
7 10.0 2 0.3 0.0
8 4.5 3 0.0 0.0
9 0.0 4 24.0 0.0
10 0.0 0 0.0 6.0
11 2.0 2 14.0 0.0
12 5.0 2 10.0 0.0
13 0.0 0 0.0 0.0
14 2.0 2 0.0 2.0
KEY
OCP: oral contraceptive




Number Distance Run Time Trained Sessions Age Years of
of Athlete PerWeek Per Week per week Started Exercise
(miles) (hours)
All-Timer Athletes
1 24 8 4 40
2 50 9 10 37
3 32 5 5 31
4 N/A 10 5 40
5 30 4 8 33
6 24 5 5 33
7 70 11 11 43
8 40 10 7 31
9 35 6 4 37
10 20 5 5 41
Late-Starter Athletes
1 20 3 3 48 8
2 40 6 5 49 8
3 25 6 4 50 4
4 30 5 6 53 9
5 20 8 5 35 15
6 12 5 5 45 6
7 30 6 6 54 9
8 18 10 6 46 4
9 15 7 6 60 8
10 25 4 5 54 9
11 45 10 7 51 5
12 30 9 6 44 4
13 20 3 3 44 8
14 20 4 4 51 9
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Postmenopausal Athletes
Maximal Oxygen Uptake and Grip Strength
Number V02max Grip Strength Grip Strength




1 39.8 30.5 28.5
2 45.5 33.5 28.5
3 49.6 37.0 38.5
4 30.0 50.5 46.0
5 43.1 38.5 29.5
6 45.3 29.5 25.0
7 40.2 27.5 25.5
8 53.8 35.0 33.5
9 40.6 40.0 32.0
10 injured 30.5 30.0
Late-Starter Athletes
1 41.0 36.0 30.0
2 23.0 32.0 28.5
3 39.8 42.0 37.5
4 40.9 28.0 31.5
5 52.8 28.5 24.0
6 42.6 32.5 30.0
7 43.3 26.0 22.5
8 31.6 36.0 32.0
9 23.1 30.0 27.5
10 37.2 28.0 30.0
11 63.0 35.0 28.5
12 44.9 32.0 27.0
13 35.6 34.0 29.0
14 32.7 23.5 24.0
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Postmenopausal Athletes
Dietary Calcium Intake and Serum Parameters of Bone Metabolism
Number Calcium Serum Serum Alkaline
ofAthlete Intake Calcium Phosphate Phosphatase
(mg.day-1) (mmol.l"1) (mmol.l-1) (mmol.l"1)
All-Timer Athletes
1 828 2.30 1.12 88.0
2 1629 2.48 1.64 87.0
3 932 2.35 1.19 77.0
4 1200 2.27 1.17 76.0
5 892 2.37 1.15 76.0
6 563 2.24 1.11 68.0
7 1090 2.26 1.33 45.0
8 457 2.27 1.39 74.0
9 1237 2.24 1.50 75.0
10 1033 * * *
Late-Starter Athletes
1 973 2.27 0.97 50.0
2 872 2.32 1.41 124.0
3 885 2.28 1.20 64.0
4 1172 2.33 0.95 51.0
5 1013 2.43 1.36 86.0
6 922 2.32 1.24 63.0
7 1126 2.30 1.13 85.0
8 1038 2.26 1.34 82.0
9 1387 2.45 1.22 70.0
10 1222 2.31 1.42 104.0
11 1408 2.35 1.43 100.0
12 1037 2.33 1.39 88.0
13 877 2.23 1.60 81.0
14 1570 2.38 1.43 77.0























































































Urinary Parameters of Bone Metabolism
Number Urinary Urinary





1 7.0 2.8 133.00 0.40 19.00
2 7.3 2.9 150.00 0.40 20.55
3 12.2 3.6 229.00 0.30 18.77
4 5.8 1.4 103.00 0.24 17.76
5 7.6 2.6 131.00 0.34 17.24
6 5.2 3.2 125.00 0.62 24.04
7 6.0 1.2 150.00 0.20 25.00
8 8.5 4.2 120.00 0.49 14.12
9 14.0 6.1 45.00 0.44 3.21



















































Number Previous sport Sport now Level now
of Athlete
All-Timer Athletes
1 100/200/400 LDR World vets (6th 10k)
2 sprint hurdles LDR National vets
3 200/400/800 LD/MDR World vets (M)
4 discus/pent golf/keep fit/athletics World vets (MR)
5 Racquet sports LDR World vets (M)
6 Racquet sports LDR/golf Club vets
7 MDR LDR World vets (M+R)
8 800/1 mile 800/LDR National
9 Rowing LD walking Intl (MR)
10 100 - 800m LDR National vets
e-Starter Athletes
1 LDR World vets (M)
2 LDR Intl. vets
3 LDR Club vets
4 LDR National vets(M)
5 MDR/XC National vets
6 Tri (Run/Swim/Shoot) National vets(M)
7 LDR World vets (MR)
8 LDR Club
9 LDR World vets(M)
10 LDR World vets(M)
11 LDR World vets (M)
12 LDR Natl vets
13 LDR Club vets




M Medal winner at National or World Championships
R World record holder for that age group
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Postmenopausal Athletes
Bone Mineral Density of Neck of Femur
Number g.cnr2 Specified Z-score
of Athlete Density (SD)
All-Timer Athletes
1 0.729 0.782 -0.060
2 0.862 0.952 0.882
3 0.793 0.862 0.088
4 0.811 0.885 0.578
5 0.704 0.751 -0.800
6 0.705 0.752 -0.843
7 0.768 0.831 0.543
8 0.786 0.853 -0.006
9 0.783 0.850 0.046
10 0.648 0.683 -0.872
Late-Starter Athletes
1 0.694 0.739 -0.638
2 0.822 0.899 0.627
3 1.077 1.250 2.529
4 0.809 0.883 0.506
5 0.707 0.755 -0.608
6 0.822 0.899 0.306
7 0.553 0.572 -1.908
8 0.811 0.885 0.204
9 0.653 0.689 -0.709
10 0.831 0.911 0.817
11 0.662 0.700 -1.091
12 0.859 0.948 0.668
13 0.813 0.888 0.276































Bone Mineral Density of Trochanteric Region
Number g.cm"2 Specified Z-score
of Athlete Density (SD)
All-Timer Athletes
1 0.638 0.672 -0.188
2 0.635 0.668 -0.472
3 0.793 0.862 1.057
4 0.743 0.799 0.774
5 0.718 0.768 0.257
6 0.678 0.719 -0.202
7 0.601 0.628 -0.391
8 0.659 0.697 -0.376
9 0.655 0.692 -0.353
10 0.628 0.660 -0.247
Late-Starter Athletes
1 0.598 0.624 -0.759
2 0.767 0.829 0.988
3 0.822 0.899 1.416
4 0.596 0.622 -0.779
5 0.572 0.594 -1.101
6 0.808 0.881 1.178
7 0.426 0.430 -2.118
8 0.692 0.736 -0.057
9 0.499 0.511 -1.430
10 0.594 0.620 -0.714
11 0.589 0.614 -0.933
12 0.692 0.736 -0.036
13 0.660 0.698 -0.344































Bone Mineral Density of Lumbar Spine
Number g.cnr2 Specified Z-score Tscore
of Athlete Density (SD) (SD)
All-Timer Athletes
1 0.888 0.986 -0.090 -1.730
2 1.032 1.185 0.847 -0.420
3 1.032 1.185 0.757 -0.420
4 0.978 1.108 0.505 -0.920
5 1.105 1.291 1.390 0.240
6 1.111 1.300 1.427 0.290
7 0.839 0.921 -0.290 -1.990
8 0.922 1.032 -0.293 -1.430
9 0.856 0.944 -0.841 -2.030
10 0.824 0.902 -0.558 -2.320
Late-Starter Athletes
1 0.981 1.113 0.494 -0.890
2 0.986 1.120 0.535 -0.850
3 0.895 0.995 -0.460 -1.670
4 0.870 0.962 -0.445 -1.900
5 0.914 1.021 -0.165 -1.500
6 1.026 1.176 0.668 -0.480
7 0.783 0.850 -0.785 -2.690
8 1.021 1.169 0.622 -0.530
9 0.783 0.850 -0.785 -2.690
10 0.840 0.923 -0.592 -2.170
11 0.769 0.832 -1.556 -2.820
12 0.909 1.014 -0.421 -1.540
13 1.000 1.139 0.469 -0.720






Number of Oestradiol FSH




























DATA AND FURTHER STATISTICAL ANALYSIS FOR TREATMENT
INTERVENTION STUDY
In this appendix the following key applies:
1 1 st visit




Number of Age Number of menses
Athlete year before study
Treatment with HRT and Calcium
Years of Menstruation Follow-up
AM/OL During Study (months)
1 27 0 10 EU 9
2 28 0 7.5 EU 9
3 34 0 12 EU 9
4 29 0 7 EU 9
5 32 0 3 EU 11
6 19 4 3 EU 10
7 30 0 6 EU 8
Treatment with Calcium
1 27 9 1.5 EU 11
2 31 0 11 AM 25
3 18 0 1.5 AM 12
4 30 0 8 EU 9
5 32 0 4.5 OL 9
6 27 0 12 AM 9
7 34 0 11 OL 9
8 35 6 8 EU 9
9 34 4 9 EU 9
10 19 0 5 AM 10
Controls
1 35 0 17 AM 11
2 21 0 5 AM 16
3 18 6 1.5 EU 14
4 27 6 12 EU 9
5 25 0 4 OL 9
6 29 4 3 EU 10
7 22 0 6 AM 9
8 28 0 5 AM 9
9 20 0 7 AM 18
KEY
AM: amenorrhoeic (0-3 cycles per year) EU: eumenorrhoeic (10"'3 cycles per year)
OL: oligomenorrhoeic (4-9 cycles per year)
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Treatment Intervention Study
Treatment compliance and side effects
No. of SE's Compliance Comments
Athlete
Treatment with HRT and Calcium
1 yes Ca+HRT-90% Stopped HRT after 9 months.
2 yes Ca40%HRT30% Stopped HRT after 3 months. Remained EU
3 no Ca+HRT>90% Satisfied with treatment
4 yes Ca+HRT>90% Increased breast size and body weight
5 yes Ca+HRT>90% Tender breasts.Stopped HRT at 10 mths, then EU
6 no Ca+HRT>90% Pelvic stress fractures prevented running
7 yes Ca+HRT>90% Chronic fatigue attributed to HRT.Constipation ?Ca
Stopped treatment after 8 mths
Treatment with Calcium


















6 N/A HRT: hormone replacement therapy
7 N/A Ca: calcium





No. of Height Weight Weight BMI BMI Body Fat Body Fat
Athlete (cm) (kg) (kg) (kg.m-2) (kg.m-2) (%) (%)
12 1 2 12
Treatment with HRT and Calcium
1 165 52.0 52.7 19.1 19.4 17.6 16.6
2 159 50.6 50.0 20.0 19.8 21.5 21.9
3 166 54.0 53.8 19.6 19.5 20.2 18.8
4 156 58.0 57.8 23.8 23.8 25.2 22.7
5 162 52.3 55.0 19.9 21.0 20.6 21.8
6 161 45.3 46.6 17.5 18.0 15.4 16.9
7 175 63.0 63.1 20.6 20.6 20.6 21.9
Treatment with Calcium
1 169 57.0 56.4 20.0 19.7 25.7 24.8
2 169 53.9 52.9 18.9 18.5 21.1 17.8
3 166.5 48.7 48.7 17.6 17.5 12.6 10.2
4 163 48.0 51.6 18.1 19.4 17.9 16.4
5 156 51.5 51.6 21.2 21.2 24.7 23.1
6 164 37.6 37.5 14.0 13.9 7.1 6.2
7 165 52.0 53.0 19.1 19.5 15.9 17.8
8 166.5 57.5 59.5 20.7 21.5 25.1 24.4
9 166 56.0 57.0 20.3 20.7 23.2 23.7
10 164.5 48.7 48.9 18.0 18.1 16.8 17.4
Controls
1 165 50.0 52.5 18.4 19.3 15.2 16.8
2 166.5 44.5 45.1 16.1 16.3 11.3 12.8
3 163 63.5 N/A 23.9 N/A N/A N/A
4 163 48.5 47.8 18.3 18.0 18.6 16.6
5 160 52.7 50.8 20.6 19.8 24.5 21.7
6 156 50.2 50.5 20.6 20.8 21.7 19.9
7 172 59.2 59.9 20.0 20.2 15.6 16.3
8 156 46.0 46.2 18.9 19.0 13.8 15.5
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Treatment Intervention Study
Bone mineral density ofWards Triangle
Number of BMD BMD Change per Change per
Athlete (g.cm"2) (g.cm"2) Year Year
1 2 (g.cm"2) (%)
Treatment with HRT and Calcium
1 0.564 0.598 0.05 8.04
2 0.711 0.744 0.04 6.19
3 0.567 0.593 0.03 6.11
4 0.875 0.886 0.01 1.68
5 0.544 0.574 0.03 6.02
6 0.806 0.802 0.00 -0.60
7 0.863 0.848 -0.02 -2.61
Treatment with Calcium
1 0.622 0.684 0.07 10.87
2 0.701 0.683 -0.01 -1.23
3 0.719 0.667 -0.05 -7.23
4 0.548 0.542 -0.01 -1.46
5 0.589 0.623 0.05 7.70
6 0.623 0.582 -0.05 -8.77
7 0.696 0.709 0.02 2.49
8 0.602 0.586 -0.02 -3.54
9 0.611 0.702 0.12 19.86
10 0.849 0.814 -0.04 -4.95
Controls
1 0.726 0.708 -0.02 -2.70
2 0.736 0.649 -0.07 -8.87
3 0.919 0.933 0.01 1.31
4 1.006 0.996 -0.01 -1.33
5 0.608 0.624 0.02 3.51
6 0.763 0.78 0.02 2.67
7 0.758 0.744 -0.02 -2.46
8 0.7 0.678 -0.03 -4.19
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Treatment Intervention Study
Bone mineral density of Neck of Femur
Number of BMD BMD Change per Change per
Athlete (g.cnr2) (g.cnr2) Year Year
1 2 (g.cnr2) (%)
Treatment with HRT and
Calcium
1 0.763 0.77 0.009 1.223
2 0.796 0.77 -0.035 -4.355
3 0.772 0.762 -0.013 -1.727
4 0.962 0.952 -0.013 -1.386
5 0.711 0.726 0.016 2.301
6 0.816 0.82 0.005 0.588
7 0.968 0.961 -0.011 -1.085
Treatment with
Calcium
1 0.794 0.782 -0.013 -1.649
2 0.871 0.827 -0.021 -2.425
3 0.814 0.759 -0.055 -6.757
4 0.706 0.703 -0.004 -0.567
5 0.742 0.787 0.060 8.086
6 0.744 0.718 -0.035 -4.659
7 0.802 0.846 0.059 7.315
8 0.819 0.833 0.019 2.279
9 0.672 0.738 0.088 13.095
10 0.856 0.846 -0.012 -1.402
Controls
1 0.808 0.791 -0.019 -2.295
2 0.801 0.721 -0.060 -7.491
3 0.816 0.834 0.015 1.891
4 1.099 1.114 0.020 1.820
5 0.77 0.781 0.015 1.905
6 0.803 0.853 0.060 7.472
7 0.837 0.821 -0.021 -2.549
8 0.769 0.76 -0.012 -1.560
9 0.913 0.921 0.005 0.584
Treatment Intervention Study
Bone mineral density of Trochanteric Region
Number of BMD BMD Change per
Athlete (g.cnr2) (g.cnr2) Year
1 2 (g.cnr2)
Treatment with HRT and Calcium
1 0.697 0.727 0.040
2 0.620 0.637 0.023
3 0.523 0.531 0.011
4 0.886 0.885 -0.001
5 0.580 0.593 0.014
6 0.765 0.744 -0.025
7 0.774 0.782 0.012
Treatment with Calcium
1 0.665 0.667 0.002
2 0.601 0.606 0.002
3 0.782 0.729 -0.053
4 0.541 0.569 0.037
5 0.506 0.530 0.032
6 0.625 0.582 -0.057
7 0.704 0.720 0.021
8 0.709 0.696 -0.017
9 0.681 0.688 0.009
10 0.861 0.838 -0.028
Controls
1 0.636 0.593 -0.047
2 0.678 0.537 -0.106
3 0.728 0.752 0.021
4 0.856 0.863 0.009
5 0.581 0.607 0.035
6 0.737 0.729 -0.010
7 0.695 0.696 0.001
8 0.607 0.602 -0.007
































Bone mineral density of Lumbar Spine (L2-L4)
Number BMD BMD Change per Change per
of
Athlete (g.cnr2) (g.cnr2) Year Year
1 2 (g.cnr2) (%)
Treatment with HRT and Calcium
1 0.857 0.884 0.036 4.201
2 0.891 0.902 0.015 1.646
3 0.713 0.850 0.183 25.619
4 1.231 1.209 -0.029 -2.383
5 0.878 0.945 0.073 8.325
6 0.961 0.953 -0.010 -0.999
7 1.054 1.077 0.034 3.273
Treatment with Calcium
1 0.999 1.038 0.043 4.259
2 1.014 0.953 -0.029 -2.888
3 1.013 0.902 -0.111 -10.958
4 0.860 0.887 0.036 4.186
5 0.825 0.834 0.011 1.389
6 0.762 0.747 -0.020 -2.625
7 0.991 1.023 0.043 4.305
8 1.040 1.025 -0.020 -1.923
9 1.044 1.086 0.056 5.364

















































Distance run per week and maximal aerobic capacity (V02max)
Number of Distance run Distance run V02max V02max
Athlete per week per week (ml.kg~t.min~1) (ml.kg~t.min~1)
12 12
Treatment with HRT and Calcium
1 32 19 59.6 52.6
2 28 25 43.9 45.3
3 30 35 54.4 59.8
4 30 20 57.8 59.7
5 80 70 61.1 54.1
6 50 45 69.0 61.2
7 65 50 53.5 57.5
Treatment with Calcium
1 25 * 57.2 injured
2 85 60 63.1 unwell
3 50 60 injured injured
4 35 25 39.9 injured
5 40 40 55.5 50.5
6 90 90 60.7 54.5
7 80 65 59.4 56.2
8 55 65 50.2 47.8
9 40 40 51.7 55.6
10 50 50 66.3 65.5
Controls
1 70 25 58.3 45.63
2 60 60 70.8 injured
3 50 * 61.6 injured
4 38 26 56.3 58.1
5 45 60 59.0 64.1
6 70 50 65.4 64.3
7 30 25 57.6 62.8
8 55 55 61.0 injured
9 60 45 65.9 injured
* athlete currently resting due to injury/illness
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Treatment Intervention Study
Dietary Calcium Intake and Serum Parameters of Bone Metabolism
No. of Calcium Serum Serum Alkaline
Athlete Intake Calciu Phosphate Phosphatase
m
(mg.day"1) (mmol.H) (mmol.l"1) (mmol.l-1)
1 2 12 12 12
Treatment with HRT and Calcium
1 1215 2215 2.37 2.28 1.45 1.26 54 46
2 1935 1400 2.23 2.25 1.42 1.41 53 57
3 327 1327 2.35 2.3 1.17 1.08 77 51
4 766 1766 2.38 2.44 0.99 1.1 40 47
5 962 1962 2.33 2.32 1.03 1.23 85 83
6 1066 2066 2.37 2.35 1.11 1.21 63 61
7 630 1974 2.38 2.35 1.11 1 54 50
Treatment with Calcium
1 476 2205 2.23 2.28 0.9 1.43 63 71
2 1118 1903 2.37 2.29 1.4 1.27 67 75
3 1134 1874 2.21 2.19 1.28 1.25 43 55
4 587 1587 2.25 2.33 1.18 1.31 109 84
5 398 1398 2.39 2.3 1.1 1.19 69 45
6 933 1933 2.45 2.3 1.24 1.16 46 41
7 981 981 2.21 2.21 1.13 1.13 49 49
8 583 1583 2.29 2.4 1.19 1.32 37 46
9 1002 2000 2.31 2.25 1.02 1.28 47 40
10 942 1942 2.2 2.41 1.42 1.3 61 57
Controls
1 1009 1009 2.28 2.22 1.24 1.34 58 45
2 1355 886 2.45 2.18 1.23 1.01 35 48
3 1063
4 590 590 2.36 2.29 0.86 1.38 59 67
5 768 768 2.32 2.14 1.35 1.32 70 61
6 1814 1198 2.29 2.2 1.19 1.24 49 46
7 706 706 2.4 2.21 1.26 1.11 55 62
8 877 1254 2.33 2.22 1.3 1.49 63 53













Treatment with HRT and Calcium
1 157 1474 7.1 <0.2 218
2 157 861 0.5 7.8 134
3 174 858 10.3 7.7 185
4 161 1579 7.1 2.6 127
5 737 678 5.9 3.1 158
6 140 95 6 6 156
7 75 125 4.5 5.5 94
tment with Calcium
1 820 179 5.2 6.6 125
2 143 N/A 8.7 N/A 134
3 75 77 3.2 5.2 127
4 70 104 5.5 4.8 113
5 134 70 9.1 0.3 106
6 77 93 0.8 0.5 394
7 70 110 4.8 5.2 146
8 80 222 8.5 6.2 82
9 76 544 2.6 2.5 350
10 90 98 5.4 8.8 314
ntrols
1 70 80 3 4 94
2 70 70 1.6 N/A 209
3 70 N/A 1.1 N/A 115
4 763 N/A 8.7 N/A N/A
5 169 102 7.5 7 161
6 368 331 3.2 6.6 142
7 127 184 8.1 5.2 173
8 165 74 4.4 4.5 166
9 137 N/A 7.8 N/A 187
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Power calculations for a full study of the effectiveness of HRT in amenorrhoeic
athletes using Lumbar Spine BMD as the end-point
Calculation 1
Let us assume a true effect of 5% per year at the spine.
SD of an individual change = 6.37% of initial value per year (from Table 3c, Chapter 8)
Ifno dropouts and full attendance;
n > 2 ((u2a + u2p) ° / 80) 2
where 80 = 5%, a = 6.37, n = number in each group
U2a defines the sgnificance and U2p the power. For a power of 80% and significance of
5% they are 1.96 and 0.84.
Therefore n = 25
Calculation 2
However 30% 'converted' one way or another to the alternative group:
Group Density Change Average Change
Calcium/ non-treatment 70% no change
Regained menses 30% +5% 1.5%
HRT Continued 60% +5%
HRT Withdrew 40% no change 3.0%
Mean difference = + 1.5% = 80 so n > 280
However, non-attenders = 50% and n must be doubled to 560 in each group
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Calculation 3
Power calculation using amenorrhoeic athletes only:
Group Density Change Average Change
Calcium/ placebo 92% no change
Regained menses 8% +5% 0.4%
HRT Continued 60% +5%
HRT Withdrew 40% no change 3.0%
Mean difference = +2.6% = 80 so n > 94
However, non-attenders = 50% and n must be doubled to 188 in each group
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